id	sid	tid	token	lemma	pos
dti-1371	1	1	drug	drug	NOUN
dti-1371	1	2	target	target	NOUN
dti-1371	1	3	insights	insight	NOUN
dti-1371	1	4	2011:5	2011:5	NUM
dti-1371	1	5	33–41	33–41	NUM
dti-1371	1	6	doi	doi	NOUN
dti-1371	1	7	:	:	PUNCT
dti-1371	1	8	10.4137	10.4137	NUM
dti-1371	1	9	/	/	SYM
dti-1371	1	10	dti.s7527	dti.s7527	NOUN
dti-1371	1	11	this	this	DET
dti-1371	1	12	article	article	NOUN
dti-1371	1	13	is	be	AUX
dti-1371	1	14	available	available	ADJ
dti-1371	1	15	from	from	ADP
dti-1371	1	16	http://www.la-press.com	http://www.la-press.com	X
dti-1371	1	17	.	.	PUNCT
dti-1371	2	1	©	©	ADP
dti-1371	2	2	the	the	DET
dti-1371	2	3	author(s	author(s	PROPN
dti-1371	2	4	)	)	PUNCT
dti-1371	2	5	,	,	PUNCT
dti-1371	2	6	publisher	publisher	NOUN
dti-1371	2	7	and	and	CCONJ
dti-1371	2	8	licensee	licensee	PROPN
dti-1371	2	9	libertas	libertas	PROPN
dti-1371	2	10	academica	academica	PROPN
dti-1371	2	11	ltd	ltd	PROPN
dti-1371	2	12	.	.	PUNCT
dti-1371	3	1	this	this	PRON
dti-1371	3	2	is	be	AUX
dti-1371	3	3	an	an	DET
dti-1371	3	4	open	open	ADJ
dti-1371	3	5	access	access	NOUN
dti-1371	3	6	article	article	NOUN
dti-1371	3	7	.	.	PUNCT
dti-1371	4	1	unrestricted	unrestricted	ADJ
dti-1371	4	2	non	non	ADJ
dti-1371	4	3	-	-	ADJ
dti-1371	4	4	commercial	commercial	ADJ
dti-1371	4	5	use	use	NOUN
dti-1371	4	6	is	be	AUX
dti-1371	4	7	permitted	permit	VERB
dti-1371	4	8	provided	provide	VERB
dti-1371	4	9	the	the	DET
dti-1371	4	10	original	original	ADJ
dti-1371	4	11	work	work	NOUN
dti-1371	4	12	is	be	AUX
dti-1371	4	13	properly	properly	ADV
dti-1371	4	14	cited	cite	VERB
dti-1371	4	15	.	.	PUNCT
dti-1371	5	1	open	open	ADJ
dti-1371	5	2	access	access	NOUN
dti-1371	5	3	full	full	ADJ
dti-1371	5	4	open	open	ADJ
dti-1371	5	5	access	access	NOUN
dti-1371	5	6	to	to	ADP
dti-1371	5	7	this	this	PRON
dti-1371	5	8	and	and	CCONJ
dti-1371	5	9	thousands	thousand	NOUN
dti-1371	5	10	of	of	ADP
dti-1371	5	11	other	other	ADJ
dti-1371	5	12	papers	paper	NOUN
dti-1371	5	13	at	at	ADP
dti-1371	5	14	http://www.la-press.com	http://www.la-press.com	X
dti-1371	5	15	.	.	PUNCT
dti-1371	6	1	drug	drug	NOUN
dti-1371	6	2	target	target	NOUN
dti-1371	6	3	insights	insight	NOUN
dti-1371	6	4	o	o	NOUN
dti-1371	6	5	r	r	NOUN
dti-1371	7	1	i	i	PRON
dti-1371	7	2	g	g	VERB
dti-1371	8	1	i	i	PRON
dti-1371	8	2	n	n	CCONJ
dti-1371	8	3	a	a	DET
dti-1371	8	4	l	l	NOUN
dti-1371	8	5	r	r	NOUN
dti-1371	8	6	e	e	NOUN
dti-1371	8	7	s	s	X
dti-1371	8	8	e	e	X
dti-1371	8	9	a	a	DET
dti-1371	8	10	r	r	NOUN
dti-1371	8	11	c	c	NOUN
dti-1371	8	12	h	h	NOUN
dti-1371	8	13	drug	drug	NOUN
dti-1371	8	14	target	target	NOUN
dti-1371	8	15	insights	insight	NOUN
dti-1371	8	16	2011:5	2011:5	NUM
dti-1371	8	17	33	33	NUM
dti-1371	8	18	predictors	predictor	NOUN
dti-1371	8	19	of	of	ADP
dti-1371	8	20	virologic	virologic	ADJ
dti-1371	8	21	failure	failure	NOUN
dti-1371	8	22	in	in	ADP
dti-1371	8	23	hiv	hiv	PROPN
dti-1371	8	24	/	/	SYM
dti-1371	8	25	aids	aid	NOUN
dti-1371	8	26	patients	patient	NOUN
dti-1371	8	27	treated	treat	VERB
dti-1371	8	28	with	with	ADP
dti-1371	8	29	highly	highly	ADV
dti-1371	8	30	active	active	ADJ
dti-1371	8	31	antiretroviral	antiretroviral	ADJ
dti-1371	8	32	therapy	therapy	NOUN
dti-1371	8	33	in	in	ADP
dti-1371	8	34	brasília	brasília	PROPN
dti-1371	8	35	,	,	PUNCT
dti-1371	8	36	brazil	brazil	PROPN
dti-1371	8	37	during	during	ADP
dti-1371	8	38	2002–2008	2002–2008	NUM
dti-1371	8	39	edson	edson	PROPN
dti-1371	8	40	josé	josé	PROPN
dti-1371	8	41	monteiro	monteiro	PROPN
dti-1371	8	42	bello1	bello1	PROPN
dti-1371	8	43	,	,	PUNCT
dti-1371	8	44	amabel	amabel	VERB
dti-1371	8	45	fernandes	fernandes	PROPN
dti-1371	8	46	correia2	correia2	PROPN
dti-1371	8	47	,	,	PUNCT
dti-1371	8	48	josé	josé	PROPN
dti-1371	8	49	ricardo	ricardo	PROPN
dti-1371	8	50	pio	pio	PROPN
dti-1371	8	51	marins3	marins3	PROPN
dti-1371	8	52	,	,	PUNCT
dti-1371	8	53	edgar	edgar	PROPN
dti-1371	8	54	merchan	merchan	PROPN
dti-1371	8	55	-	-	PUNCT
dti-1371	8	56	hamann4	hamann4	PROPN
dti-1371	8	57	and	and	CCONJ
dti-1371	8	58	luis	luis	PROPN
dti-1371	8	59	isamu	isamu	PROPN
dti-1371	8	60	barros	barros	PROPN
dti-1371	9	1	kanzaki5	kanzaki5	PROPN
dti-1371	9	2	1m.sc	1m.sc	X
dti-1371	9	3	.	.	PUNCT
dti-1371	10	1	in	in	ADP
dti-1371	10	2	health	health	NOUN
dti-1371	10	3	sciences	science	NOUN
dti-1371	10	4	,	,	PUNCT
dti-1371	10	5	nucleus	nucleus	NOUN
dti-1371	10	6	of	of	ADP
dti-1371	10	7	virology	virology	NOUN
dti-1371	10	8	,	,	PUNCT
dti-1371	10	9	2	2	NUM
dti-1371	10	10	m.sc	m.sc	NOUN
dti-1371	10	11	in	in	ADP
dti-1371	10	12	health	health	NOUN
dti-1371	10	13	sciences	sciences	PROPN
dti-1371	10	14	nucleus	nucleus	PROPN
dti-1371	10	15	of	of	ADP
dti-1371	10	16	parasitology	parasitology	NOUN
dti-1371	10	17	,	,	PUNCT
dti-1371	10	18	central	central	ADJ
dti-1371	10	19	public	public	ADJ
dti-1371	10	20	health	health	NOUN
dti-1371	10	21	laboratory	laboratory	NOUN
dti-1371	10	22	,	,	PUNCT
dti-1371	10	23	brasilia	brasilia	PROPN
dti-1371	10	24	,	,	PUNCT
dti-1371	10	25	df	df	PROPN
dti-1371	10	26	,	,	PUNCT
dti-1371	10	27	brazil	brazil	PROPN
dti-1371	10	28	,	,	PUNCT
dti-1371	10	29	cep	cep	NOUN
dti-1371	10	30	70830	70830	NUM
dti-1371	10	31	-	-	SYM
dti-1371	10	32	010	010	NUM
dti-1371	10	33	.	.	PROPN
dti-1371	10	34	3	3	NUM
dti-1371	10	35	ph.d	ph.d	PROPN
dti-1371	10	36	secretary	secretary	PROPN
dti-1371	10	37	of	of	ADP
dti-1371	10	38	state	state	PROPN
dti-1371	10	39	for	for	ADP
dti-1371	10	40	health	health	NOUN
dti-1371	10	41	,	,	PUNCT
dti-1371	10	42	federal	federal	ADJ
dti-1371	10	43	district	district	NOUN
dti-1371	10	44	,	,	PUNCT
dti-1371	10	45	central	central	ADJ
dti-1371	10	46	public	public	ADJ
dti-1371	10	47	health	health	NOUN
dti-1371	10	48	laboratory	laboratory	NOUN
dti-1371	10	49	,	,	PUNCT
dti-1371	10	50	federal	federal	ADJ
dti-1371	10	51	district	district	NOUN
dti-1371	10	52	,	,	PUNCT
dti-1371	10	53	brasília	brasília	PROPN
dti-1371	10	54	,	,	PUNCT
dti-1371	10	55	df	df	PROPN
dti-1371	10	56	,	,	PUNCT
dti-1371	10	57	brazil	brazil	PROPN
dti-1371	10	58	,	,	PUNCT
dti-1371	10	59	cep	cep	NOUN
dti-1371	10	60	70058	70058	NUM
dti-1371	10	61	-	-	SYM
dti-1371	10	62	900	900	NUM
dti-1371	10	63	.	.	X
dti-1371	10	64	4	4	NUM
dti-1371	10	65	ph.d	ph.d	NOUN
dti-1371	10	66	departament	departament	NOUN
dti-1371	10	67	of	of	ADP
dti-1371	10	68	public	public	ADJ
dti-1371	10	69	health	health	NOUN
dti-1371	10	70	,	,	PUNCT
dti-1371	10	71	faculty	faculty	NOUN
dti-1371	10	72	of	of	ADP
dti-1371	10	73	health	health	NOUN
dti-1371	10	74	sciences	sciences	PROPN
dti-1371	10	75	,	,	PUNCT
dti-1371	10	76	5d.sc	5d.sc	NOUN
dti-1371	10	77	.	.	PUNCT
dti-1371	11	1	laboratory	laboratory	NOUN
dti-1371	11	2	of	of	ADP
dti-1371	11	3	bioprospection	bioprospection	NOUN
dti-1371	11	4	,	,	PUNCT
dti-1371	11	5	university	university	PROPN
dti-1371	11	6	of	of	ADP
dti-1371	11	7	brasilia	brasilia	PROPN
dti-1371	11	8	,	,	PUNCT
dti-1371	11	9	brasília	brasília	PROPN
dti-1371	11	10	,	,	PUNCT
dti-1371	11	11	df	df	PROPN
dti-1371	11	12	,	,	PUNCT
dti-1371	11	13	brazil	brazil	PROPN
dti-1371	11	14	,	,	PUNCT
dti-1371	11	15	cep	cep	NOUN
dti-1371	11	16	70910	70910	NUM
dti-1371	11	17	-	-	SYM
dti-1371	11	18	900	900	NUM
dti-1371	11	19	.	.	PUNCT
dti-1371	12	1	corresponding	correspond	VERB
dti-1371	12	2	author	author	NOUN
dti-1371	12	3	email	email	NOUN
dti-1371	12	4	:	:	PUNCT
dti-1371	13	1	kanzaki@unb.br	kanzaki@unb.br	PROPN
dti-1371	13	2	abstract	abstract	NOUN
dti-1371	13	3	:	:	PUNCT
dti-1371	13	4	little	little	ADJ
dti-1371	13	5	data	datum	NOUN
dti-1371	13	6	exists	exist	VERB
dti-1371	13	7	concerning	concern	VERB
dti-1371	13	8	the	the	DET
dti-1371	13	9	efficacy	efficacy	NOUN
dti-1371	13	10	of	of	ADP
dti-1371	13	11	the	the	DET
dti-1371	13	12	antiretroviral	antiretroviral	ADJ
dti-1371	13	13	therapy	therapy	NOUN
dti-1371	13	14	in	in	ADP
dti-1371	13	15	the	the	DET
dti-1371	13	16	federal	federal	ADJ
dti-1371	13	17	district	district	NOUN
dti-1371	13	18	in	in	ADP
dti-1371	13	19	brazil	brazil	PROPN
dti-1371	13	20	,	,	PUNCT
dti-1371	13	21	therefore	therefore	ADV
dti-1371	13	22	in	in	ADP
dti-1371	13	23	order	order	NOUN
dti-1371	13	24	to	to	PART
dti-1371	13	25	improve	improve	VERB
dti-1371	13	26	hiv	hiv	PROPN
dti-1371	13	27	/	/	SYM
dti-1371	13	28	aids	aids	PROPN
dti-1371	13	29	patients	patient	NOUN
dti-1371	13	30	’	'	PUNCT
dti-1371	13	31	therapy	therapy	NOUN
dti-1371	13	32	and	and	CCONJ
dti-1371	13	33	to	to	PART
dti-1371	13	34	pinpoint	pinpoint	VERB
dti-1371	13	35	hot	hot	ADJ
dti-1371	13	36	spots	spot	NOUN
dti-1371	13	37	in	in	ADP
dti-1371	13	38	the	the	DET
dti-1371	13	39	treatment	treatment	NOUN
dti-1371	13	40	,	,	PUNCT
dti-1371	13	41	this	this	DET
dti-1371	13	42	research	research	NOUN
dti-1371	13	43	work	work	NOUN
dti-1371	13	44	was	be	AUX
dti-1371	13	45	conducted	conduct	VERB
dti-1371	13	46	.	.	PUNCT
dti-1371	14	1	of	of	ADP
dti-1371	14	2	139	139	NUM
dti-1371	14	3	hiv	hiv	PROPN
dti-1371	14	4	/	/	SYM
dti-1371	14	5	aids	aid	NOUN
dti-1371	14	6	patients	patient	NOUN
dti-1371	14	7	submitted	submit	VERB
dti-1371	14	8	to	to	ADP
dti-1371	14	9	the	the	DET
dti-1371	14	10	highly	highly	ADV
dti-1371	14	11	active	active	ADJ
dti-1371	14	12	antiretroviral	antiretroviral	ADJ
dti-1371	14	13	therapy	therapy	NOUN
dti-1371	14	14	,	,	PUNCT
dti-1371	14	15	12.2	12.2	NUM
dti-1371	14	16	%	%	NOUN
dti-1371	14	17	failed	fail	VERB
dti-1371	14	18	virologically	virologically	ADV
dti-1371	14	19	.	.	PUNCT
dti-1371	15	1	the	the	DET
dti-1371	15	2	significant	significant	ADJ
dti-1371	15	3	associated	associate	VERB
dti-1371	15	4	factors	factor	NOUN
dti-1371	15	5	related	relate	VERB
dti-1371	15	6	to	to	ADP
dti-1371	15	7	unresponsiveness	unresponsiveness	NOUN
dti-1371	15	8	to	to	ADP
dti-1371	15	9	the	the	DET
dti-1371	15	10	lentiviral	lentiviral	ADJ
dti-1371	15	11	treatment	treatment	NOUN
dti-1371	15	12	were	be	AUX
dti-1371	15	13	:	:	PUNCT
dti-1371	15	14	patients	patient	NOUN
dti-1371	15	15	’	'	PUNCT
dti-1371	15	16	place	place	NOUN
dti-1371	15	17	of	of	ADP
dti-1371	15	18	origin	origin	NOUN
dti-1371	15	19	(	(	PUNCT
dti-1371	15	20	or	or	CCONJ
dti-1371	15	21	=	=	SYM
dti-1371	15	22	3.28	3.28	NUM
dti-1371	15	23	;	;	PUNCT
dti-1371	15	24	ic95	ic95	PROPN
dti-1371	15	25	%	%	NOUN
dti-1371	15	26	=	=	SYM
dti-1371	15	27	1.0–9.73	1.0–9.73	NUM
dti-1371	15	28	;	;	PUNCT
dti-1371	15	29	p	p	X
dti-1371	15	30	=	=	NOUN
dti-1371	15	31	0.032	0.032	NUM
dti-1371	15	32	)	)	PUNCT
dti-1371	15	33	and	and	CCONJ
dti-1371	15	34	mycobacterium	mycobacterium	NOUN
dti-1371	15	35	tuberculosis	tuberculosis	NOUN
dti-1371	15	36	infection	infection	NOUN
dti-1371	15	37	(	(	PUNCT
dti-1371	15	38	rr	rr	NOUN
dti-1371	15	39	=	=	SYM
dti-1371	15	40	2.90	2.90	NUM
dti-1371	15	41	;	;	PUNCT
dti-1371	15	42	ic95	ic95	PROPN
dti-1371	15	43	%	%	NOUN
dti-1371	15	44	=	=	SYM
dti-1371	15	45	1.19–7.02	1.19–7.02	NUM
dti-1371	15	46	;	;	PUNCT
dti-1371	15	47	p	p	X
dti-1371	15	48	=	=	NOUN
dti-1371	15	49	0.019	0.019	NUM
dti-1371	15	50	)	)	PUNCT
dti-1371	15	51	.	.	PUNCT
dti-1371	16	1	in	in	ADP
dti-1371	16	2	the	the	DET
dti-1371	16	3	logistic	logistic	ADJ
dti-1371	16	4	regression	regression	NOUN
dti-1371	16	5	analysis	analysis	NOUN
dti-1371	16	6	,	,	PUNCT
dti-1371	16	7	the	the	DET
dti-1371	16	8	remaining	remain	VERB
dti-1371	16	9	variables	variable	NOUN
dti-1371	16	10	in	in	ADP
dti-1371	16	11	the	the	DET
dti-1371	16	12	model	model	NOUN
dti-1371	16	13	were	be	AUX
dti-1371	16	14	:	:	PUNCT
dti-1371	16	15	patients	patient	NOUN
dti-1371	16	16	’	'	PUNCT
dti-1371	16	17	birthplace	birthplace	NOUN
dti-1371	16	18	(	(	PUNCT
dti-1371	16	19	or	or	CCONJ
dti-1371	16	20	=	=	SYM
dti-1371	16	21	3.28	3.28	NUM
dti-1371	16	22	;	;	PUNCT
dti-1371	16	23	ic95	ic95	PROPN
dti-1371	16	24	%	%	NOUN
dti-1371	16	25	=	=	SYM
dti-1371	16	26	1.10–9.73	1.10–9.73	PROPN
dti-1371	16	27	;	;	PUNCT
dti-1371	16	28	p	p	X
dti-1371	16	29	=	=	NOUN
dti-1371	16	30	0.032	0.032	NUM
dti-1371	16	31	)	)	PUNCT
dti-1371	16	32	and	and	CCONJ
dti-1371	16	33	tuberculosis	tuberculosis	PRON
dti-1371	16	34	comorbidity	comorbidity	NOUN
dti-1371	16	35	(	(	PUNCT
dti-1371	16	36	or	or	CCONJ
dti-1371	16	37	=	=	SYM
dti-1371	16	38	3.82	3.82	NUM
dti-1371	16	39	;	;	PUNCT
dti-1371	16	40	ic95	ic95	PROPN
dti-1371	16	41	%	%	NOUN
dti-1371	16	42	=	=	SYM
dti-1371	16	43	1.19–12.22	1.19–12.22	NUM
dti-1371	16	44	;	;	PUNCT
dti-1371	16	45	p	p	PROPN
dti-1371	16	46	=	=	NOUN
dti-1371	16	47	0.024	0.024	NUM
dti-1371	16	48	)	)	PUNCT
dti-1371	16	49	.	.	PUNCT
dti-1371	17	1	the	the	DET
dti-1371	17	2	patients	patient	NOUN
dti-1371	17	3	enrolled	enrol	VERB
dti-1371	17	4	in	in	ADP
dti-1371	17	5	this	this	DET
dti-1371	17	6	survey	survey	NOUN
dti-1371	17	7	had	have	VERB
dti-1371	17	8	an	an	DET
dti-1371	17	9	88.0	88.0	NUM
dti-1371	17	10	%	%	NOUN
dti-1371	17	11	therapeutic	therapeutic	ADJ
dti-1371	17	12	success	success	NOUN
dti-1371	17	13	rate	rate	NOUN
dti-1371	17	14	for	for	ADP
dti-1371	17	15	the	the	DET
dti-1371	17	16	maximum	maximum	ADJ
dti-1371	17	17	period	period	NOUN
dti-1371	17	18	of	of	ADP
dti-1371	17	19	one	one	NUM
dti-1371	17	20	year	year	NOUN
dti-1371	17	21	of	of	ADP
dti-1371	17	22	treatment	treatment	NOUN
dti-1371	17	23	,	,	PUNCT
dti-1371	17	24	predicting	predict	VERB
dti-1371	17	25	that	that	SCONJ
dti-1371	17	26	t	t	PROPN
dti-1371	17	27	cd4	cd4	PROPN
dti-1371	17	28	+	+	PROPN
dti-1371	17	29	low	low	ADJ
dti-1371	17	30	values	value	NOUN
dti-1371	17	31	and	and	CCONJ
dti-1371	17	32	elevated	elevate	VERB
dti-1371	17	33	viral	viral	ADJ
dti-1371	17	34	loads	load	NOUN
dti-1371	17	35	at	at	ADP
dti-1371	17	36	pretreatment	pretreatment	NOUN
dti-1371	17	37	should	should	AUX
dti-1371	17	38	be	be	AUX
dti-1371	17	39	particularly	particularly	ADV
dti-1371	17	40	considered	consider	VERB
dti-1371	17	41	in	in	ADP
dti-1371	17	42	tuberculosis	tuberculosis	NOUN
dti-1371	17	43	coinfection	coinfection	NOUN
dti-1371	17	44	,	,	PUNCT
dti-1371	17	45	besides	besides	SCONJ
dti-1371	17	46	the	the	DET
dti-1371	17	47	availability	availability	NOUN
dti-1371	17	48	of	of	ADP
dti-1371	17	49	new	new	ADJ
dti-1371	17	50	antiretroviral	antiretroviral	ADJ
dti-1371	17	51	drugs	drug	NOUN
dti-1371	17	52	displaying	display	VERB
dti-1371	17	53	optimal	optimal	ADJ
dti-1371	17	54	activity	activity	NOUN
dti-1371	17	55	both	both	CCONJ
dti-1371	17	56	in	in	ADP
dti-1371	17	57	viral	viral	ADJ
dti-1371	17	58	suppression	suppression	NOUN
dti-1371	17	59	and	and	CCONJ
dti-1371	17	60	immunological	immunological	ADJ
dti-1371	17	61	reconstitution	reconstitution	NOUN
dti-1371	17	62	.	.	PUNCT
dti-1371	18	1	keywords	keyword	NOUN
dti-1371	18	2	:	:	PUNCT
dti-1371	18	3	antiretroviral	antiretroviral	ADJ
dti-1371	18	4	therapy	therapy	NOUN
dti-1371	18	5	,	,	PUNCT
dti-1371	18	6	tuberculosis	tuberculosis	NOUN
dti-1371	18	7	coinfection	coinfection	NOUN
dti-1371	18	8	,	,	PUNCT
dti-1371	18	9	brasilia	brasilia	PROPN
dti-1371	18	10	,	,	PUNCT
dti-1371	18	11	epidemiology	epidemiology	NOUN
dti-1371	18	12	http://dx.doi.org/10.4137/dti.s7527	http://dx.doi.org/10.4137/dti.s7527	NOUN
dti-1371	18	13	http://www.la-press.com	http://www.la-press.com	X
dti-1371	18	14	http://www.la-press.com	http://www.la-press.com	X
dti-1371	18	15	http://www.la-press.com/drug-target-insights-journal-j23	http://www.la-press.com/drug-target-insights-journal-j23	PROPN
dti-1371	18	16	http://www.la-press.com	http://www.la-press.com	X
dti-1371	18	17	mailto:kanzaki@unb.br	mailto:kanzaki@unb.br	PROPN
dti-1371	18	18	bello	bello	PROPN
dti-1371	18	19	et	et	PROPN
dti-1371	18	20	al	al	PROPN
dti-1371	18	21	34	34	NUM
dti-1371	18	22	drug	drug	NOUN
dti-1371	18	23	target	target	NOUN
dti-1371	18	24	insights	insight	NOUN
dti-1371	18	25	2011:5	2011:5	NUM
dti-1371	18	26	introduction	introduction	NOUN
dti-1371	18	27	plasmatic	plasmatic	ADJ
dti-1371	18	28	viral	viral	ADJ
dti-1371	18	29	load	load	NOUN
dti-1371	18	30	strongly	strongly	ADV
dti-1371	18	31	predicts	predict	VERB
dti-1371	18	32	t	t	PROPN
dti-1371	18	33	cd4	cd4	PROPN
dti-1371	18	34	+	+	PROPN
dti-1371	18	35	cell	cell	NOUN
dti-1371	18	36	count	count	NOUN
dti-1371	18	37	decline	decline	NOUN
dti-1371	18	38	,	,	PUNCT
dti-1371	18	39	aids	aid	NOUN
dti-1371	18	40	progression	progression	NOUN
dti-1371	18	41	and	and	CCONJ
dti-1371	18	42	death	death	NOUN
dti-1371	18	43	.	.	PUNCT
dti-1371	19	1	anyway	anyway	ADV
dti-1371	19	2	,	,	PUNCT
dti-1371	19	3	disease	disease	NOUN
dti-1371	19	4	prognosis	prognosis	NOUN
dti-1371	19	5	in	in	ADP
dti-1371	19	6	hiv	hiv	PROPN
dti-1371	19	7	infected	infected	ADJ
dti-1371	19	8	subjects	subject	NOUN
dti-1371	19	9	is	be	AUX
dti-1371	19	10	more	more	ADV
dti-1371	19	11	rigorously	rigorously	ADV
dti-1371	19	12	defined	define	VERB
dti-1371	19	13	by	by	ADP
dti-1371	19	14	the	the	DET
dti-1371	19	15	combination	combination	NOUN
dti-1371	19	16	of	of	ADP
dti-1371	19	17	plasmatic	plasmatic	ADJ
dti-1371	19	18	viral	viral	ADJ
dti-1371	19	19	load	load	NOUN
dti-1371	19	20	quantification	quantification	NOUN
dti-1371	19	21	and	and	CCONJ
dti-1371	19	22	t	t	NOUN
dti-1371	19	23	cd4	cd4	PROPN
dti-1371	19	24	+	+	PROPN
dti-1371	19	25	cell	cell	NOUN
dti-1371	19	26	count.1	count.1	SCONJ
dti-1371	19	27	it	it	PRON
dti-1371	19	28	is	be	AUX
dti-1371	19	29	internationally	internationally	ADV
dti-1371	19	30	noted	note	VERB
dti-1371	19	31	that	that	SCONJ
dti-1371	19	32	the	the	DET
dti-1371	19	33	main	main	ADJ
dti-1371	19	34	predictive	predictive	ADJ
dti-1371	19	35	factors	factor	NOUN
dti-1371	19	36	for	for	ADP
dti-1371	19	37	failure	failure	NOUN
dti-1371	19	38	of	of	ADP
dti-1371	19	39	antiretroviral	antiretroviral	ADJ
dti-1371	19	40	therapy	therapy	NOUN
dti-1371	19	41	are	be	AUX
dti-1371	19	42	t	t	PROPN
dti-1371	19	43	cd4	cd4	PROPN
dti-1371	19	44	+	+	PROPN
dti-1371	19	45	cells	cell	NOUN
dti-1371	19	46	low	low	ADJ
dti-1371	19	47	count	count	NOUN
dti-1371	19	48	and	and	CCONJ
dti-1371	19	49	elevated	elevated	ADJ
dti-1371	19	50	viral	viral	ADJ
dti-1371	19	51	load	load	NOUN
dti-1371	19	52	before	before	ADP
dti-1371	19	53	commencing	commence	VERB
dti-1371	19	54	treatment.2	treatment.2	NOUN
dti-1371	19	55	the	the	DET
dti-1371	19	56	efficacy	efficacy	NOUN
dti-1371	19	57	of	of	ADP
dti-1371	19	58	the	the	DET
dti-1371	19	59	highly	highly	ADV
dti-1371	19	60	active	active	ADJ
dti-1371	19	61	antiretroviral	antiretroviral	ADJ
dti-1371	19	62	therapy	therapy	NOUN
dti-1371	19	63	(	(	PUNCT
dti-1371	19	64	haart	haart	PROPN
dti-1371	19	65	)	)	PUNCT
dti-1371	19	66	and	and	CCONJ
dti-1371	19	67	the	the	DET
dti-1371	19	68	pattern	pattern	NOUN
dti-1371	19	69	of	of	ADP
dti-1371	19	70	therapy	therapy	NOUN
dti-1371	19	71	management	management	NOUN
dti-1371	19	72	could	could	AUX
dti-1371	19	73	be	be	AUX
dti-1371	19	74	evaluated	evaluate	VERB
dti-1371	19	75	based	base	VERB
dti-1371	19	76	on	on	ADP
dti-1371	19	77	plasmatic	plasmatic	ADJ
dti-1371	19	78	rna	rna	NOUN
dti-1371	19	79	viral	viral	ADJ
dti-1371	19	80	load	load	NOUN
dti-1371	19	81	assessement	assessement	NOUN
dti-1371	19	82	.	.	PUNCT
dti-1371	20	1	in	in	ADP
dti-1371	20	2	hiv	hiv	PROPN
dti-1371	20	3	/	/	SYM
dti-1371	20	4	aids	aids	PROPN
dti-1371	20	5	treatment	treatment	NOUN
dti-1371	20	6	the	the	DET
dti-1371	20	7	response	response	NOUN
dti-1371	20	8	is	be	AUX
dti-1371	20	9	considered	consider	VERB
dti-1371	20	10	successful	successful	ADJ
dti-1371	20	11	when	when	SCONJ
dti-1371	20	12	the	the	DET
dti-1371	20	13	hiv	hiv	PROPN
dti-1371	20	14	rna	rna	PROPN
dti-1371	20	15	levels	level	NOUN
dti-1371	20	16	remain	remain	VERB
dti-1371	20	17	undetectable	undetectable	ADJ
dti-1371	20	18	by	by	ADP
dti-1371	20	19	certified	certified	ADJ
dti-1371	20	20	commercial	commercial	ADJ
dti-1371	20	21	assays	assay	NOUN
dti-1371	20	22	,	,	PUNCT
dti-1371	20	23	notwithstanding	notwithstanding	ADP
dti-1371	20	24	in	in	ADP
dti-1371	20	25	a	a	DET
dti-1371	20	26	variable	variable	ADJ
dti-1371	20	27	proportion	proportion	NOUN
dti-1371	20	28	of	of	ADP
dti-1371	20	29	haart	haart	PROPN
dti-1371	20	30	submitted	submit	VERB
dti-1371	20	31	patients	patient	NOUN
dti-1371	20	32	,	,	PUNCT
dti-1371	20	33	the	the	DET
dti-1371	20	34	viral	viral	ADJ
dti-1371	20	35	replication	replication	NOUN
dti-1371	20	36	and	and	CCONJ
dti-1371	20	37	evolution	evolution	NOUN
dti-1371	20	38	goes	go	VERB
dti-1371	20	39	on	on	ADP
dti-1371	20	40	which	which	PRON
dti-1371	20	41	could	could	AUX
dti-1371	20	42	eventually	eventually	ADV
dti-1371	20	43	contribute	contribute	VERB
dti-1371	20	44	to	to	ADP
dti-1371	20	45	the	the	DET
dti-1371	20	46	development	development	NOUN
dti-1371	20	47	of	of	ADP
dti-1371	20	48	antiretroviral	antiretroviral	ADJ
dti-1371	20	49	drug	drug	NOUN
dti-1371	20	50	resistance	resistance	NOUN
dti-1371	20	51	and	and	CCONJ
dti-1371	20	52	therapeutic	therapeutic	ADJ
dti-1371	20	53	failure.3	failure.3	NOUN
dti-1371	20	54	unsuccessful	unsuccessful	ADJ
dti-1371	20	55	antiretroviral	antiretroviral	ADJ
dti-1371	20	56	therapy	therapy	NOUN
dti-1371	20	57	could	could	AUX
dti-1371	20	58	occur	occur	VERB
dti-1371	20	59	due	due	ADJ
dti-1371	20	60	to	to	ADP
dti-1371	20	61	virologic	virologic	ADJ
dti-1371	20	62	and	and	CCONJ
dti-1371	20	63	immunologic	immunologic	ADJ
dti-1371	20	64	failure	failure	NOUN
dti-1371	20	65	and	and	CCONJ
dti-1371	20	66	clinical	clinical	ADJ
dti-1371	20	67	manifestations	manifestation	NOUN
dti-1371	20	68	that	that	PRON
dti-1371	20	69	can	can	AUX
dti-1371	20	70	appear	appear	VERB
dti-1371	20	71	during	during	ADP
dti-1371	20	72	the	the	DET
dti-1371	20	73	course	course	NOUN
dti-1371	20	74	of	of	ADP
dti-1371	20	75	hiv	hiv	PROPN
dti-1371	20	76	infection	infection	NOUN
dti-1371	20	77	.	.	PUNCT
dti-1371	21	1	the	the	DET
dti-1371	21	2	identification	identification	NOUN
dti-1371	21	3	of	of	ADP
dti-1371	21	4	therapeutic	therapeutic	ADJ
dti-1371	21	5	failure	failure	NOUN
dti-1371	21	6	is	be	AUX
dti-1371	21	7	based	base	VERB
dti-1371	21	8	on	on	ADP
dti-1371	21	9	patient	patient	ADJ
dti-1371	21	10	follow	follow	NOUN
dti-1371	21	11	-	-	PUNCT
dti-1371	21	12	up	up	NOUN
dti-1371	21	13	during	during	ADP
dti-1371	21	14	treatment	treatment	NOUN
dti-1371	21	15	,	,	PUNCT
dti-1371	21	16	taking	take	VERB
dti-1371	21	17	into	into	ADP
dti-1371	21	18	account	account	NOUN
dti-1371	21	19	the	the	DET
dti-1371	21	20	initial	initial	ADJ
dti-1371	21	21	level	level	NOUN
dti-1371	21	22	of	of	ADP
dti-1371	21	23	t	t	PROPN
dti-1371	21	24	cd4	cd4	PROPN
dti-1371	21	25	+	+	PROPN
dti-1371	21	26	,	,	PUNCT
dti-1371	21	27	plasmatic	plasmatic	ADJ
dti-1371	21	28	hiv	hiv	PROPN
dti-1371	21	29	rna	rna	NOUN
dti-1371	21	30	load	load	NOUN
dti-1371	21	31	and	and	CCONJ
dti-1371	21	32	the	the	DET
dti-1371	21	33	patient	patient	ADJ
dti-1371	21	34	clinical	clinical	ADJ
dti-1371	21	35	evolution	evolution	NOUN
dti-1371	21	36	.	.	PUNCT
dti-1371	22	1	also	also	ADV
dti-1371	22	2	,	,	PUNCT
dti-1371	22	3	many	many	ADJ
dti-1371	22	4	factors	factor	NOUN
dti-1371	22	5	could	could	AUX
dti-1371	22	6	be	be	AUX
dti-1371	22	7	related	relate	VERB
dti-1371	22	8	to	to	ADP
dti-1371	22	9	therapeutic	therapeutic	ADJ
dti-1371	22	10	failure	failure	NOUN
dti-1371	22	11	such	such	ADJ
dti-1371	22	12	as	as	ADP
dti-1371	22	13	low	low	ADJ
dti-1371	22	14	treatment	treatment	NOUN
dti-1371	22	15	adhesion	adhesion	NOUN
dti-1371	22	16	,	,	PUNCT
dti-1371	22	17	insufficient	insufficient	ADJ
dti-1371	22	18	drug	drug	NOUN
dti-1371	22	19	dosage	dosage	NOUN
dti-1371	22	20	,	,	PUNCT
dti-1371	22	21	mal	mal	ADJ
dti-1371	22	22	-	-	NOUN
dti-1371	22	23	absorption	absorption	NOUN
dti-1371	22	24	,	,	PUNCT
dti-1371	22	25	hiv	hiv	PROPN
dti-1371	22	26	antiretroviral	antiretroviral	ADJ
dti-1371	22	27	resistance	resistance	NOUN
dti-1371	22	28	and	and	CCONJ
dti-1371	22	29	drug	drug	NOUN
dti-1371	22	30	interactions	interaction	NOUN
dti-1371	22	31	that	that	PRON
dti-1371	22	32	could	could	AUX
dti-1371	22	33	reduce	reduce	VERB
dti-1371	22	34	the	the	DET
dti-1371	22	35	efficacy	efficacy	NOUN
dti-1371	22	36	and	and	CCONJ
dti-1371	22	37	hiv	hiv	PROPN
dti-1371	22	38	resistance	resistance	NOUN
dti-1371	22	39	to	to	ADP
dti-1371	22	40	antiretroviral	antiretroviral	ADJ
dti-1371	22	41	medications	medication	NOUN
dti-1371	22	42	.	.	PUNCT
dti-1371	23	1	patients	patient	NOUN
dti-1371	23	2	that	that	PRON
dti-1371	23	3	failed	fail	VERB
dti-1371	23	4	to	to	PART
dti-1371	23	5	respond	respond	VERB
dti-1371	23	6	to	to	ADP
dti-1371	23	7	antiretroviral	antiretroviral	ADJ
dti-1371	23	8	therapy	therapy	NOUN
dti-1371	23	9	confirmed	confirm	VERB
dti-1371	23	10	by	by	ADP
dti-1371	23	11	the	the	DET
dti-1371	23	12	genotype	genotype	NOUN
dti-1371	23	13	resistant	resistant	ADJ
dti-1371	23	14	assay	assay	NOUN
dti-1371	23	15	will	will	AUX
dti-1371	23	16	be	be	AUX
dti-1371	23	17	guided	guide	VERB
dti-1371	23	18	to	to	PART
dti-1371	23	19	choose	choose	VERB
dti-1371	23	20	new	new	ADJ
dti-1371	23	21	drugs	drug	NOUN
dti-1371	23	22	.	.	PUNCT
dti-1371	24	1	this	this	DET
dti-1371	24	2	choice	choice	NOUN
dti-1371	24	3	is	be	AUX
dti-1371	24	4	based	base	VERB
dti-1371	24	5	on	on	ADP
dti-1371	24	6	the	the	DET
dti-1371	24	7	knowledge	knowledge	NOUN
dti-1371	24	8	of	of	ADP
dti-1371	24	9	previous	previous	ADJ
dti-1371	24	10	treatments	treatment	NOUN
dti-1371	24	11	and	and	CCONJ
dti-1371	24	12	yet	yet	ADV
dti-1371	24	13	the	the	DET
dti-1371	24	14	reason	reason	NOUN
dti-1371	24	15	to	to	PART
dti-1371	24	16	remove	remove	VERB
dti-1371	24	17	a	a	DET
dti-1371	24	18	drug	drug	NOUN
dti-1371	24	19	from	from	ADP
dti-1371	24	20	the	the	DET
dti-1371	24	21	antiretroviral	antiretroviral	ADJ
dti-1371	24	22	regimen	regimen	NOUN
dti-1371	24	23	is	be	AUX
dti-1371	24	24	mainly	mainly	ADV
dti-1371	24	25	justified	justify	VERB
dti-1371	24	26	by	by	ADP
dti-1371	24	27	the	the	DET
dti-1371	24	28	in	in	ADV
dti-1371	24	29	vitro	vitro	X
dti-1371	24	30	antiretroviral	antiretroviral	ADJ
dti-1371	24	31	resistance	resistance	NOUN
dti-1371	24	32	profile	profile	NOUN
dti-1371	24	33	.	.	PUNCT
dti-1371	25	1	the	the	DET
dti-1371	25	2	antiretroviral	antiretroviral	ADJ
dti-1371	25	3	therapeutic	therapeutic	ADJ
dti-1371	25	4	suspension	suspension	NOUN
dti-1371	25	5	as	as	ADP
dti-1371	25	6	an	an	DET
dti-1371	25	7	alternative	alternative	ADJ
dti-1371	25	8	therapy	therapy	NOUN
dti-1371	25	9	is	be	AUX
dti-1371	25	10	based	base	VERB
dti-1371	25	11	on	on	ADP
dti-1371	25	12	the	the	DET
dti-1371	25	13	reemergence	reemergence	NOUN
dti-1371	25	14	of	of	ADP
dti-1371	25	15	the	the	DET
dti-1371	25	16	initial	initial	ADJ
dti-1371	25	17	virus	virus	NOUN
dti-1371	25	18	population	population	NOUN
dti-1371	25	19	before	before	ADP
dti-1371	25	20	treatment	treatment	NOUN
dti-1371	25	21	initiation	initiation	NOUN
dti-1371	25	22	,	,	PUNCT
dti-1371	25	23	which	which	PRON
dti-1371	25	24	would	would	AUX
dti-1371	25	25	be	be	AUX
dti-1371	25	26	susceptible	susceptible	ADJ
dti-1371	25	27	to	to	ADP
dti-1371	25	28	the	the	DET
dti-1371	25	29	antiretroviral	antiretroviral	ADJ
dti-1371	25	30	drugs	drug	NOUN
dti-1371	25	31	earlier	early	ADV
dti-1371	25	32	prescribed	prescribe	VERB
dti-1371	25	33	,	,	PUNCT
dti-1371	25	34	so	so	SCONJ
dti-1371	25	35	this	this	DET
dti-1371	25	36	proposal	proposal	NOUN
dti-1371	25	37	is	be	AUX
dti-1371	25	38	presently	presently	ADV
dti-1371	25	39	under	under	ADP
dti-1371	25	40	evaluation	evaluation	NOUN
dti-1371	25	41	.	.	PUNCT
dti-1371	26	1	the	the	DET
dti-1371	26	2	essential	essential	ADJ
dti-1371	26	3	objective	objective	NOUN
dti-1371	26	4	of	of	ADP
dti-1371	26	5	treatment	treatment	NOUN
dti-1371	26	6	in	in	ADP
dti-1371	26	7	patients	patient	NOUN
dti-1371	26	8	presenting	present	VERB
dti-1371	26	9	therapeutic	therapeutic	ADJ
dti-1371	26	10	failure	failure	NOUN
dti-1371	26	11	is	be	AUX
dti-1371	26	12	to	to	PART
dti-1371	26	13	maintain	maintain	VERB
dti-1371	26	14	t	t	PROPN
dti-1371	26	15	cd4	cd4	PROPN
dti-1371	26	16	+	+	CCONJ
dti-1371	26	17	acceptable	acceptable	ADJ
dti-1371	26	18	cell	cell	NOUN
dti-1371	26	19	population	population	NOUN
dti-1371	26	20	density	density	NOUN
dti-1371	26	21	,	,	PUNCT
dti-1371	26	22	whilst	whilst	SCONJ
dti-1371	26	23	new	new	ADJ
dti-1371	26	24	therapeutic	therapeutic	ADJ
dti-1371	26	25	options	option	NOUN
dti-1371	26	26	are	be	AUX
dti-1371	26	27	awaited	await	VERB
dti-1371	26	28	,	,	PUNCT
dti-1371	26	29	contrary	contrary	ADV
dti-1371	26	30	to	to	ADP
dti-1371	26	31	the	the	DET
dti-1371	26	32	priority	priority	NOUN
dti-1371	26	33	aim	aim	VERB
dti-1371	26	34	to	to	PART
dti-1371	26	35	reach	reach	VERB
dti-1371	26	36	and	and	CCONJ
dti-1371	26	37	keep	keep	VERB
dti-1371	26	38	up	up	ADP
dti-1371	26	39	an	an	DET
dti-1371	26	40	undetectable	undetectable	ADJ
dti-1371	26	41	viral	viral	ADJ
dti-1371	26	42	load.4	load.4	NOUN
dti-1371	26	43	according	accord	VERB
dti-1371	26	44	to	to	ADP
dti-1371	26	45	moore	moore	PROPN
dti-1371	26	46	et	et	PROPN
dti-1371	26	47	al,5	al,5	ADV
dti-1371	26	48	virological	virological	ADJ
dti-1371	26	49	failure	failure	NOUN
dti-1371	26	50	is	be	AUX
dti-1371	26	51	characterized	characterize	VERB
dti-1371	26	52	by	by	ADP
dti-1371	26	53	viral	viral	ADJ
dti-1371	26	54	load	load	NOUN
dti-1371	26	55	higher	high	ADJ
dti-1371	26	56	than	than	ADP
dti-1371	26	57	400	400	NUM
dti-1371	26	58	copies	copy	NOUN
dti-1371	26	59	/	/	SYM
dti-1371	26	60	ml	ml	NOUN
dti-1371	26	61	after	after	ADP
dti-1371	26	62	48	48	NUM
dti-1371	26	63	weeks	week	NOUN
dti-1371	26	64	of	of	ADP
dti-1371	26	65	initial	initial	ADJ
dti-1371	26	66	treatment	treatment	NOUN
dti-1371	26	67	or	or	CCONJ
dti-1371	26	68	among	among	ADP
dti-1371	26	69	subjects	subject	NOUN
dti-1371	26	70	that	that	PRON
dti-1371	26	71	had	have	VERB
dti-1371	26	72	complete	complete	ADJ
dti-1371	26	73	viral	viral	ADJ
dti-1371	26	74	suppression	suppression	NOUN
dti-1371	26	75	,	,	PUNCT
dti-1371	26	76	but	but	CCONJ
dti-1371	26	77	later	later	ADV
dti-1371	26	78	on	on	ADP
dti-1371	26	79	the	the	DET
dti-1371	26	80	viral	viral	ADJ
dti-1371	26	81	load	load	NOUN
dti-1371	26	82	will	will	AUX
dti-1371	26	83	recrudesce	recrudesce	VERB
dti-1371	26	84	.	.	PUNCT
dti-1371	27	1	the	the	DET
dti-1371	27	2	viral	viral	ADJ
dti-1371	27	3	failure	failure	NOUN
dti-1371	27	4	precedes	precede	VERB
dti-1371	27	5	the	the	DET
dti-1371	27	6	immunologic	immunologic	ADJ
dti-1371	27	7	failure	failure	NOUN
dti-1371	27	8	which	which	PRON
dti-1371	27	9	is	be	AUX
dti-1371	27	10	defined	define	VERB
dti-1371	27	11	by	by	ADP
dti-1371	27	12	a	a	DET
dti-1371	27	13	decline	decline	NOUN
dti-1371	27	14	of	of	ADP
dti-1371	27	15	more	more	ADJ
dti-1371	27	16	than	than	ADP
dti-1371	27	17	25.0	25.0	NUM
dti-1371	27	18	%	%	NOUN
dti-1371	27	19	in	in	ADP
dti-1371	27	20	the	the	DET
dti-1371	27	21	subsequent	subsequent	ADJ
dti-1371	27	22	count	count	NOUN
dti-1371	27	23	of	of	ADP
dti-1371	27	24	t	t	PROPN
dti-1371	27	25	cd4	cd4	PROPN
dti-1371	27	26	+	+	PROPN
dti-1371	27	27	lymphocytes	lymphocyte	NOUN
dti-1371	27	28	or	or	CCONJ
dti-1371	27	29	regresion	regresion	NOUN
dti-1371	27	30	to	to	ADP
dti-1371	27	31	the	the	DET
dti-1371	27	32	initial	initial	ADJ
dti-1371	27	33	t	t	PROPN
dti-1371	27	34	cd4	cd4	PROPN
dti-1371	27	35	+	+	PROPN
dti-1371	27	36	cell	cell	NOUN
dti-1371	27	37	count	count	NOUN
dti-1371	27	38	before	before	ADP
dti-1371	27	39	treatment	treatment	NOUN
dti-1371	27	40	.	.	PUNCT
dti-1371	28	1	these	these	DET
dti-1371	28	2	conditions	condition	NOUN
dti-1371	28	3	are	be	AUX
dti-1371	28	4	mainly	mainly	ADV
dti-1371	28	5	suggestive	suggestive	ADJ
dti-1371	28	6	of	of	ADP
dti-1371	28	7	immunologic	immunologic	ADJ
dti-1371	28	8	failure	failure	NOUN
dti-1371	28	9	but	but	CCONJ
dti-1371	28	10	laboratory	laboratory	NOUN
dti-1371	28	11	analysis	analysis	NOUN
dti-1371	28	12	confirmation	confirmation	NOUN
dti-1371	28	13	is	be	AUX
dti-1371	28	14	mandatory.6	mandatory.6	PROPN
dti-1371	28	15	cozzi	cozzi	ADJ
dti-1371	28	16	-	-	PUNCT
dti-1371	28	17	lepri	lepri	NOUN
dti-1371	28	18	et	et	NOUN
dti-1371	28	19	al7	al7	PROPN
dti-1371	28	20	concluded	conclude	VERB
dti-1371	28	21	that	that	SCONJ
dti-1371	28	22	patients	patient	NOUN
dti-1371	28	23	remaining	remain	VERB
dti-1371	28	24	in	in	ADP
dti-1371	28	25	haart	haart	PROPN
dti-1371	28	26	failure	failure	NOUN
dti-1371	28	27	presented	present	VERB
dti-1371	28	28	viral	viral	ADJ
dti-1371	28	29	load	load	NOUN
dti-1371	28	30	slowly	slowly	ADV
dti-1371	28	31	progressing	progress	VERB
dti-1371	28	32	during	during	ADP
dti-1371	28	33	the	the	DET
dti-1371	28	34	next	next	ADJ
dti-1371	28	35	12	12	NUM
dti-1371	28	36	months	month	NOUN
dti-1371	28	37	,	,	PUNCT
dti-1371	28	38	differently	differently	ADV
dti-1371	28	39	to	to	ADP
dti-1371	28	40	t	t	PROPN
dti-1371	28	41	cd4	cd4	PROPN
dti-1371	28	42	+	+	PROPN
dti-1371	28	43	cell	cell	NOUN
dti-1371	28	44	count	count	NOUN
dti-1371	28	45	which	which	PRON
dti-1371	28	46	remained	remain	VERB
dti-1371	28	47	stable	stable	ADJ
dti-1371	28	48	.	.	PUNCT
dti-1371	29	1	the	the	DET
dti-1371	29	2	impact	impact	NOUN
dti-1371	29	3	of	of	ADP
dti-1371	29	4	haart	haart	PROPN
dti-1371	29	5	on	on	ADP
dti-1371	29	6	t	t	PROPN
dti-1371	29	7	cd4	cd4	PROPN
dti-1371	29	8	+	+	PROPN
dti-1371	29	9	cell	cell	NOUN
dti-1371	29	10	count	count	NOUN
dti-1371	29	11	and	and	CCONJ
dti-1371	29	12	viral	viral	ADJ
dti-1371	29	13	load	load	NOUN
dti-1371	29	14	of	of	ADP
dti-1371	29	15	hiv	hiv	PROPN
dti-1371	29	16	infected	infect	VERB
dti-1371	29	17	patients	patient	NOUN
dti-1371	29	18	has	have	AUX
dti-1371	29	19	been	be	AUX
dti-1371	29	20	demonstrated	demonstrate	VERB
dti-1371	29	21	to	to	PART
dti-1371	29	22	improve	improve	VERB
dti-1371	29	23	the	the	DET
dti-1371	29	24	patient	patient	NOUN
dti-1371	29	25	’s	’s	PART
dti-1371	29	26	immunological	immunological	ADJ
dti-1371	29	27	status	status	NOUN
dti-1371	29	28	and	and	CCONJ
dti-1371	29	29	it	it	PRON
dti-1371	29	30	also	also	ADV
dti-1371	29	31	diminished	diminish	VERB
dti-1371	29	32	the	the	DET
dti-1371	29	33	viral	viral	ADJ
dti-1371	29	34	load	load	NOUN
dti-1371	29	35	,	,	PUNCT
dti-1371	29	36	interrupting	interrupt	VERB
dti-1371	29	37	the	the	DET
dti-1371	29	38	aids	aid	NOUN
dti-1371	29	39	progression.8	progression.8	NOUN
dti-1371	29	40	however	however	ADV
dti-1371	29	41	there	there	PRON
dti-1371	29	42	are	be	VERB
dti-1371	29	43	crucial	crucial	ADJ
dti-1371	29	44	limitations	limitation	NOUN
dti-1371	29	45	of	of	ADP
dti-1371	29	46	haart	haart	PROPN
dti-1371	29	47	regimen	regiman	NOUN
dti-1371	29	48	,	,	PUNCT
dti-1371	29	49	as	as	SCONJ
dti-1371	29	50	it	it	PRON
dti-1371	29	51	does	do	AUX
dti-1371	29	52	not	not	PART
dti-1371	29	53	eradicate	eradicate	VERB
dti-1371	29	54	viral	viral	ADJ
dti-1371	29	55	infection	infection	NOUN
dti-1371	29	56	despite	despite	SCONJ
dti-1371	29	57	long	long	ADV
dti-1371	29	58	and	and	CCONJ
dti-1371	29	59	permanent	permanent	ADJ
dti-1371	29	60	antiretroviral	antiretroviral	ADJ
dti-1371	29	61	therapy	therapy	NOUN
dti-1371	29	62	.	.	PUNCT
dti-1371	30	1	consequently	consequently	ADV
dti-1371	30	2	,	,	PUNCT
dti-1371	30	3	a	a	DET
dti-1371	30	4	significant	significant	ADJ
dti-1371	30	5	number	number	NOUN
dti-1371	30	6	of	of	ADP
dti-1371	30	7	these	these	DET
dti-1371	30	8	patients	patient	NOUN
dti-1371	30	9	on	on	ADP
dti-1371	30	10	haart	haart	PROPN
dti-1371	30	11	therapy	therapy	NOUN
dti-1371	30	12	develop	develop	VERB
dti-1371	30	13	viral	viral	ADJ
dti-1371	30	14	resistance	resistance	NOUN
dti-1371	30	15	to	to	ADP
dti-1371	30	16	the	the	DET
dti-1371	30	17	drugs	drug	NOUN
dti-1371	30	18	besides	besides	SCONJ
dti-1371	30	19	diverse	diverse	ADJ
dti-1371	30	20	side	side	NOUN
dti-1371	30	21	effects	effect	NOUN
dti-1371	30	22	including	include	VERB
dti-1371	30	23	metabolic	metabolic	NOUN
dti-1371	30	24	disorders	disorder	NOUN
dti-1371	30	25	.	.	PUNCT
dti-1371	31	1	therefore	therefore	ADV
dti-1371	31	2	new	new	ADJ
dti-1371	31	3	approaches	approach	NOUN
dti-1371	31	4	are	be	AUX
dti-1371	31	5	necessary	necessary	ADJ
dti-1371	31	6	to	to	PART
dti-1371	31	7	control	control	VERB
dti-1371	31	8	and/or	and/or	CCONJ
dti-1371	31	9	eradicate	eradicate	VERB
dti-1371	31	10	hiv	hiv	PROPN
dti-1371	31	11	infection.9,10	infection.9,10	PROPN
dti-1371	31	12	this	this	DET
dti-1371	31	13	research	research	NOUN
dti-1371	31	14	work	work	NOUN
dti-1371	31	15	aimed	aim	VERB
dti-1371	31	16	to	to	PART
dti-1371	31	17	analyze	analyze	VERB
dti-1371	31	18	t	t	PROPN
dti-1371	31	19	cd4	cd4	PROPN
dti-1371	31	20	+	+	PROPN
dti-1371	31	21	cell	cell	NOUN
dti-1371	31	22	density	density	NOUN
dti-1371	31	23	and	and	CCONJ
dti-1371	31	24	viral	viral	ADJ
dti-1371	31	25	load	load	NOUN
dti-1371	31	26	response	response	NOUN
dti-1371	31	27	in	in	ADP
dti-1371	31	28	hiv	hiv	PROPN
dti-1371	31	29	infected	infect	VERB
dti-1371	31	30	patients	patient	NOUN
dti-1371	31	31	undergoing	undergo	VERB
dti-1371	31	32	different	different	ADJ
dti-1371	31	33	therapeutic	therapeutic	ADJ
dti-1371	31	34	regimens	regimen	NOUN
dti-1371	31	35	which	which	PRON
dti-1371	31	36	failed	fail	VERB
dti-1371	31	37	virologically	virologically	ADV
dti-1371	31	38	,	,	PUNCT
dti-1371	31	39	and	and	CCONJ
dti-1371	31	40	also	also	ADV
dti-1371	31	41	the	the	DET
dti-1371	31	42	associated	associated	ADJ
dti-1371	31	43	factors	factor	NOUN
dti-1371	31	44	to	to	ADP
dti-1371	31	45	it	it	PRON
dti-1371	31	46	during	during	ADP
dti-1371	31	47	2002–2008	2002–2008	NUM
dti-1371	31	48	in	in	ADP
dti-1371	31	49	brasilia	brasilia	PROPN
dti-1371	31	50	,	,	PUNCT
dti-1371	31	51	federal	federal	ADJ
dti-1371	31	52	district	district	PROPN
dti-1371	31	53	,	,	PUNCT
dti-1371	31	54	brazil	brazil	PROPN
dti-1371	31	55	.	.	PUNCT
dti-1371	32	1	material	material	NOUN
dti-1371	32	2	and	and	CCONJ
dti-1371	32	3	methods	method	NOUN
dti-1371	32	4	patients	patient	NOUN
dti-1371	32	5	a	a	DET
dti-1371	32	6	cohort	cohort	NOUN
dti-1371	32	7	study	study	NOUN
dti-1371	32	8	was	be	AUX
dti-1371	32	9	conducted	conduct	VERB
dti-1371	32	10	in	in	ADP
dti-1371	32	11	the	the	DET
dti-1371	32	12	health	health	NOUN
dti-1371	32	13	center	center	NOUN
dti-1371	32	14	number	number	NOUN
dti-1371	32	15	01	01	NUM
dti-1371	32	16	attached	attach	VERB
dti-1371	32	17	to	to	ADP
dti-1371	32	18	the	the	DET
dti-1371	32	19	secretary	secretary	PROPN
dti-1371	32	20	of	of	ADP
dti-1371	32	21	health	health	PROPN
dti-1371	32	22	,	,	PUNCT
dti-1371	32	23	federal	federal	ADJ
dti-1371	32	24	district	district	NOUN
dti-1371	32	25	(	(	PUNCT
dti-1371	32	26	ses	ses	PROPN
dti-1371	32	27	/	/	SYM
dti-1371	32	28	df	df	PROPN
dti-1371	32	29	)	)	PUNCT
dti-1371	32	30	(	(	PUNCT
dti-1371	32	31	centro	centro	X
dti-1371	32	32	de	de	X
dti-1371	32	33	saúde	saúde	PROPN
dti-1371	32	34	número	número	NOUN
dti-1371	32	35	01	01	NUM
dti-1371	32	36	,	,	PUNCT
dti-1371	32	37	secretaria	secretaria	PROPN
dti-1371	32	38	de	de	PROPN
dti-1371	32	39	saúde	saúde	PROPN
dti-1371	32	40	do	do	VERB
dti-1371	32	41	distrito	distrito	PROPN
dti-1371	32	42	federal	federal	PROPN
dti-1371	32	43	)	)	PUNCT
dti-1371	32	44	which	which	PRON
dti-1371	32	45	included	include	VERB
dti-1371	32	46	139	139	NUM
dti-1371	32	47	hiv-1	hiv-1	X
dti-1371	32	48	infected	infected	ADJ
dti-1371	32	49	patients	patient	NOUN
dti-1371	32	50	.	.	PUNCT
dti-1371	33	1	the	the	DET
dti-1371	33	2	patients	patient	NOUN
dti-1371	33	3	had	have	VERB
dti-1371	33	4	clinical	clinical	ADJ
dti-1371	33	5	and	and	CCONJ
dti-1371	33	6	laboratory	laboratory	NOUN
dti-1371	33	7	diagnosis	diagnosis	NOUN
dti-1371	33	8	as	as	SCONJ
dti-1371	33	9	defined	define	VERB
dti-1371	33	10	by	by	ADP
dti-1371	33	11	the	the	DET
dti-1371	33	12	1993	1993	NUM
dti-1371	33	13	aids	aids	PROPN
dti-1371	33	14	clinical	clinical	ADJ
dti-1371	33	15	course	course	NOUN
dti-1371	33	16	criteria	criterion	NOUN
dti-1371	33	17	and	and	CCONJ
dti-1371	33	18	by	by	ADP
dti-1371	33	19	the	the	DET
dti-1371	33	20	us	us	PROPN
dti-1371	33	21	center	center	NOUN
dti-1371	33	22	for	for	ADP
dti-1371	33	23	disease	disease	NOUN
dti-1371	33	24	control	control	NOUN
dti-1371	33	25	(	(	PUNCT
dti-1371	33	26	cdc)11	cdc)11	X
dti-1371	33	27	and	and	CCONJ
dti-1371	33	28	also	also	ADV
dti-1371	33	29	by	by	ADP
dti-1371	33	30	the	the	DET
dti-1371	33	31	recommendations	recommendation	NOUN
dti-1371	33	32	of	of	ADP
dti-1371	33	33	the	the	DET
dti-1371	33	34	brazilian	brazilian	ADJ
dti-1371	33	35	consensus	consensus	NOUN
dti-1371	33	36	of	of	ADP
dti-1371	33	37	antiretroviral	antiretroviral	ADJ
dti-1371	33	38	therapy	therapy	NOUN
dti-1371	33	39	in	in	ADP
dti-1371	33	40	infected	infected	ADJ
dti-1371	33	41	adults	adult	NOUN
dti-1371	33	42	and	and	CCONJ
dti-1371	33	43	adolescents	adolescent	NOUN
dti-1371	33	44	by	by	ADP
dti-1371	33	45	the	the	DET
dti-1371	33	46	ministry	ministry	PROPN
dti-1371	33	47	of	of	ADP
dti-1371	33	48	health	health	PROPN
dti-1371	33	49	,	,	PUNCT
dti-1371	33	50	secretary	secretary	NOUN
dti-1371	33	51	of	of	ADP
dti-1371	33	52	http://www.la-press.com	http://www.la-press.com	X
dti-1371	33	53	antiretroviral	antiretroviral	ADJ
dti-1371	33	54	treatment	treatment	NOUN
dti-1371	33	55	in	in	ADP
dti-1371	33	56	the	the	DET
dti-1371	33	57	federal	federal	ADJ
dti-1371	33	58	district	district	PROPN
dti-1371	33	59	,	,	PUNCT
dti-1371	33	60	brazil	brazil	PROPN
dti-1371	33	61	,	,	PUNCT
dti-1371	33	62	federal	federal	ADJ
dti-1371	33	63	district	district	NOUN
dti-1371	33	64	drug	drug	NOUN
dti-1371	33	65	target	target	NOUN
dti-1371	33	66	insights	insight	NOUN
dti-1371	33	67	2011:5	2011:5	NUM
dti-1371	33	68	35	35	NUM
dti-1371	33	69	health	health	NOUN
dti-1371	33	70	surveillance	surveillance	NOUN
dti-1371	33	71	,	,	PUNCT
dti-1371	33	72	brazilian	brazilian	ADJ
dti-1371	33	73	national	national	ADJ
dti-1371	33	74	program	program	NOUN
dti-1371	33	75	of	of	ADP
dti-1371	33	76	sexually	sexually	ADV
dti-1371	33	77	transmitted	transmit	VERB
dti-1371	33	78	diseases	disease	NOUN
dti-1371	33	79	and	and	CCONJ
dti-1371	33	80	aids.12	aids.12	NOUN
dti-1371	33	81	patients	patient	NOUN
dti-1371	33	82	selected	select	VERB
dti-1371	33	83	for	for	ADP
dti-1371	33	84	the	the	DET
dti-1371	33	85	study	study	NOUN
dti-1371	33	86	were	be	AUX
dti-1371	33	87	identified	identify	VERB
dti-1371	33	88	in	in	ADP
dti-1371	33	89	the	the	DET
dti-1371	33	90	records	record	NOUN
dti-1371	33	91	of	of	ADP
dti-1371	33	92	logistic	logistic	ADJ
dti-1371	33	93	system	system	NOUN
dti-1371	33	94	of	of	ADP
dti-1371	33	95	the	the	DET
dti-1371	33	96	ministry	ministry	PROPN
dti-1371	33	97	of	of	ADP
dti-1371	33	98	health	health	PROPN
dti-1371	33	99	,	,	PUNCT
dti-1371	33	100	siclom13	siclom13	NOUN
dti-1371	33	101	utilized	utilize	VERB
dti-1371	33	102	by	by	ADP
dti-1371	33	103	the	the	DET
dti-1371	33	104	hospital	hospital	PROPN
dti-1371	33	105	dia	dia	PROPN
dti-1371	33	106	,	,	PUNCT
dti-1371	33	107	ses	ses	PROPN
dti-1371	33	108	/	/	SYM
dti-1371	33	109	df	df	PROPN
dti-1371	33	110	.	.	PUNCT
dti-1371	34	1	the	the	DET
dti-1371	34	2	plasmatic	plasmatic	ADJ
dti-1371	34	3	hiv	hiv	PROPN
dti-1371	34	4	rna	rna	PROPN
dti-1371	34	5	load	load	NOUN
dti-1371	34	6	was	be	AUX
dti-1371	34	7	quantified	quantify	VERB
dti-1371	34	8	by	by	ADP
dti-1371	34	9	the	the	DET
dti-1371	34	10	bdna	bdna	NOUN
dti-1371	34	11	system	system	NOUN
dti-1371	34	12	340	340	NUM
dti-1371	34	13	presenting	presenting	NOUN
dti-1371	34	14	sensitivity	sensitivity	NOUN
dti-1371	34	15	of	of	ADP
dti-1371	34	16	less	less	ADJ
dti-1371	34	17	than	than	ADP
dti-1371	34	18	50	50	NUM
dti-1371	34	19	copies	copy	NOUN
dti-1371	34	20	/	/	SYM
dti-1371	34	21	ml	ml	NOUN
dti-1371	34	22	.	.	PUNCT
dti-1371	35	1	the	the	DET
dti-1371	35	2	t	t	PROPN
dti-1371	35	3	cd4	cd4	PROPN
dti-1371	35	4	+	+	PROPN
dti-1371	35	5	helper	helper	NOUN
dti-1371	35	6	lymphocytes	lymphocyte	NOUN
dti-1371	35	7	’	'	PUNCT
dti-1371	35	8	count	count	NOUN
dti-1371	35	9	was	be	AUX
dti-1371	35	10	carried	carry	VERB
dti-1371	35	11	out	out	ADP
dti-1371	35	12	by	by	ADP
dti-1371	35	13	automatized	automatize	VERB
dti-1371	35	14	flow	flow	NOUN
dti-1371	35	15	cytometry	cytometry	NOUN
dti-1371	35	16	utilizing	utilize	VERB
dti-1371	35	17	the	the	DET
dti-1371	35	18	facscalibur	facscalibur	NOUN
dti-1371	35	19	count	count	NOUN
dti-1371	35	20	®	®	NOUN
dti-1371	35	21	system	system	NOUN
dti-1371	35	22	.	.	PUNCT
dti-1371	36	1	the	the	DET
dti-1371	36	2	sampling	sampling	NOUN
dti-1371	36	3	utilized	utilize	VERB
dti-1371	36	4	for	for	ADP
dti-1371	36	5	patient	patient	ADJ
dti-1371	36	6	selection	selection	NOUN
dti-1371	36	7	was	be	AUX
dti-1371	36	8	by	by	ADP
dti-1371	36	9	convenience	convenience	NOUN
dti-1371	36	10	whose	whose	DET
dti-1371	36	11	inclusion	inclusion	NOUN
dti-1371	36	12	criteria	criterion	NOUN
dti-1371	36	13	were	be	AUX
dti-1371	36	14	:	:	PUNCT
dti-1371	36	15	(	(	PUNCT
dti-1371	36	16	a	a	X
dti-1371	36	17	)	)	PUNCT
dti-1371	36	18	age	age	NOUN
dti-1371	36	19	higher	high	ADJ
dti-1371	36	20	than	than	ADP
dti-1371	36	21	18	18	NUM
dti-1371	36	22	years	year	NOUN
dti-1371	36	23	old	old	ADJ
dti-1371	36	24	and	and	CCONJ
dti-1371	36	25	of	of	ADP
dti-1371	36	26	both	both	DET
dti-1371	36	27	sexes	sex	NOUN
dti-1371	36	28	;	;	PUNCT
dti-1371	36	29	(	(	PUNCT
dti-1371	36	30	b	b	X
dti-1371	36	31	)	)	PUNCT
dti-1371	36	32	hiv	hiv	NOUN
dti-1371	36	33	infection	infection	NOUN
dti-1371	36	34	diagnosis	diagnosis	NOUN
dti-1371	36	35	defined	define	VERB
dti-1371	36	36	by	by	ADP
dti-1371	36	37	the	the	DET
dti-1371	36	38	brazillian	brazillian	PROPN
dti-1371	36	39	ministry	ministry	PROPN
dti-1371	36	40	of	of	ADP
dti-1371	36	41	health	health	PROPN
dti-1371	36	42	standardized	standardize	VERB
dti-1371	36	43	patterns	pattern	NOUN
dti-1371	36	44	;	;	PUNCT
dti-1371	36	45	(	(	PUNCT
dti-1371	36	46	c	c	X
dti-1371	36	47	)	)	PUNCT
dti-1371	36	48	detectable	detectable	ADJ
dti-1371	36	49	viral	viral	ADJ
dti-1371	36	50	load	load	NOUN
dti-1371	36	51	previous	previous	ADJ
dti-1371	36	52	to	to	ADP
dti-1371	36	53	haart	haart	PROPN
dti-1371	36	54	beginning	begin	VERB
dti-1371	36	55	.400	.400	NUM
dti-1371	36	56	copies	copy	NOUN
dti-1371	36	57	/	/	SYM
dti-1371	36	58	ml	ml	ADP
dti-1371	36	59	;	;	PUNCT
dti-1371	36	60	(	(	PUNCT
dti-1371	36	61	d	d	X
dti-1371	36	62	)	)	PUNCT
dti-1371	36	63	t	t	PROPN
dti-1371	36	64	cd4	cd4	PROPN
dti-1371	36	65	+	+	PROPN
dti-1371	36	66	cell	cell	NOUN
dti-1371	36	67	count	count	NOUN
dti-1371	36	68	,	,	PUNCT
dti-1371	36	69	500	500	NUM
dti-1371	36	70	cells	cell	NOUN
dti-1371	36	71	/	/	SYM
dti-1371	36	72	mm3	mm3	NOUN
dti-1371	36	73	before	before	ADP
dti-1371	36	74	haart	haart	PROPN
dti-1371	36	75	regimen	regimen	NOUN
dti-1371	36	76	initiation	initiation	NOUN
dti-1371	36	77	;	;	PUNCT
dti-1371	36	78	(	(	PUNCT
dti-1371	36	79	e	e	NOUN
dti-1371	36	80	)	)	PUNCT
dti-1371	36	81	present	present	ADJ
dti-1371	36	82	laboratory	laboratory	NOUN
dti-1371	36	83	analysis	analysis	NOUN
dti-1371	36	84	for	for	ADP
dti-1371	36	85	viral	viral	ADJ
dti-1371	36	86	load	load	NOUN
dti-1371	36	87	and	and	CCONJ
dti-1371	36	88	t	t	X
dti-1371	36	89	cd4	cd4	PROPN
dti-1371	36	90	+	+	PROPN
dti-1371	36	91	count	count	NOUN
dti-1371	36	92	between	between	ADP
dti-1371	36	93	6	6	NUM
dti-1371	36	94	and	and	CCONJ
dti-1371	36	95	12	12	NUM
dti-1371	36	96	months	month	NOUN
dti-1371	36	97	in	in	ADP
dti-1371	36	98	order	order	NOUN
dti-1371	36	99	to	to	PART
dti-1371	36	100	compare	compare	VERB
dti-1371	36	101	the	the	DET
dti-1371	36	102	former	former	ADJ
dti-1371	36	103	ones	one	NOUN
dti-1371	36	104	with	with	ADP
dti-1371	36	105	those	those	PRON
dti-1371	36	106	of	of	ADP
dti-1371	36	107	baseline	baseline	NOUN
dti-1371	36	108	;	;	PUNCT
dti-1371	36	109	(	(	PUNCT
dti-1371	36	110	f	f	X
dti-1371	36	111	)	)	PUNCT
dti-1371	36	112	patients	patient	NOUN
dti-1371	36	113	have	have	AUX
dti-1371	36	114	had	have	VERB
dti-1371	36	115	clinical	clinical	ADJ
dti-1371	36	116	and	and	CCONJ
dti-1371	36	117	immunological	immunological	ADJ
dti-1371	36	118	follow	follow	NOUN
dti-1371	36	119	up	up	ADP
dti-1371	36	120	during	during	ADP
dti-1371	36	121	3	3	NUM
dti-1371	36	122	months	month	NOUN
dti-1371	36	123	intervals	interval	NOUN
dti-1371	36	124	.	.	PUNCT
dti-1371	37	1	if	if	SCONJ
dti-1371	37	2	undetectable	undetectable	ADJ
dti-1371	37	3	viral	viral	ADJ
dti-1371	37	4	load	load	NOUN
dti-1371	37	5	of	of	ADP
dti-1371	37	6	50	50	NUM
dti-1371	37	7	copies	copy	NOUN
dti-1371	37	8	/	/	SYM
dti-1371	37	9	ml	ml	PROPN
dti-1371	37	10	was	be	AUX
dti-1371	37	11	not	not	PART
dti-1371	37	12	sustained	sustain	VERB
dti-1371	37	13	during	during	ADP
dti-1371	37	14	24	24	NUM
dti-1371	37	15	weeks	week	NOUN
dti-1371	37	16	of	of	ADP
dti-1371	37	17	treatment	treatment	NOUN
dti-1371	37	18	or	or	CCONJ
dti-1371	37	19	higher	high	ADJ
dti-1371	37	20	than	than	ADP
dti-1371	37	21	400	400	NUM
dti-1371	37	22	copies	copy	NOUN
dti-1371	37	23	/	/	SYM
dti-1371	37	24	ml	ml	NOUN
dti-1371	37	25	after	after	ADP
dti-1371	37	26	48	48	NUM
dti-1371	37	27	weeks	week	NOUN
dti-1371	37	28	treatment	treatment	NOUN
dti-1371	37	29	,	,	PUNCT
dti-1371	37	30	it	it	PRON
dti-1371	37	31	was	be	AUX
dti-1371	37	32	considered	consider	VERB
dti-1371	37	33	virological	virological	ADJ
dti-1371	37	34	failure	failure	NOUN
dti-1371	37	35	to	to	ADP
dti-1371	37	36	the	the	DET
dti-1371	37	37	initial	initial	ADJ
dti-1371	37	38	antiretroviral	antiretroviral	ADJ
dti-1371	37	39	therapeutic	therapeutic	ADJ
dti-1371	37	40	regimen.5	regimen.5	ADJ
dti-1371	37	41	immunological	immunological	ADJ
dti-1371	37	42	failure	failure	NOUN
dti-1371	37	43	was	be	AUX
dti-1371	37	44	considered	consider	VERB
dti-1371	37	45	by	by	ADP
dti-1371	37	46	the	the	DET
dti-1371	37	47	declining	declining	NOUN
dti-1371	37	48	of	of	ADP
dti-1371	37	49	t	t	PROPN
dti-1371	37	50	cd4	cd4	PROPN
dti-1371	37	51	+	+	PROPN
dti-1371	37	52	cell	cell	NOUN
dti-1371	37	53	counting	count	VERB
dti-1371	37	54	$	$	SYM
dti-1371	37	55	25.0	25.0	NUM
dti-1371	37	56	%	%	NOUN
dti-1371	37	57	of	of	ADP
dti-1371	37	58	the	the	DET
dti-1371	37	59	absolute	absolute	ADJ
dti-1371	37	60	values6	values6	NOUN
dti-1371	37	61	or	or	CCONJ
dti-1371	37	62	by	by	ADP
dti-1371	37	63	returning	return	VERB
dti-1371	37	64	to	to	ADP
dti-1371	37	65	the	the	DET
dti-1371	37	66	t	t	PROPN
dti-1371	37	67	cd4	cd4	PROPN
dti-1371	37	68	+	+	PROPN
dti-1371	37	69	cell	cell	NOUN
dti-1371	37	70	count	count	NOUN
dti-1371	37	71	initial	initial	ADJ
dti-1371	37	72	values	value	NOUN
dti-1371	37	73	before	before	ADP
dti-1371	37	74	antiretroviral	antiretroviral	ADJ
dti-1371	37	75	therapy	therapy	NOUN
dti-1371	37	76	initiation	initiation	NOUN
dti-1371	37	77	.	.	PUNCT
dti-1371	38	1	the	the	DET
dti-1371	38	2	viral	viral	ADJ
dti-1371	38	3	load	load	NOUN
dti-1371	38	4	previous	previous	ADJ
dti-1371	38	5	to	to	AUX
dti-1371	38	6	haart	haart	VERB
dti-1371	38	7	regimen	regimen	NOUN
dti-1371	38	8	initiation	initiation	NOUN
dti-1371	38	9	and	and	CCONJ
dti-1371	38	10	t	t	NOUN
dti-1371	38	11	cd4	cd4	PROPN
dti-1371	38	12	+	+	PROPN
dti-1371	38	13	cell	cell	NOUN
dti-1371	38	14	count	count	NOUN
dti-1371	38	15	were	be	AUX
dti-1371	38	16	evaluated	evaluate	VERB
dti-1371	38	17	as	as	ADP
dti-1371	38	18	possible	possible	ADJ
dti-1371	38	19	predictors	predictor	NOUN
dti-1371	38	20	of	of	ADP
dti-1371	38	21	viral	viral	ADJ
dti-1371	38	22	failure	failure	NOUN
dti-1371	38	23	leading	lead	VERB
dti-1371	38	24	us	we	PRON
dti-1371	38	25	to	to	PART
dti-1371	38	26	establish	establish	VERB
dti-1371	38	27	the	the	DET
dti-1371	38	28	cut	cut	NOUN
dti-1371	38	29	off	off	ADP
dti-1371	38	30	values	value	NOUN
dti-1371	38	31	to	to	ADP
dti-1371	38	32	viral	viral	ADJ
dti-1371	38	33	load	load	NOUN
dti-1371	38	34	.	.	PUNCT
dti-1371	39	1	100.000	100.000	NUM
dti-1371	39	2	copies	copy	NOUN
dti-1371	39	3	/	/	SYM
dti-1371	39	4	ml	ml	NOUN
dti-1371	39	5	or	or	CCONJ
dti-1371	39	6	#	#	SYM
dti-1371	39	7	100.000	100.000	NUM
dti-1371	39	8	copies	copy	NOUN
dti-1371	39	9	/	/	SYM
dti-1371	39	10	ml	ml	X
dti-1371	39	11	as	as	ADV
dti-1371	39	12	also	also	ADV
dti-1371	39	13	t	t	PROPN
dti-1371	39	14	cd4	cd4	PROPN
dti-1371	39	15	+	+	PROPN
dti-1371	39	16	.	.	PUNCT
dti-1371	39	17	200	200	NUM
dti-1371	39	18	cells	cell	NOUN
dti-1371	39	19	/	/	SYM
dti-1371	39	20	mm3	mm3	NOUN
dti-1371	39	21	or	or	CCONJ
dti-1371	39	22	#	#	SYM
dti-1371	39	23	200	200	NUM
dti-1371	39	24	cells	cell	NOUN
dti-1371	39	25	/	/	SYM
dti-1371	39	26	mm3	mm3	NOUN
dti-1371	39	27	.	.	PUNCT
dti-1371	40	1	the	the	DET
dti-1371	40	2	antiretroviral	antiretroviral	ADJ
dti-1371	40	3	therapy	therapy	NOUN
dti-1371	40	4	regimen	regiman	NOUN
dti-1371	40	5	were	be	AUX
dti-1371	40	6	:	:	PUNCT
dti-1371	40	7	(	(	PUNCT
dti-1371	40	8	a	a	X
dti-1371	40	9	)	)	PUNCT
dti-1371	40	10	double	double	ADJ
dti-1371	40	11	with	with	ADP
dti-1371	40	12	two	two	NUM
dti-1371	40	13	nucleoside	nucleoside	ADV
dti-1371	40	14	reverse	reverse	NOUN
dti-1371	40	15	transcriptase	transcriptase	NOUN
dti-1371	40	16	inhibitor	inhibitor	NOUN
dti-1371	40	17	and	and	CCONJ
dti-1371	40	18	non	non	ADJ
dti-1371	40	19	nucleoside	nucleoside	ADV
dti-1371	40	20	reverse	reverse	ADJ
dti-1371	40	21	transcriptase	transcriptase	NOUN
dti-1371	40	22	inhibitor	inhibitor	NOUN
dti-1371	40	23	;	;	PUNCT
dti-1371	40	24	(	(	PUNCT
dti-1371	40	25	b	b	X
dti-1371	40	26	)	)	PUNCT
dti-1371	40	27	triple	triple	NOUN
dti-1371	40	28	with	with	ADP
dti-1371	40	29	two	two	NUM
dti-1371	40	30	nucleoside	nucleoside	ADV
dti-1371	40	31	reverse	reverse	NOUN
dti-1371	40	32	transcriptase	transcriptase	NOUN
dti-1371	40	33	inhibitor	inhibitor	NOUN
dti-1371	40	34	and	and	CCONJ
dti-1371	40	35	one	one	NUM
dti-1371	40	36	protease	protease	NOUN
dti-1371	40	37	inhibitor	inhibitor	NOUN
dti-1371	40	38	and	and	CCONJ
dti-1371	40	39	(	(	PUNCT
dti-1371	40	40	c	c	NOUN
dti-1371	40	41	)	)	PUNCT
dti-1371	40	42	three	three	NUM
dti-1371	40	43	nucleoside	nucleoside	ADV
dti-1371	40	44	reverse	reverse	ADJ
dti-1371	40	45	transcriptase	transcriptase	NOUN
dti-1371	40	46	inhibitor	inhibitor	NOUN
dti-1371	40	47	,	,	PUNCT
dti-1371	40	48	according	accord	VERB
dti-1371	40	49	to	to	ADP
dti-1371	40	50	cdc	cdc	PROPN
dti-1371	40	51	classification	classification	NOUN
dti-1371	40	52	and	and	CCONJ
dti-1371	40	53	the	the	DET
dti-1371	40	54	brazilian	brazilian	ADJ
dti-1371	40	55	ministry	ministry	PROPN
dti-1371	40	56	of	of	ADP
dti-1371	40	57	health	health	PROPN
dti-1371	40	58	guidelines	guideline	NOUN
dti-1371	40	59	as	as	SCONJ
dti-1371	40	60	previously	previously	ADV
dti-1371	40	61	described	describe	VERB
dti-1371	40	62	.	.	PUNCT
dti-1371	41	1	in	in	ADP
dti-1371	41	2	the	the	DET
dti-1371	41	3	population	population	NOUN
dti-1371	41	4	here	here	ADV
dti-1371	41	5	studied	study	VERB
dti-1371	41	6	,	,	PUNCT
dti-1371	41	7	the	the	DET
dti-1371	41	8	chosen	choose	VERB
dti-1371	41	9	antiretroviral	antiretroviral	ADJ
dti-1371	41	10	regimen	regiman	NOUN
dti-1371	41	11	was	be	AUX
dti-1371	41	12	decided	decide	VERB
dti-1371	41	13	by	by	ADP
dti-1371	41	14	the	the	DET
dti-1371	41	15	physician	physician	NOUN
dti-1371	41	16	in	in	ADP
dti-1371	41	17	charge	charge	NOUN
dti-1371	41	18	without	without	ADP
dti-1371	41	19	interference	interference	NOUN
dti-1371	41	20	by	by	ADP
dti-1371	41	21	the	the	DET
dti-1371	41	22	authors	author	NOUN
dti-1371	41	23	of	of	ADP
dti-1371	41	24	this	this	DET
dti-1371	41	25	research	research	NOUN
dti-1371	41	26	work	work	NOUN
dti-1371	41	27	.	.	PUNCT
dti-1371	42	1	the	the	DET
dti-1371	42	2	criteria	criterion	NOUN
dti-1371	42	3	for	for	ADP
dti-1371	42	4	the	the	DET
dti-1371	42	5	diagnosis	diagnosis	NOUN
dti-1371	42	6	of	of	ADP
dti-1371	42	7	hepatitis	hepatitis	PROPN
dti-1371	42	8	b	b	PROPN
dti-1371	42	9	and	and	CCONJ
dti-1371	42	10	c	c	PROPN
dti-1371	42	11	virus	virus	NOUN
dti-1371	42	12	infection	infection	NOUN
dti-1371	42	13	followed	follow	VERB
dti-1371	42	14	the	the	DET
dti-1371	42	15	guidelines	guideline	NOUN
dti-1371	42	16	established	establish	VERB
dti-1371	42	17	by	by	ADP
dti-1371	42	18	the	the	DET
dti-1371	42	19	manual	manual	NOUN
dti-1371	42	20	of	of	ADP
dti-1371	42	21	viral	viral	ADJ
dti-1371	42	22	hepatitis	hepatitis	NOUN
dti-1371	42	23	consultancy	consultancy	NOUN
dti-1371	42	24	,	,	PUNCT
dti-1371	42	25	secretary	secretary	PROPN
dti-1371	42	26	of	of	ADP
dti-1371	42	27	health	health	PROPN
dti-1371	42	28	surveillance	surveillance	NOUN
dti-1371	42	29	,	,	PUNCT
dti-1371	42	30	department	department	NOUN
dti-1371	42	31	of	of	ADP
dti-1371	42	32	epidemiological	epidemiological	ADJ
dti-1371	42	33	surveillance	surveillance	NOUN
dti-1371	42	34	,	,	PUNCT
dti-1371	42	35	brasília	brasília	PROPN
dti-1371	42	36	,	,	PUNCT
dti-1371	42	37	ministry	ministry	NOUN
dti-1371	42	38	of	of	ADP
dti-1371	42	39	health14	health14	NOUN
dti-1371	42	40	and	and	CCONJ
dti-1371	42	41	also	also	ADV
dti-1371	42	42	for	for	ADP
dti-1371	42	43	the	the	DET
dti-1371	42	44	tuberculosis	tuberculosis	NOUN
dti-1371	42	45	diagnosis	diagnosis	NOUN
dti-1371	42	46	,	,	PUNCT
dti-1371	42	47	the	the	DET
dti-1371	42	48	technical	technical	ADJ
dti-1371	42	49	manual	manual	NOUN
dti-1371	42	50	for	for	ADP
dti-1371	42	51	tuberculosis	tuberculosis	NOUN
dti-1371	42	52	control	control	NOUN
dti-1371	42	53	,	,	PUNCT
dti-1371	42	54	notebook	notebook	NOUN
dti-1371	42	55	of	of	ADP
dti-1371	42	56	basic	basic	ADJ
dti-1371	42	57	attention	attention	NOUN
dti-1371	42	58	,	,	PUNCT
dti-1371	42	59	secretary	secretary	NOUN
dti-1371	42	60	of	of	ADP
dti-1371	42	61	health	health	NOUN
dti-1371	42	62	politics	politic	NOUN
dti-1371	42	63	,	,	PUNCT
dti-1371	42	64	department	department	NOUN
dti-1371	42	65	of	of	ADP
dti-1371	42	66	basic	basic	ADJ
dti-1371	42	67	attention	attention	NOUN
dti-1371	42	68	,	,	PUNCT
dti-1371	42	69	brasília	brasília	PROPN
dti-1371	42	70	.	.	PUNCT
dti-1371	43	1	ministry	ministry	PROPN
dti-1371	43	2	of	of	ADP
dti-1371	43	3	health.15	health.15	PROPN
dti-1371	43	4	the	the	DET
dti-1371	43	5	exclusion	exclusion	NOUN
dti-1371	43	6	criteria	criterion	NOUN
dti-1371	43	7	for	for	ADP
dti-1371	43	8	this	this	DET
dti-1371	43	9	research	research	NOUN
dti-1371	43	10	were	be	AUX
dti-1371	43	11	:	:	PUNCT
dti-1371	43	12	(	(	PUNCT
dti-1371	43	13	a	a	X
dti-1371	43	14	)	)	PUNCT
dti-1371	43	15	be	be	AUX
dti-1371	43	16	pregnant	pregnant	ADJ
dti-1371	43	17	or	or	CCONJ
dti-1371	43	18	minor	minor	ADJ
dti-1371	43	19	under	under	ADP
dti-1371	43	20	18	18	NUM
dti-1371	43	21	years	year	NOUN
dti-1371	43	22	old	old	ADJ
dti-1371	43	23	;	;	PUNCT
dti-1371	43	24	(	(	PUNCT
dti-1371	43	25	b	b	X
dti-1371	43	26	)	)	PUNCT
dti-1371	43	27	be	be	AUX
dti-1371	43	28	prescribed	prescribe	VERB
dti-1371	43	29	with	with	ADP
dti-1371	43	30	medications	medication	NOUN
dti-1371	43	31	which	which	PRON
dti-1371	43	32	could	could	AUX
dti-1371	43	33	metabolically	metabolically	ADV
dti-1371	43	34	interact	interact	VERB
dti-1371	43	35	with	with	ADP
dti-1371	43	36	antiretroviral	antiretroviral	ADJ
dti-1371	43	37	drugs	drug	NOUN
dti-1371	43	38	,	,	PUNCT
dti-1371	43	39	including	include	VERB
dti-1371	43	40	phytotherapics	phytotherapic	NOUN
dti-1371	43	41	;	;	PUNCT
dti-1371	43	42	(	(	PUNCT
dti-1371	43	43	c	c	X
dti-1371	43	44	)	)	PUNCT
dti-1371	43	45	have	have	AUX
dti-1371	43	46	had	have	VERB
dti-1371	43	47	last	last	ADJ
dti-1371	43	48	clinical	clinical	ADJ
dti-1371	43	49	appointment	appointment	NOUN
dti-1371	43	50	in	in	ADP
dti-1371	43	51	a	a	DET
dti-1371	43	52	period	period	NOUN
dti-1371	43	53	longer	long	ADV
dti-1371	43	54	than	than	ADP
dti-1371	43	55	6	6	NUM
dti-1371	43	56	months	month	NOUN
dti-1371	43	57	which	which	PRON
dti-1371	43	58	was	be	AUX
dti-1371	43	59	considered	consider	VERB
dti-1371	43	60	lost	lose	VERB
dti-1371	43	61	to	to	PART
dti-1371	43	62	follow	follow	VERB
dti-1371	43	63	-	-	PUNCT
dti-1371	43	64	up	up	NOUN
dti-1371	43	65	.	.	PUNCT
dti-1371	44	1	the	the	DET
dti-1371	44	2	analysis	analysis	NOUN
dti-1371	44	3	of	of	ADP
dti-1371	44	4	baseline	baseline	ADJ
dti-1371	44	5	characteristics	characteristic	NOUN
dti-1371	44	6	(	(	PUNCT
dti-1371	44	7	initial	initial	ADJ
dti-1371	44	8	data	datum	NOUN
dti-1371	44	9	previous	previous	ADJ
dti-1371	44	10	to	to	ADP
dti-1371	44	11	initiation	initiation	NOUN
dti-1371	44	12	of	of	ADP
dti-1371	44	13	treatment	treatment	NOUN
dti-1371	44	14	referring	refer	VERB
dti-1371	44	15	to	to	ADP
dti-1371	44	16	t	t	PROPN
dti-1371	44	17	cd4	cd4	PROPN
dti-1371	44	18	+	+	PROPN
dti-1371	44	19	cell	cell	NOUN
dti-1371	44	20	count	count	NOUN
dti-1371	44	21	and	and	CCONJ
dti-1371	44	22	viral	viral	ADJ
dti-1371	44	23	load	load	NOUN
dti-1371	44	24	)	)	PUNCT
dti-1371	44	25	included	include	VERB
dti-1371	44	26	frequency	frequency	NOUN
dti-1371	44	27	tables	table	NOUN
dti-1371	44	28	of	of	ADP
dti-1371	44	29	categorical	categorical	ADJ
dti-1371	44	30	variables	variable	NOUN
dti-1371	44	31	and	and	CCONJ
dti-1371	44	32	their	their	PRON
dti-1371	44	33	descriptive	descriptive	ADJ
dti-1371	44	34	statistics	statistic	NOUN
dti-1371	44	35	(	(	PUNCT
dti-1371	44	36	median	median	ADJ
dti-1371	44	37	,	,	PUNCT
dti-1371	44	38	arithmetic	arithmetic	ADJ
dti-1371	44	39	mean	mean	NOUN
dti-1371	44	40	and	and	CCONJ
dti-1371	44	41	standard	standard	ADJ
dti-1371	44	42	deviation	deviation	NOUN
dti-1371	44	43	)	)	PUNCT
dti-1371	44	44	as	as	ADV
dti-1371	44	45	also	also	ADV
dti-1371	44	46	as	as	ADP
dti-1371	44	47	continuous	continuous	ADJ
dti-1371	44	48	variables	variable	NOUN
dti-1371	44	49	.	.	PUNCT
dti-1371	45	1	in	in	ADP
dti-1371	45	2	order	order	NOUN
dti-1371	45	3	to	to	PART
dti-1371	45	4	measure	measure	VERB
dti-1371	45	5	the	the	DET
dti-1371	45	6	dependent	dependent	ADJ
dti-1371	45	7	association	association	NOUN
dti-1371	45	8	between	between	ADP
dti-1371	45	9	two	two	NUM
dti-1371	45	10	categorial	categorial	ADJ
dti-1371	45	11	variables	variable	NOUN
dti-1371	45	12	it	it	PRON
dti-1371	45	13	was	be	AUX
dti-1371	45	14	utilized	utilize	VERB
dti-1371	45	15	the	the	DET
dti-1371	45	16	chi	chi	ADJ
dti-1371	45	17	-	-	PUNCT
dti-1371	45	18	square	square	ADJ
dti-1371	45	19	test	test	NOUN
dti-1371	45	20	(	(	PUNCT
dti-1371	45	21	x2	x2	NOUN
dti-1371	45	22	)	)	PUNCT
dti-1371	45	23	or	or	CCONJ
dti-1371	45	24	when	when	SCONJ
dti-1371	45	25	necessary	necessary	ADJ
dti-1371	45	26	the	the	DET
dti-1371	45	27	exact	exact	ADJ
dti-1371	45	28	fisher	fisher	PROPN
dti-1371	45	29	test	test	NOUN
dti-1371	45	30	.	.	PUNCT
dti-1371	46	1	to	to	PART
dti-1371	46	2	compare	compare	VERB
dti-1371	46	3	before	before	ADV
dti-1371	46	4	and	and	CCONJ
dti-1371	46	5	after	after	ADP
dti-1371	46	6	results	result	NOUN
dti-1371	46	7	the	the	DET
dti-1371	46	8	macnemar	macnemar	PROPN
dti-1371	46	9	test	test	NOUN
dti-1371	46	10	was	be	AUX
dti-1371	46	11	applied	apply	VERB
dti-1371	46	12	.	.	PUNCT
dti-1371	47	1	for	for	ADP
dti-1371	47	2	the	the	DET
dti-1371	47	3	analysis	analysis	NOUN
dti-1371	47	4	of	of	ADP
dti-1371	47	5	logistic	logistic	ADJ
dti-1371	47	6	regression	regression	NOUN
dti-1371	47	7	and	and	CCONJ
dti-1371	47	8	to	to	PART
dti-1371	47	9	predict	predict	VERB
dti-1371	47	10	the	the	DET
dti-1371	47	11	event	event	NOUN
dti-1371	47	12	of	of	ADP
dti-1371	47	13	virological	virological	ADJ
dti-1371	47	14	failure16	failure16	NOUN
dti-1371	47	15	(	(	PUNCT
dti-1371	47	16	depedent	depedent	PROPN
dti-1371	47	17	variable	variable	PROPN
dti-1371	47	18	)	)	PUNCT
dti-1371	47	19	,	,	PUNCT
dti-1371	47	20	the	the	DET
dti-1371	47	21	wald	wald	NOUN
dti-1371	47	22	method	method	NOUN
dti-1371	47	23	was	be	AUX
dti-1371	47	24	applied	apply	VERB
dti-1371	47	25	.	.	PUNCT
dti-1371	48	1	the	the	DET
dti-1371	48	2	association	association	NOUN
dti-1371	48	3	measurement	measurement	NOUN
dti-1371	48	4	calculated	calculate	VERB
dti-1371	48	5	from	from	ADP
dti-1371	48	6	the	the	DET
dti-1371	48	7	logistic	logistic	ADJ
dti-1371	48	8	model	model	NOUN
dti-1371	48	9	is	be	AUX
dti-1371	48	10	the	the	DET
dti-1371	48	11	adjusted	adjust	VERB
dti-1371	48	12	odds	odd	NOUN
dti-1371	48	13	ratio	ratio	NOUN
dti-1371	48	14	(	(	PUNCT
dti-1371	48	15	or	or	CCONJ
dti-1371	48	16	)	)	PUNCT
dti-1371	48	17	.	.	PUNCT
dti-1371	49	1	the	the	DET
dti-1371	49	2	statistical	statistical	ADJ
dti-1371	49	3	analysis	analysis	NOUN
dti-1371	49	4	was	be	AUX
dti-1371	49	5	carried	carry	VERB
dti-1371	49	6	out	out	ADP
dti-1371	49	7	utilizing	utilize	VERB
dti-1371	49	8	spss	spss	PROPN
dti-1371	49	9	17.0	17.0	NUM
dti-1371	49	10	.	.	PUNCT
dti-1371	50	1	the	the	DET
dti-1371	50	2	statistical	statistical	ADJ
dti-1371	50	3	association	association	NOUN
dti-1371	50	4	was	be	AUX
dti-1371	50	5	considered	consider	VERB
dti-1371	50	6	when	when	SCONJ
dti-1371	50	7	p	p	NOUN
dti-1371	50	8	,	,	PUNCT
dti-1371	50	9	0.05	0.05	NUM
dti-1371	50	10	.	.	PUNCT
dti-1371	51	1	the	the	DET
dti-1371	51	2	patients	patient	NOUN
dti-1371	51	3	’	’	PART
dti-1371	51	4	data	datum	NOUN
dti-1371	51	5	were	be	AUX
dti-1371	51	6	confidential	confidential	ADJ
dti-1371	51	7	and	and	CCONJ
dti-1371	51	8	consentment	consentment	VERB
dti-1371	51	9	to	to	PART
dti-1371	51	10	utilize	utilize	VERB
dti-1371	51	11	information	information	NOUN
dti-1371	51	12	were	be	AUX
dti-1371	51	13	obtained	obtain	VERB
dti-1371	51	14	at	at	ADP
dti-1371	51	15	the	the	DET
dti-1371	51	16	health	health	NOUN
dti-1371	51	17	center	center	NOUN
dti-1371	51	18	number	number	NOUN
dti-1371	51	19	01	01	NUM
dti-1371	51	20	direction	direction	NOUN
dti-1371	51	21	according	accord	VERB
dti-1371	51	22	to	to	ADP
dti-1371	51	23	the	the	DET
dti-1371	51	24	federal	federal	ADJ
dti-1371	51	25	district	district	NOUN
dti-1371	51	26	secretary	secretary	NOUN
dti-1371	51	27	(	(	PUNCT
dti-1371	51	28	ses	ses	PROPN
dti-1371	51	29	/	/	SYM
dti-1371	51	30	df	df	PROPN
dti-1371	51	31	)	)	PUNCT
dti-1371	51	32	of	of	ADP
dti-1371	51	33	health	health	NOUN
dti-1371	51	34	agreement	agreement	NOUN
dti-1371	51	35	.	.	PUNCT
dti-1371	52	1	the	the	DET
dti-1371	52	2	research	research	NOUN
dti-1371	52	3	work	work	NOUN
dti-1371	52	4	protocol	protocol	NOUN
dti-1371	52	5	was	be	AUX
dti-1371	52	6	approved	approve	VERB
dti-1371	52	7	by	by	ADP
dti-1371	52	8	the	the	DET
dti-1371	52	9	federal	federal	ADJ
dti-1371	52	10	district	district	PROPN
dti-1371	52	11	secretary	secretary	PROPN
dti-1371	52	12	of	of	ADP
dti-1371	52	13	health	health	PROPN
dti-1371	52	14	researh	researh	PROPN
dti-1371	52	15	ethics	ethic	NOUN
dti-1371	52	16	committee	committee	NOUN
dti-1371	52	17	,	,	PUNCT
dti-1371	52	18	foundation	foundation	NOUN
dti-1371	52	19	of	of	ADP
dti-1371	52	20	teaching	teaching	NOUN
dti-1371	52	21	and	and	CCONJ
dti-1371	52	22	research	research	NOUN
dti-1371	52	23	in	in	ADP
dti-1371	52	24	health	health	NOUN
dti-1371	52	25	sciences	science	NOUN
dti-1371	52	26	(	(	PUNCT
dti-1371	52	27	fepecs	fepec	NOUN
dti-1371	52	28	)	)	PUNCT
dti-1371	52	29	.	.	PUNCT
dti-1371	53	1	results	result	NOUN
dti-1371	53	2	and	and	CCONJ
dti-1371	53	3	discussion	discussion	NOUN
dti-1371	53	4	initially	initially	ADV
dti-1371	53	5	,	,	PUNCT
dti-1371	53	6	165	165	NUM
dti-1371	53	7	patients	patient	NOUN
dti-1371	53	8	were	be	AUX
dti-1371	53	9	eligible	eligible	ADJ
dti-1371	53	10	to	to	PART
dti-1371	53	11	participate	participate	VERB
dti-1371	53	12	in	in	ADP
dti-1371	53	13	the	the	DET
dti-1371	53	14	study	study	NOUN
dti-1371	53	15	for	for	ADP
dti-1371	53	16	starting	start	VERB
dti-1371	53	17	the	the	DET
dti-1371	53	18	treatment	treatment	NOUN
dti-1371	53	19	in	in	ADP
dti-1371	53	20	the	the	DET
dti-1371	53	21	period	period	NOUN
dti-1371	53	22	2002–2008	2002–2008	NUM
dti-1371	53	23	.	.	PUNCT
dti-1371	54	1	however	however	ADV
dti-1371	54	2	,	,	PUNCT
dti-1371	54	3	only	only	ADV
dti-1371	54	4	139	139	NUM
dti-1371	54	5	patients	patient	NOUN
dti-1371	54	6	met	meet	VERB
dti-1371	54	7	the	the	DET
dti-1371	54	8	inclusion	inclusion	NOUN
dti-1371	54	9	criteria	criterion	NOUN
dti-1371	54	10	.	.	PUNCT
dti-1371	55	1	among	among	ADP
dti-1371	55	2	them	they	PRON
dti-1371	55	3	(	(	PUNCT
dti-1371	55	4	table	table	NOUN
dti-1371	55	5	1a	1a	NOUN
dti-1371	55	6	and	and	CCONJ
dti-1371	55	7	b	b	X
dti-1371	55	8	)	)	PUNCT
dti-1371	55	9	,	,	PUNCT
dti-1371	55	10	http://www.la-press.com	http://www.la-press.com	X
dti-1371	55	11	bello	bello	PROPN
dti-1371	55	12	et	et	PROPN
dti-1371	55	13	al	al	PROPN
dti-1371	55	14	36	36	NUM
dti-1371	55	15	drug	drug	NOUN
dti-1371	55	16	target	target	NOUN
dti-1371	55	17	insights	insight	NOUN
dti-1371	55	18	2011:5	2011:5	NUM
dti-1371	55	19	males	male	NOUN
dti-1371	55	20	predominated	predominate	VERB
dti-1371	55	21	(	(	PUNCT
dti-1371	55	22	74.1	74.1	NUM
dti-1371	55	23	%	%	NOUN
dti-1371	55	24	)	)	PUNCT
dti-1371	55	25	.	.	PUNCT
dti-1371	56	1	ages	age	NOUN
dti-1371	56	2	ranged	range	VERB
dti-1371	56	3	from	from	ADP
dti-1371	56	4	20–65	20–65	NUM
dti-1371	56	5	years	year	NOUN
dti-1371	56	6	old	old	ADJ
dti-1371	56	7	(	(	PUNCT
dti-1371	56	8	mean	mean	NOUN
dti-1371	56	9	=	=	SYM
dti-1371	56	10	39.7	39.7	NUM
dti-1371	56	11	years	year	NOUN
dti-1371	56	12	,	,	PUNCT
dti-1371	56	13	median	median	NOUN
dti-1371	56	14	=	=	PROPN
dti-1371	56	15	40.0	40.0	NUM
dti-1371	56	16	)	)	PUNCT
dti-1371	56	17	.	.	PUNCT
dti-1371	57	1	there	there	PRON
dti-1371	57	2	was	be	VERB
dti-1371	57	3	a	a	DET
dti-1371	57	4	slight	slight	ADJ
dti-1371	57	5	predominance	predominance	NOUN
dti-1371	57	6	of	of	ADP
dti-1371	57	7	patients	patient	NOUN
dti-1371	57	8	in	in	ADP
dti-1371	57	9	the	the	DET
dti-1371	57	10	range	range	NOUN
dti-1371	57	11	of	of	ADP
dti-1371	57	12	41–65	41–65	NUM
dti-1371	57	13	years	year	NOUN
dti-1371	57	14	old	old	ADJ
dti-1371	57	15	(	(	PUNCT
dti-1371	57	16	51.1	51.1	NUM
dti-1371	57	17	%	%	NOUN
dti-1371	57	18	)	)	PUNCT
dti-1371	57	19	compared	compare	VERB
dti-1371	57	20	to	to	ADP
dti-1371	57	21	younger	young	ADJ
dti-1371	57	22	patients	patient	NOUN
dti-1371	57	23	.	.	PUNCT
dti-1371	58	1	as	as	ADP
dti-1371	58	2	for	for	ADP
dti-1371	58	3	race	race	NOUN
dti-1371	58	4	/	/	SYM
dti-1371	58	5	ethnical	ethnical	ADJ
dti-1371	58	6	background	background	NOUN
dti-1371	58	7	,	,	PUNCT
dti-1371	58	8	there	there	PRON
dti-1371	58	9	was	be	VERB
dti-1371	58	10	a	a	DET
dti-1371	58	11	predominance	predominance	NOUN
dti-1371	58	12	of	of	ADP
dti-1371	58	13	mestizos	mestizo	NOUN
dti-1371	58	14	(	(	PUNCT
dti-1371	58	15	54.6	54.6	NUM
dti-1371	58	16	%	%	NOUN
dti-1371	58	17	)	)	PUNCT
dti-1371	58	18	.	.	PUNCT
dti-1371	59	1	regarding	regard	VERB
dti-1371	59	2	to	to	ADP
dti-1371	59	3	the	the	DET
dti-1371	59	4	marital	marital	ADJ
dti-1371	59	5	status	status	NOUN
dti-1371	59	6	,	,	PUNCT
dti-1371	59	7	there	there	PRON
dti-1371	59	8	was	be	VERB
dti-1371	59	9	a	a	DET
dti-1371	59	10	predominance	predominance	NOUN
dti-1371	59	11	of	of	ADP
dti-1371	59	12	single	single	ADJ
dti-1371	59	13	people	people	NOUN
dti-1371	59	14	(	(	PUNCT
dti-1371	59	15	48.2	48.2	NUM
dti-1371	59	16	%	%	NOUN
dti-1371	59	17	)	)	PUNCT
dti-1371	59	18	.	.	PUNCT
dti-1371	60	1	high	high	ADJ
dti-1371	60	2	school	school	NOUN
dti-1371	60	3	education	education	NOUN
dti-1371	60	4	(	(	PUNCT
dti-1371	60	5	25.9	25.9	NUM
dti-1371	60	6	%	%	NOUN
dti-1371	60	7	)	)	PUNCT
dti-1371	60	8	predominated	predominate	VERB
dti-1371	60	9	over	over	ADP
dti-1371	60	10	other	other	ADJ
dti-1371	60	11	categories	category	NOUN
dti-1371	60	12	.	.	PUNCT
dti-1371	61	1	people	people	NOUN
dti-1371	61	2	living	live	VERB
dti-1371	61	3	in	in	ADP
dti-1371	61	4	taguatinga	taguatinga	NOUN
dti-1371	61	5	(	(	PUNCT
dti-1371	61	6	13.7	13.7	NUM
dti-1371	61	7	%	%	NOUN
dti-1371	61	8	)	)	PUNCT
dti-1371	61	9	,	,	PUNCT
dti-1371	61	10	a	a	DET
dti-1371	61	11	satellite	satellite	NOUN
dti-1371	61	12	city	city	NOUN
dti-1371	61	13	located	locate	VERB
dti-1371	61	14	in	in	ADP
dti-1371	61	15	the	the	DET
dti-1371	61	16	surrounding	surround	VERB
dti-1371	61	17	areas	area	NOUN
dti-1371	61	18	of	of	ADP
dti-1371	61	19	brasília	brasília	PROPN
dti-1371	61	20	,	,	PUNCT
dti-1371	61	21	represented	represent	VERB
dti-1371	61	22	the	the	DET
dti-1371	61	23	majority	majority	NOUN
dti-1371	61	24	of	of	ADP
dti-1371	61	25	the	the	DET
dti-1371	61	26	patients	patient	NOUN
dti-1371	61	27	enrolled	enrol	VERB
dti-1371	61	28	in	in	ADP
dti-1371	61	29	this	this	DET
dti-1371	61	30	study	study	NOUN
dti-1371	61	31	.	.	PUNCT
dti-1371	62	1	the	the	DET
dti-1371	62	2	place	place	NOUN
dti-1371	62	3	of	of	ADP
dti-1371	62	4	birth	birth	NOUN
dti-1371	62	5	showed	show	VERB
dti-1371	62	6	that	that	SCONJ
dti-1371	62	7	patients	patient	NOUN
dti-1371	62	8	predominated	predominate	VERB
dti-1371	62	9	from	from	ADP
dti-1371	62	10	the	the	DET
dti-1371	62	11	midwest	midwest	NOUN
dti-1371	62	12	(	(	PUNCT
dti-1371	62	13	40.3	40.3	NUM
dti-1371	62	14	%	%	NOUN
dti-1371	62	15	)	)	PUNCT
dti-1371	62	16	and	and	CCONJ
dti-1371	62	17	the	the	DET
dti-1371	62	18	northeast	northeast	NOUN
dti-1371	62	19	of	of	ADP
dti-1371	62	20	brazil	brazil	PROPN
dti-1371	62	21	(	(	PUNCT
dti-1371	62	22	34.5	34.5	NUM
dti-1371	62	23	%	%	NOUN
dti-1371	62	24	)	)	PUNCT
dti-1371	62	25	.	.	PUNCT
dti-1371	63	1	hetrosexual	hetrosexual	ADJ
dti-1371	63	2	relationships	relationship	NOUN
dti-1371	63	3	predominated	predominate	VERB
dti-1371	63	4	(	(	PUNCT
dti-1371	63	5	51.8	51.8	NUM
dti-1371	63	6	%	%	NOUN
dti-1371	63	7	)	)	PUNCT
dti-1371	63	8	,	,	PUNCT
dti-1371	63	9	followed	follow	VERB
dti-1371	63	10	by	by	ADP
dti-1371	63	11	the	the	DET
dti-1371	63	12	homosexual	homosexual	ADJ
dti-1371	63	13	relationships	relationship	NOUN
dti-1371	63	14	(	(	PUNCT
dti-1371	63	15	23.7	23.7	NUM
dti-1371	63	16	%	%	NOUN
dti-1371	63	17	)	)	PUNCT
dti-1371	63	18	.	.	PUNCT
dti-1371	64	1	the	the	DET
dti-1371	64	2	initial	initial	ADJ
dti-1371	64	3	viral	viral	ADJ
dti-1371	64	4	load	load	NOUN
dti-1371	64	5	ranged	range	VERB
dti-1371	64	6	between	between	ADP
dti-1371	64	7	1.643	1.643	NUM
dti-1371	64	8	copies	copy	NOUN
dti-1371	64	9	/	/	SYM
dti-1371	64	10	ml	ml	NOUN
dti-1371	64	11	to	to	ADP
dti-1371	64	12	500.000	500.000	NUM
dti-1371	64	13	copies	copy	NOUN
dti-1371	64	14	/	/	SYM
dti-1371	64	15	ml	ml	PROPN
dti-1371	64	16	(	(	PUNCT
dti-1371	64	17	mean	mean	VERB
dti-1371	64	18	=	=	SYM
dti-1371	64	19	180.721	180.721	NUM
dti-1371	64	20	copies	copy	NOUN
dti-1371	64	21	/	/	SYM
dti-1371	64	22	ml	ml	PROPN
dti-1371	64	23	;	;	PUNCT
dti-1371	64	24	arithmetic	arithmetic	ADJ
dti-1371	64	25	mean	mean	NOUN
dti-1371	64	26	=	=	SYM
dti-1371	64	27	126.417	126.417	NUM
dti-1371	64	28	copies	copy	NOUN
dti-1371	64	29	/	/	SYM
dti-1371	64	30	ml	ml	NOUN
dti-1371	64	31	)	)	PUNCT
dti-1371	64	32	presenting	present	VERB
dti-1371	64	33	more	more	ADJ
dti-1371	64	34	than	than	ADP
dti-1371	64	35	half	half	NOUN
dti-1371	64	36	of	of	ADP
dti-1371	64	37	the	the	DET
dti-1371	64	38	patients	patient	NOUN
dti-1371	64	39	(	(	PUNCT
dti-1371	64	40	55.4	55.4	NUM
dti-1371	64	41	%	%	NOUN
dti-1371	64	42	)	)	PUNCT
dti-1371	64	43	cell	cell	NOUN
dti-1371	64	44	density	density	NOUN
dti-1371	64	45	higher	high	ADJ
dti-1371	64	46	than	than	ADP
dti-1371	64	47	100.000	100.000	NUM
dti-1371	64	48	copies	copy	NOUN
dti-1371	64	49	/	/	SYM
dti-1371	64	50	ml	ml	PROPN
dti-1371	64	51	(	(	PUNCT
dti-1371	64	52	table	table	NOUN
dti-1371	64	53	2	2	NUM
dti-1371	64	54	)	)	PUNCT
dti-1371	64	55	.	.	PUNCT
dti-1371	65	1	after	after	ADP
dti-1371	65	2	antiretroviral	antiretroviral	ADJ
dti-1371	65	3	therapy	therapy	NOUN
dti-1371	65	4	,	,	PUNCT
dti-1371	65	5	the	the	DET
dti-1371	65	6	initial	initial	ADJ
dti-1371	65	7	profile	profile	NOUN
dti-1371	65	8	changed	change	VERB
dti-1371	65	9	substantially	substantially	ADV
dti-1371	65	10	more	more	ADJ
dti-1371	65	11	than	than	ADP
dti-1371	65	12	70	70	NUM
dti-1371	65	13	%	%	NOUN
dti-1371	65	14	of	of	ADP
dti-1371	65	15	the	the	DET
dti-1371	65	16	patients	patient	NOUN
dti-1371	65	17	had	have	VERB
dti-1371	65	18	viral	viral	ADJ
dti-1371	65	19	load	load	NOUN
dti-1371	65	20	lower	low	ADJ
dti-1371	65	21	than	than	ADP
dti-1371	65	22	50	50	NUM
dti-1371	65	23	copies	copy	NOUN
dti-1371	65	24	/	/	SYM
dti-1371	65	25	ml	ml	NOUN
dti-1371	65	26	.	.	PUNCT
dti-1371	66	1	in	in	ADP
dti-1371	66	2	reference	reference	NOUN
dti-1371	66	3	to	to	ADP
dti-1371	66	4	the	the	DET
dti-1371	66	5	initial	initial	ADJ
dti-1371	66	6	t	t	PROPN
dti-1371	66	7	cd4	cd4	PROPN
dti-1371	66	8	+	+	PROPN
dti-1371	66	9	cell	cell	NOUN
dti-1371	66	10	count	count	NOUN
dti-1371	66	11	,	,	PUNCT
dti-1371	66	12	68.3	68.3	NUM
dti-1371	66	13	%	%	NOUN
dti-1371	66	14	of	of	ADP
dti-1371	66	15	the	the	DET
dti-1371	66	16	patients	patient	NOUN
dti-1371	66	17	were	be	AUX
dti-1371	66	18	in	in	ADP
dti-1371	66	19	the	the	DET
dti-1371	66	20	range	range	NOUN
dti-1371	66	21	of	of	ADP
dti-1371	66	22	0–200	0–200	NUM
dti-1371	66	23	cells	cell	NOUN
dti-1371	66	24	/	/	SYM
dti-1371	66	25	mm3	mm3	PROPN
dti-1371	66	26	.	.	PUNCT
dti-1371	67	1	after	after	ADP
dti-1371	67	2	treatment	treatment	NOUN
dti-1371	67	3	a	a	DET
dti-1371	67	4	relevant	relevant	ADJ
dti-1371	67	5	change	change	NOUN
dti-1371	67	6	was	be	AUX
dti-1371	67	7	observed	observe	VERB
dti-1371	67	8	in	in	ADP
dti-1371	67	9	the	the	DET
dti-1371	67	10	patients	patient	NOUN
dti-1371	67	11	profile	profile	VERB
dti-1371	67	12	concerning	concern	VERB
dti-1371	67	13	t	t	PROPN
dti-1371	67	14	cd4	cd4	PROPN
dti-1371	67	15	+	+	PROPN
dti-1371	67	16	cell	cell	NOUN
dti-1371	67	17	counts	count	NOUN
dti-1371	67	18	,	,	PUNCT
dti-1371	67	19	remaining	remain	VERB
dti-1371	67	20	less	less	ADJ
dti-1371	67	21	than	than	ADP
dti-1371	67	22	37	37	NUM
dti-1371	67	23	%	%	NOUN
dti-1371	67	24	of	of	ADP
dti-1371	67	25	the	the	DET
dti-1371	67	26	cases	case	NOUN
dti-1371	67	27	in	in	ADP
dti-1371	67	28	this	this	DET
dti-1371	67	29	stage	stage	NOUN
dti-1371	67	30	.	.	PUNCT
dti-1371	68	1	in	in	ADP
dti-1371	68	2	the	the	DET
dti-1371	68	3	following	follow	VERB
dti-1371	68	4	cell	cell	NOUN
dti-1371	68	5	density	density	NOUN
dti-1371	68	6	interval	interval	NOUN
dti-1371	68	7	,	,	PUNCT
dti-1371	68	8	there	there	PRON
dti-1371	68	9	was	be	VERB
dti-1371	68	10	an	an	DET
dti-1371	68	11	expressive	expressive	ADJ
dti-1371	68	12	increment	increment	NOUN
dti-1371	68	13	in	in	ADP
dti-1371	68	14	the	the	DET
dti-1371	68	15	number	number	NOUN
dti-1371	68	16	of	of	ADP
dti-1371	68	17	cases	case	NOUN
dti-1371	68	18	,	,	PUNCT
dti-1371	68	19	representing	represent	VERB
dti-1371	68	20	more	more	ADJ
dti-1371	68	21	than	than	ADP
dti-1371	68	22	43.0	43.0	NUM
dti-1371	68	23	%	%	NOUN
dti-1371	68	24	of	of	ADP
dti-1371	68	25	the	the	DET
dti-1371	68	26	patients	patient	NOUN
dti-1371	68	27	(	(	PUNCT
dti-1371	68	28	table	table	NOUN
dti-1371	68	29	2	2	NUM
dti-1371	68	30	)	)	PUNCT
dti-1371	68	31	.	.	PUNCT
dti-1371	69	1	initially	initially	ADV
dti-1371	69	2	the	the	DET
dti-1371	69	3	most	most	ADV
dti-1371	69	4	utilized	utilize	VERB
dti-1371	69	5	antiretroviral	antiretroviral	ADJ
dti-1371	69	6	regimen	regiman	NOUN
dti-1371	69	7	included	include	VERB
dti-1371	69	8	two	two	NUM
dti-1371	69	9	drugs	drug	NOUN
dti-1371	69	10	,	,	PUNCT
dti-1371	69	11	the	the	DET
dti-1371	69	12	nucleoside	nucleoside	NOUN
dti-1371	69	13	reverse	reverse	NOUN
dti-1371	69	14	transcriptase	transcriptase	NOUN
dti-1371	69	15	inhibitor	inhibitor	NOUN
dti-1371	69	16	and	and	CCONJ
dti-1371	69	17	non	non	ADJ
dti-1371	69	18	nucleoside	nucleoside	ADV
dti-1371	69	19	reverse	reverse	VERB
dti-1371	69	20	transcriptase	transcriptase	NOUN
dti-1371	69	21	inhibitor	inhibitor	NOUN
dti-1371	69	22	in	in	ADP
dti-1371	69	23	71.2	71.2	NUM
dti-1371	69	24	%	%	NOUN
dti-1371	69	25	of	of	ADP
dti-1371	69	26	the	the	DET
dti-1371	69	27	cases	case	NOUN
dti-1371	69	28	and	and	CCONJ
dti-1371	69	29	the	the	DET
dti-1371	69	30	remaining	remain	VERB
dti-1371	69	31	28.1	28.1	NUM
dti-1371	69	32	%	%	NOUN
dti-1371	69	33	included	include	VERB
dti-1371	69	34	two	two	NUM
dti-1371	69	35	nucleoside	nucleoside	ADV
dti-1371	69	36	reverse	reverse	ADJ
dti-1371	69	37	transcriptase	transcriptase	NOUN
dti-1371	69	38	inhibitor	inhibitor	NOUN
dti-1371	69	39	and	and	CCONJ
dti-1371	69	40	one	one	NUM
dti-1371	69	41	protease	protease	NOUN
dti-1371	69	42	inhibitor	inhibitor	NOUN
dti-1371	69	43	.	.	PUNCT
dti-1371	70	1	during	during	ADP
dti-1371	70	2	the	the	DET
dti-1371	70	3	course	course	NOUN
dti-1371	70	4	of	of	ADP
dti-1371	70	5	the	the	DET
dti-1371	70	6	treatment	treatment	NOUN
dti-1371	70	7	,	,	PUNCT
dti-1371	70	8	the	the	DET
dti-1371	70	9	presented	present	VERB
dti-1371	70	10	regimen	regimen	NOUN
dti-1371	70	11	distribution	distribution	NOUN
dti-1371	70	12	slightly	slightly	ADV
dti-1371	70	13	changed	change	VERB
dti-1371	70	14	to	to	ADP
dti-1371	70	15	66.9	66.9	NUM
dti-1371	70	16	%	%	NOUN
dti-1371	70	17	to	to	ADP
dti-1371	70	18	the	the	DET
dti-1371	70	19	first	first	ADJ
dti-1371	70	20	drug	drug	NOUN
dti-1371	70	21	combination	combination	NOUN
dti-1371	70	22	and	and	CCONJ
dti-1371	70	23	table	table	NOUN
dti-1371	70	24	1b	1b	NUM
dti-1371	70	25	.	.	PUNCT
dti-1371	71	1	distribution	distribution	NOUN
dti-1371	71	2	of	of	ADP
dti-1371	71	3	socioeconomic	socioeconomic	ADJ
dti-1371	71	4	and	and	CCONJ
dti-1371	71	5	demographic	demographic	ADJ
dti-1371	71	6	profile	profile	NOUN
dti-1371	71	7	of	of	ADP
dti-1371	71	8	patients	patient	NOUN
dti-1371	71	9	attended	attend	VERB
dti-1371	71	10	in	in	ADP
dti-1371	71	11	the	the	DET
dti-1371	71	12	health	health	NOUN
dti-1371	71	13	center	center	NOUN
dti-1371	71	14	no	no	INTJ
dti-1371	71	15	.	.	NOUN
dti-1371	71	16	1	1	NUM
dti-1371	71	17	(	(	PUNCT
dti-1371	71	18	hospita	hospita	PROPN
dti-1371	71	19	dia	dia	PROPN
dti-1371	71	20	)	)	PUNCT
dti-1371	71	21	during	during	ADP
dti-1371	71	22	2002–2008	2002–2008	NUM
dti-1371	71	23	.	.	PUNCT
dti-1371	72	1	variable	variable	ADJ
dti-1371	72	2	category	category	NOUN
dti-1371	72	3	n	n	CCONJ
dti-1371	72	4	%	%	NOUN
dti-1371	72	5	residence	residence	NOUN
dti-1371	72	6	pilot	pilot	NOUN
dti-1371	72	7	plan	plan	NOUN
dti-1371	72	8	29	29	NUM
dti-1371	72	9	20.9	20.9	NUM
dti-1371	72	10	guara	guara	NOUN
dti-1371	72	11	16	16	NUM
dti-1371	72	12	11.5	11.5	NUM
dti-1371	72	13	ceilandia	ceilandia	NOUN
dti-1371	72	14	17	17	NUM
dti-1371	72	15	12.2	12.2	NUM
dti-1371	72	16	taguatinga	taguatinga	NOUN
dti-1371	72	17	19	19	NUM
dti-1371	72	18	13.7	13.7	NUM
dti-1371	72	19	bandeirante	bandeirante	NOUN
dti-1371	72	20	9	9	NUM
dti-1371	72	21	6.5	6.5	NUM
dti-1371	72	22	gama	gama	NOUN
dti-1371	72	23	14	14	NUM
dti-1371	72	24	10.0	10.0	NUM
dti-1371	72	25	sobradinho	sobradinho	NOUN
dti-1371	72	26	3	3	NUM
dti-1371	72	27	2.2	2.2	NUM
dti-1371	72	28	planaltina	planaltina	NOUN
dti-1371	72	29	4	4	NUM
dti-1371	72	30	2.9	2.9	NUM
dti-1371	72	31	san	san	PROPN
dti-1371	72	32	sebastian	sebastian	PROPN
dti-1371	72	33	7	7	NUM
dti-1371	72	34	5.0	5.0	NUM
dti-1371	72	35	paranoa	paranoa	ADJ
dti-1371	72	36	2	2	NUM
dti-1371	72	37	1.4	1.4	NUM
dti-1371	72	38	around	around	ADP
dti-1371	72	39	brasília	brasília	PROPN
dti-1371	72	40	19	19	NUM
dti-1371	72	41	13.7	13.7	NUM
dti-1371	72	42	birthplace	birthplace	NOUN
dti-1371	72	43	north	north	NOUN
dti-1371	72	44	4	4	NUM
dti-1371	72	45	2.9	2.9	NUM
dti-1371	72	46	northeast	northeast	ADV
dti-1371	72	47	48	48	NUM
dti-1371	72	48	34.5	34.5	NUM
dti-1371	72	49	south	south	NOUN
dti-1371	72	50	4	4	NUM
dti-1371	72	51	2.9	2.9	NUM
dti-1371	72	52	southeast	southeast	NOUN
dti-1371	72	53	25	25	NUM
dti-1371	72	54	18.0	18.0	NUM
dti-1371	72	55	midwest	midwest	NOUN
dti-1371	72	56	56	56	NUM
dti-1371	72	57	40.3	40.3	NUM
dti-1371	72	58	african	african	ADJ
dti-1371	72	59	continent	continent	NOUN
dti-1371	72	60	2	2	NUM
dti-1371	72	61	1.4	1.4	NUM
dti-1371	72	62	exposure	exposure	NOUN
dti-1371	72	63	category	category	NOUN
dti-1371	72	64	accident	accident	NOUN
dti-1371	72	65	at	at	ADP
dti-1371	72	66	work	work	NOUN
dti-1371	72	67	1	1	NUM
dti-1371	72	68	0.7	0.7	NUM
dti-1371	72	69	bisexual	bisexual	NOUN
dti-1371	72	70	23	23	NUM
dti-1371	72	71	16.7	16.7	NUM
dti-1371	72	72	heterosexual	heterosexual	ADJ
dti-1371	72	73	72	72	NUM
dti-1371	72	74	51.8	51.8	NUM
dti-1371	72	75	homosexual	homosexual	ADJ
dti-1371	72	76	33	33	NUM
dti-1371	72	77	23.7	23.7	NUM
dti-1371	72	78	blood	blood	NOUN
dti-1371	72	79	transfusion	transfusion	NOUN
dti-1371	72	80	1	1	NUM
dti-1371	72	81	0.7	0.7	NUM
dti-1371	72	82	udi	udi	NOUN
dti-1371	72	83	9	9	NUM
dti-1371	72	84	6.6	6.6	NUM
dti-1371	72	85	total	total	NOUN
dti-1371	72	86	139	139	NUM
dti-1371	72	87	100	100	NUM
dti-1371	72	88	source	source	NOUN
dti-1371	72	89	:	:	PUNCT
dti-1371	72	90	siclom	siclom	NOUN
dti-1371	72	91	(	(	PUNCT
dti-1371	72	92	ms	ms	PROPN
dti-1371	72	93	-	-	PUNCT
dti-1371	72	94	brazil	brazil	PROPN
dti-1371	72	95	)	)	PUNCT
dti-1371	72	96	.	.	PUNCT
dti-1371	73	1	abbreviation	abbreviation	NOUN
dti-1371	73	2	:	:	PUNCT
dti-1371	74	1	udi	udi	PROPN
dti-1371	74	2	,	,	PUNCT
dti-1371	74	3	user	user	NOUN
dti-1371	74	4	injecting	inject	VERB
dti-1371	74	5	drug	drug	NOUN
dti-1371	74	6	.	.	PUNCT
dti-1371	75	1	table	table	NOUN
dti-1371	75	2	1a	1a	NOUN
dti-1371	75	3	.	.	PUNCT
dti-1371	76	1	distribution	distribution	NOUN
dti-1371	76	2	of	of	ADP
dti-1371	76	3	socioeconomic	socioeconomic	ADJ
dti-1371	76	4	and	and	CCONJ
dti-1371	76	5	demographic	demographic	ADJ
dti-1371	76	6	profiles	profile	NOUN
dti-1371	76	7	of	of	ADP
dti-1371	76	8	patients	patient	NOUN
dti-1371	76	9	attended	attend	VERB
dti-1371	76	10	at	at	ADP
dti-1371	76	11	health	health	NOUN
dti-1371	76	12	center	center	NOUN
dti-1371	76	13	no	no	INTJ
dti-1371	76	14	.	.	NOUN
dti-1371	76	15	1	1	NUM
dti-1371	76	16	(	(	PUNCT
dti-1371	76	17	hospital	hospital	NOUN
dti-1371	76	18	dia	dia	PROPN
dti-1371	76	19	)	)	PUNCT
dti-1371	76	20	during	during	ADP
dti-1371	76	21	2002–2008	2002–2008	NUM
dti-1371	76	22	.	.	PUNCT
dti-1371	77	1	variable	variable	ADJ
dti-1371	77	2	category	category	NOUN
dti-1371	77	3	n	n	CCONJ
dti-1371	77	4	%	%	NOUN
dti-1371	77	5	sex	sex	NOUN
dti-1371	77	6	male	male	NOUN
dti-1371	77	7	103	103	NUM
dti-1371	77	8	74.1	74.1	NUM
dti-1371	77	9	female	female	ADJ
dti-1371	77	10	36	36	NUM
dti-1371	77	11	25.9	25.9	NUM
dti-1371	77	12	age	age	NOUN
dti-1371	77	13	20–40	20–40	NUM
dti-1371	77	14	68	68	NUM
dti-1371	77	15	48.9	48.9	NUM
dti-1371	77	16	41–65	41–65	NUM
dti-1371	77	17	71	71	NUM
dti-1371	77	18	51.1	51.1	NUM
dti-1371	77	19	race	race	NOUN
dti-1371	77	20	/	/	SYM
dti-1371	77	21	ethnical	ethnical	ADJ
dti-1371	77	22	background	background	NOUN
dti-1371	77	23	white	white	ADJ
dti-1371	77	24	60	60	NUM
dti-1371	77	25	43.2	43.2	NUM
dti-1371	77	26	mestizo	mestizo	NOUN
dti-1371	77	27	76	76	NUM
dti-1371	77	28	54.6	54.6	NUM
dti-1371	77	29	black	black	ADJ
dti-1371	77	30	3	3	NUM
dti-1371	77	31	2.2	2.2	NUM
dti-1371	77	32	marital	marital	ADJ
dti-1371	77	33	status	status	NOUN
dti-1371	77	34	single	single	ADJ
dti-1371	77	35	67	67	NUM
dti-1371	77	36	48.2	48.2	NUM
dti-1371	77	37	married	marry	VERB
dti-1371	77	38	41	41	NUM
dti-1371	77	39	29.5	29.5	NUM
dti-1371	77	40	stable	stable	ADJ
dti-1371	77	41	18	18	NUM
dti-1371	77	42	12.9	12.9	NUM
dti-1371	77	43	separate	separate	ADJ
dti-1371	77	44	10	10	NUM
dti-1371	77	45	7.2	7.2	NUM
dti-1371	77	46	widow	widow	NOUN
dti-1371	77	47	3	3	NUM
dti-1371	77	48	2.2	2.2	NUM
dti-1371	77	49	education	education	NOUN
dti-1371	77	50	incomplete	incomplete	ADJ
dti-1371	77	51	elementary	elementary	NOUN
dti-1371	77	52	schooling	schooling	NOUN
dti-1371	77	53	28	28	NUM
dti-1371	77	54	20.1	20.1	NUM
dti-1371	77	55	complete	complete	ADJ
dti-1371	77	56	elementary	elementary	ADJ
dti-1371	77	57	schooling	schooling	NOUN
dti-1371	77	58	24	24	NUM
dti-1371	77	59	17.3	17.3	NUM
dti-1371	77	60	middle	middle	ADJ
dti-1371	77	61	incomplete	incomplete	ADJ
dti-1371	77	62	schooling	schooling	NOUN
dti-1371	77	63	19	19	NUM
dti-1371	77	64	7.2	7.2	NUM
dti-1371	77	65	middle	middle	ADJ
dti-1371	77	66	complete	complete	ADJ
dti-1371	77	67	schooling	school	VERB
dti-1371	77	68	36	36	NUM
dti-1371	77	69	25.9	25.9	NUM
dti-1371	77	70	incomplete	incomplete	ADJ
dti-1371	77	71	higher	high	ADJ
dti-1371	77	72	schooling	schooling	NOUN
dti-1371	77	73	4	4	NUM
dti-1371	77	74	2.9	2.9	NUM
dti-1371	77	75	complete	complete	ADJ
dti-1371	77	76	college	college	NOUN
dti-1371	77	77	schooling	school	VERB
dti-1371	77	78	27	27	NUM
dti-1371	77	79	19.4	19.4	NUM
dti-1371	77	80	illiterate	illiterate	ADJ
dti-1371	77	81	9	9	NUM
dti-1371	77	82	6.5	6.5	NUM
dti-1371	77	83	not	not	PART
dti-1371	77	84	informed	inform	VERB
dti-1371	77	85	1	1	NUM
dti-1371	77	86	0.7	0.7	NUM
dti-1371	77	87	total	total	NOUN
dti-1371	77	88	139	139	NUM
dti-1371	77	89	100.0	100.0	NUM
dti-1371	77	90	source	source	NOUN
dti-1371	77	91	:	:	PUNCT
dti-1371	77	92	siclom	siclom	NOUN
dti-1371	77	93	(	(	PUNCT
dti-1371	77	94	ms	ms	PROPN
dti-1371	77	95	-	-	PUNCT
dti-1371	77	96	brazil	brazil	PROPN
dti-1371	77	97	)	)	PUNCT
dti-1371	77	98	.	.	PUNCT
dti-1371	78	1	http://www.la-press.com	http://www.la-press.com	X
dti-1371	79	1	antiretroviral	antiretroviral	ADJ
dti-1371	79	2	treatment	treatment	NOUN
dti-1371	79	3	in	in	ADP
dti-1371	79	4	the	the	DET
dti-1371	79	5	federal	federal	ADJ
dti-1371	79	6	district	district	PROPN
dti-1371	79	7	,	,	PUNCT
dti-1371	79	8	brazil	brazil	PROPN
dti-1371	79	9	,	,	PUNCT
dti-1371	79	10	federal	federal	ADJ
dti-1371	79	11	district	district	NOUN
dti-1371	79	12	drug	drug	NOUN
dti-1371	79	13	target	target	NOUN
dti-1371	79	14	insights	insight	NOUN
dti-1371	79	15	2011:5	2011:5	NUM
dti-1371	79	16	37	37	NUM
dti-1371	79	17	32.4	32.4	NUM
dti-1371	79	18	%	%	NOUN
dti-1371	79	19	to	to	ADP
dti-1371	79	20	the	the	DET
dti-1371	79	21	second	second	ADJ
dti-1371	79	22	one	one	NOUN
dti-1371	79	23	,	,	PUNCT
dti-1371	79	24	there	there	PRON
dti-1371	79	25	remaining	remain	VERB
dti-1371	79	26	only	only	ADV
dti-1371	79	27	one	one	NUM
dti-1371	79	28	utilizing	utilize	VERB
dti-1371	79	29	three	three	NUM
dti-1371	79	30	nucleoside	nucleoside	ADV
dti-1371	79	31	reverse	reverse	ADJ
dti-1371	79	32	transcriptase	transcriptase	NOUN
dti-1371	79	33	inhibitor	inhibitor	NOUN
dti-1371	79	34	(	(	PUNCT
dti-1371	79	35	table	table	NOUN
dti-1371	79	36	2	2	NUM
dti-1371	79	37	)	)	PUNCT
dti-1371	79	38	.	.	PUNCT
dti-1371	80	1	virologic	virologic	ADJ
dti-1371	80	2	failure	failure	NOUN
dti-1371	80	3	was	be	AUX
dti-1371	80	4	12.2	12.2	NUM
dti-1371	80	5	%	%	NOUN
dti-1371	80	6	(	(	PUNCT
dti-1371	80	7	table	table	NOUN
dti-1371	80	8	3	3	NUM
dti-1371	80	9	)	)	PUNCT
dti-1371	80	10	,	,	PUNCT
dti-1371	80	11	or	or	CCONJ
dti-1371	80	12	antiretroviral	antiretroviral	ADJ
dti-1371	80	13	treatment	treatment	NOUN
dti-1371	80	14	success	success	NOUN
dti-1371	80	15	was	be	AUX
dti-1371	80	16	88.8	88.8	NUM
dti-1371	80	17	%	%	NOUN
dti-1371	80	18	,	,	PUNCT
dti-1371	80	19	exceeding	exceed	VERB
dti-1371	80	20	the	the	DET
dti-1371	80	21	results	result	NOUN
dti-1371	80	22	obtained	obtain	VERB
dti-1371	80	23	by	by	ADP
dti-1371	80	24	johnson	johnson	PROPN
dti-1371	80	25	and	and	CCONJ
dti-1371	80	26	way	way	NOUN
dti-1371	80	27	of	of	ADP
dti-1371	80	28	80%.17	80%.17	NUM
dti-1371	80	29	among	among	ADP
dti-1371	80	30	the	the	DET
dti-1371	80	31	socioeconomic	socioeconomic	ADJ
dti-1371	80	32	and	and	CCONJ
dti-1371	80	33	demographic	demographic	ADJ
dti-1371	80	34	variables	variable	NOUN
dti-1371	80	35	,	,	PUNCT
dti-1371	80	36	just	just	ADV
dti-1371	80	37	the	the	DET
dti-1371	80	38	birthplace	birthplace	NOUN
dti-1371	80	39	and	and	CCONJ
dti-1371	80	40	the	the	DET
dti-1371	80	41	fact	fact	NOUN
dti-1371	80	42	that	that	SCONJ
dti-1371	80	43	originating	originate	VERB
dti-1371	80	44	in	in	ADP
dti-1371	80	45	the	the	DET
dti-1371	80	46	midwest	midwest	PROPN
dti-1371	80	47	region	region	NOUN
dti-1371	80	48	which	which	PRON
dti-1371	80	49	includes	include	VERB
dti-1371	80	50	the	the	DET
dti-1371	80	51	federal	federal	ADJ
dti-1371	80	52	district	district	NOUN
dti-1371	80	53	,	,	PUNCT
dti-1371	80	54	was	be	AUX
dti-1371	80	55	associated	associate	VERB
dti-1371	80	56	with	with	ADP
dti-1371	80	57	the	the	DET
dti-1371	80	58	occurrence	occurrence	NOUN
dti-1371	80	59	of	of	ADP
dti-1371	80	60	virologic	virologic	ADJ
dti-1371	80	61	failure	failure	NOUN
dti-1371	80	62	in	in	ADP
dti-1371	80	63	the	the	DET
dti-1371	80	64	study	study	NOUN
dti-1371	80	65	.	.	PUNCT
dti-1371	81	1	cole	cole	PROPN
dti-1371	81	2	et	et	PROPN
dti-1371	82	1	al18	al18	PROPN
dti-1371	82	2	stated	state	VERB
dti-1371	82	3	that	that	SCONJ
dti-1371	82	4	hiv	hiv	PROPN
dti-1371	82	5	infection	infection	NOUN
dti-1371	82	6	is	be	AUX
dti-1371	82	7	sufficiently	sufficiently	ADV
dti-1371	82	8	widespread	widespread	ADJ
dti-1371	82	9	,	,	PUNCT
dti-1371	82	10	suggesting	suggest	VERB
dti-1371	82	11	that	that	SCONJ
dti-1371	82	12	it	it	PRON
dti-1371	82	13	is	be	AUX
dti-1371	82	14	a	a	DET
dti-1371	82	15	multidimensional	multidimensional	ADJ
dti-1371	82	16	epidemic	epidemic	NOUN
dti-1371	82	17	,	,	PUNCT
dti-1371	82	18	with	with	ADP
dti-1371	82	19	demographic	demographic	ADJ
dti-1371	82	20	,	,	PUNCT
dti-1371	82	21	residential	residential	ADJ
dti-1371	82	22	,	,	PUNCT
dti-1371	82	23	social	social	ADJ
dti-1371	82	24	,	,	PUNCT
dti-1371	82	25	biological	biological	ADJ
dti-1371	82	26	and	and	CCONJ
dti-1371	82	27	behavioral	behavioral	ADJ
dti-1371	82	28	significance	significance	NOUN
dti-1371	82	29	.	.	PUNCT
dti-1371	83	1	perhaps	perhaps	ADV
dti-1371	83	2	this	this	PRON
dti-1371	83	3	is	be	AUX
dti-1371	83	4	a	a	DET
dti-1371	83	5	natural	natural	ADJ
dti-1371	83	6	social	social	ADJ
dti-1371	83	7	structural	structural	ADJ
dti-1371	83	8	marker	marker	NOUN
dti-1371	83	9	as	as	SCONJ
dti-1371	83	10	the	the	DET
dti-1371	83	11	study	study	NOUN
dti-1371	83	12	was	be	AUX
dti-1371	83	13	conducted	conduct	VERB
dti-1371	83	14	in	in	ADP
dti-1371	83	15	the	the	DET
dti-1371	83	16	midwest	midwest	NOUN
dti-1371	83	17	region	region	NOUN
dti-1371	83	18	compared	compare	VERB
dti-1371	83	19	to	to	ADP
dti-1371	83	20	those	those	DET
dti-1371	83	21	migrating	migrate	VERB
dti-1371	83	22	people	people	NOUN
dti-1371	83	23	from	from	ADP
dti-1371	83	24	other	other	ADJ
dti-1371	83	25	regions	region	NOUN
dti-1371	83	26	to	to	ADP
dti-1371	83	27	the	the	DET
dti-1371	83	28	federal	federal	ADJ
dti-1371	83	29	district	district	NOUN
dti-1371	83	30	.	.	PUNCT
dti-1371	84	1	there	there	PRON
dti-1371	84	2	was	be	VERB
dti-1371	84	3	a	a	DET
dti-1371	84	4	trend	trend	NOUN
dti-1371	84	5	toward	toward	ADP
dti-1371	84	6	a	a	DET
dti-1371	84	7	higher	high	ADJ
dti-1371	84	8	incidence	incidence	NOUN
dti-1371	84	9	of	of	ADP
dti-1371	84	10	virologic	virologic	ADJ
dti-1371	84	11	failure	failure	NOUN
dti-1371	84	12	being	be	AUX
dti-1371	84	13	male	male	NOUN
dti-1371	84	14	,	,	PUNCT
dti-1371	84	15	over	over	ADP
dti-1371	84	16	40	40	NUM
dti-1371	84	17	years	year	NOUN
dti-1371	84	18	old	old	ADJ
dti-1371	84	19	,	,	PUNCT
dti-1371	84	20	mestizo	mestizo	NOUN
dti-1371	84	21	,	,	PUNCT
dti-1371	84	22	unmarried	unmarried	ADJ
dti-1371	84	23	or	or	CCONJ
dti-1371	84	24	separate	separate	ADJ
dti-1371	84	25	and	and	CCONJ
dti-1371	84	26	also	also	ADV
dti-1371	84	27	heterossexual	heterossexual	ADJ
dti-1371	84	28	exposure	exposure	NOUN
dti-1371	84	29	category	category	NOUN
dti-1371	84	30	.	.	PUNCT
dti-1371	85	1	however	however	ADV
dti-1371	85	2	,	,	PUNCT
dti-1371	85	3	there	there	PRON
dti-1371	85	4	was	be	VERB
dti-1371	85	5	not	not	PART
dti-1371	85	6	any	any	DET
dti-1371	85	7	statistical	statistical	ADJ
dti-1371	85	8	significance	significance	NOUN
dti-1371	85	9	of	of	ADP
dti-1371	85	10	such	such	ADJ
dti-1371	85	11	associations	association	NOUN
dti-1371	85	12	.	.	PUNCT
dti-1371	86	1	it	it	PRON
dti-1371	86	2	was	be	AUX
dti-1371	86	3	found	find	VERB
dti-1371	86	4	that	that	SCONJ
dti-1371	86	5	only	only	ADV
dti-1371	86	6	the	the	DET
dti-1371	86	7	birthplace	birthplace	NOUN
dti-1371	86	8	presented	present	VERB
dti-1371	86	9	statistical	statistical	ADJ
dti-1371	86	10	significance	significance	NOUN
dti-1371	86	11	.	.	PUNCT
dti-1371	87	1	patients	patient	NOUN
dti-1371	87	2	from	from	ADP
dti-1371	87	3	the	the	DET
dti-1371	87	4	midwestern	midwestern	NOUN
dti-1371	87	5	had	have	VERB
dti-1371	87	6	2.7	2.7	NUM
dti-1371	87	7	times	time	NOUN
dti-1371	87	8	greater	great	ADJ
dti-1371	87	9	risk	risk	NOUN
dti-1371	87	10	of	of	ADP
dti-1371	87	11	virologic	virologic	ADJ
dti-1371	87	12	failure	failure	NOUN
dti-1371	87	13	than	than	ADP
dti-1371	87	14	those	those	PRON
dti-1371	87	15	from	from	ADP
dti-1371	87	16	other	other	ADJ
dti-1371	87	17	regions	region	NOUN
dti-1371	87	18	of	of	ADP
dti-1371	87	19	brazil	brazil	PROPN
dti-1371	87	20	,	,	PUNCT
dti-1371	87	21	especially	especially	ADV
dti-1371	87	22	because	because	SCONJ
dti-1371	87	23	the	the	DET
dti-1371	87	24	study	study	NOUN
dti-1371	87	25	was	be	AUX
dti-1371	87	26	conducted	conduct	VERB
dti-1371	87	27	in	in	ADP
dti-1371	87	28	brasilia	brasilia	PROPN
dti-1371	87	29	,	,	PUNCT
dti-1371	87	30	which	which	PRON
dti-1371	87	31	is	be	AUX
dti-1371	87	32	part	part	NOUN
dti-1371	87	33	of	of	ADP
dti-1371	87	34	this	this	DET
dti-1371	87	35	region	region	NOUN
dti-1371	87	36	.	.	PUNCT
dti-1371	88	1	in	in	ADP
dti-1371	88	2	this	this	DET
dti-1371	88	3	study	study	NOUN
dti-1371	88	4	,	,	PUNCT
dti-1371	88	5	the	the	DET
dti-1371	88	6	initial	initial	ADJ
dti-1371	88	7	viral	viral	ADJ
dti-1371	88	8	load	load	NOUN
dti-1371	88	9	is	be	AUX
dti-1371	88	10	not	not	PART
dti-1371	88	11	statistically	statistically	ADV
dti-1371	88	12	associated	associate	VERB
dti-1371	88	13	and	and	CCONJ
dti-1371	88	14	significant	significant	ADJ
dti-1371	88	15	to	to	ADP
dti-1371	88	16	the	the	DET
dti-1371	88	17	occurrence	occurrence	NOUN
dti-1371	88	18	of	of	ADP
dti-1371	88	19	virologic	virologic	ADJ
dti-1371	88	20	failure	failure	NOUN
dti-1371	88	21	.	.	PUNCT
dti-1371	89	1	however	however	ADV
dti-1371	89	2	,	,	PUNCT
dti-1371	89	3	there	there	PRON
dti-1371	89	4	is	be	VERB
dti-1371	89	5	the	the	DET
dti-1371	89	6	presence	presence	NOUN
dti-1371	89	7	of	of	ADP
dti-1371	89	8	a	a	DET
dti-1371	89	9	higher	high	ADJ
dti-1371	89	10	incidence	incidence	NOUN
dti-1371	89	11	of	of	ADP
dti-1371	89	12	virologic	virologic	ADJ
dti-1371	89	13	failure	failure	NOUN
dti-1371	89	14	among	among	ADP
dti-1371	89	15	those	those	PRON
dti-1371	89	16	who	who	PRON
dti-1371	89	17	had	have	VERB
dti-1371	89	18	viral	viral	ADJ
dti-1371	89	19	load	load	NOUN
dti-1371	89	20	greater	great	ADJ
dti-1371	89	21	than	than	ADP
dti-1371	89	22	100.000	100.000	NUM
dti-1371	89	23	copies	copy	NOUN
dti-1371	89	24	/	/	SYM
dti-1371	89	25	ml	ml	NOUN
dti-1371	89	26	after	after	ADP
dti-1371	89	27	the	the	DET
dti-1371	89	28	introduction	introduction	NOUN
dti-1371	89	29	of	of	ADP
dti-1371	89	30	haart	haart	PROPN
dti-1371	89	31	.	.	PUNCT
dti-1371	90	1	the	the	DET
dti-1371	90	2	virologic	virologic	ADJ
dti-1371	90	3	target	target	NOUN
dti-1371	90	4	for	for	ADP
dti-1371	90	5	patients	patient	NOUN
dti-1371	90	6	on	on	ADP
dti-1371	90	7	haart	haart	PROPN
dti-1371	90	8	is	be	AUX
dti-1371	90	9	to	to	PART
dti-1371	90	10	achieve	achieve	VERB
dti-1371	90	11	viral	viral	ADJ
dti-1371	90	12	load	load	NOUN
dti-1371	90	13	plasma	plasma	NOUN
dti-1371	90	14	levels	level	NOUN
dti-1371	90	15	below	below	ADP
dti-1371	90	16	50	50	NUM
dti-1371	90	17	copies	copy	NOUN
dti-1371	90	18	/	/	SYM
dti-1371	90	19	ml	ml	PROPN
dti-1371	90	20	when	when	SCONJ
dti-1371	90	21	two	two	NUM
dti-1371	90	22	or	or	CCONJ
dti-1371	90	23	more	more	ADV
dti-1371	90	24	potent	potent	ADJ
dti-1371	90	25	drugs	drug	NOUN
dti-1371	90	26	are	be	AUX
dti-1371	90	27	used	use	VERB
dti-1371	90	28	.	.	PUNCT
dti-1371	91	1	these	these	DET
dti-1371	91	2	results	result	NOUN
dti-1371	91	3	highlight	highlight	VERB
dti-1371	91	4	the	the	DET
dti-1371	91	5	importance	importance	NOUN
dti-1371	91	6	of	of	ADP
dti-1371	91	7	compliance	compliance	NOUN
dti-1371	91	8	with	with	ADP
dti-1371	91	9	primary	primary	ADJ
dti-1371	91	10	success	success	NOUN
dti-1371	91	11	and	and	CCONJ
dti-1371	91	12	reinforces	reinforce	VERB
dti-1371	91	13	the	the	DET
dti-1371	91	14	need	need	NOUN
dti-1371	91	15	to	to	PART
dti-1371	91	16	work	work	VERB
dti-1371	91	17	on	on	ADP
dti-1371	91	18	the	the	DET
dti-1371	91	19	accession	accession	NOUN
dti-1371	91	20	of	of	ADP
dti-1371	91	21	such	such	ADJ
dti-1371	91	22	patients	patient	NOUN
dti-1371	91	23	.	.	PUNCT
dti-1371	92	1	some	some	DET
dti-1371	92	2	authors19	authors19	NOUN
dti-1371	92	3	interpret	interpret	NOUN
dti-1371	92	4	and	and	CCONJ
dti-1371	92	5	agree	agree	VERB
dti-1371	92	6	that	that	SCONJ
dti-1371	92	7	those	those	PRON
dti-1371	92	8	with	with	ADP
dti-1371	92	9	viral	viral	ADJ
dti-1371	92	10	load	load	NOUN
dti-1371	92	11	higher	high	ADJ
dti-1371	92	12	than	than	ADP
dti-1371	92	13	the	the	DET
dti-1371	92	14	baseline	baseline	ADJ
dti-1371	92	15	level	level	NOUN
dti-1371	92	16	of	of	ADP
dti-1371	92	17	100.000	100.000	NUM
dti-1371	92	18	copies	copy	NOUN
dti-1371	92	19	/	/	PUNCT
dti-1371	92	20	ml	ml	PROPN
dti-1371	92	21	had	have	VERB
dti-1371	92	22	a	a	DET
dti-1371	92	23	slower	slow	ADJ
dti-1371	92	24	pace	pace	NOUN
dti-1371	92	25	to	to	PART
dti-1371	92	26	achieve	achieve	VERB
dti-1371	92	27	viral	viral	ADJ
dti-1371	92	28	suppression	suppression	NOUN
dti-1371	92	29	.	.	PUNCT
dti-1371	93	1	however	however	ADV
dti-1371	93	2	,	,	PUNCT
dti-1371	93	3	a	a	DET
dti-1371	93	4	potent	potent	NOUN
dti-1371	93	5	and	and	CCONJ
dti-1371	93	6	well	well	ADV
dti-1371	93	7	tolerated	tolerate	VERB
dti-1371	93	8	prophylactic	prophylactic	ADJ
dti-1371	93	9	regimen	regiman	NOUN
dti-1371	93	10	with	with	ADP
dti-1371	93	11	haart	haart	PROPN
dti-1371	93	12	can	can	AUX
dti-1371	93	13	improve	improve	VERB
dti-1371	93	14	cd4	cd4	PROPN
dti-1371	93	15	+	+	PROPN
dti-1371	93	16	t	t	NOUN
dti-1371	93	17	cell	cell	NOUN
dti-1371	93	18	count	count	NOUN
dti-1371	93	19	at	at	ADP
dti-1371	93	20	the	the	DET
dti-1371	93	21	beginning	beginning	NOUN
dti-1371	93	22	,	,	PUNCT
dti-1371	93	23	during	during	ADP
dti-1371	93	24	and	and	CCONJ
dti-1371	93	25	after	after	ADP
dti-1371	93	26	treatment	treatment	NOUN
dti-1371	93	27	.	.	PUNCT
dti-1371	94	1	kantor	kantor	PROPN
dti-1371	94	2	et	et	PROPN
dti-1371	94	3	al2	al2	PROPN
dti-1371	94	4	concluded	conclude	VERB
dti-1371	94	5	table	table	NOUN
dti-1371	94	6	2	2	NUM
dti-1371	94	7	.	.	PUNCT
dti-1371	94	8	viral	viral	ADJ
dti-1371	94	9	load	load	NOUN
dti-1371	94	10	and	and	CCONJ
dti-1371	94	11	t	t	X
dti-1371	94	12	cd4	cd4	PROPN
dti-1371	94	13	+	+	PROPN
dti-1371	94	14	cell	cell	NOUN
dti-1371	94	15	counts	count	VERB
dti-1371	94	16	distribution	distribution	NOUN
dti-1371	94	17	in	in	ADP
dti-1371	94	18	139	139	NUM
dti-1371	94	19	patients	patient	NOUN
dti-1371	94	20	submitted	submit	VERB
dti-1371	94	21	to	to	ADP
dti-1371	94	22	antiretroviral	antiretroviral	ADJ
dti-1371	94	23	therapy	therapy	NOUN
dti-1371	94	24	in	in	ADP
dti-1371	94	25	the	the	DET
dti-1371	94	26	health	health	NOUN
dti-1371	94	27	center	center	NOUN
dti-1371	94	28	no	no	INTJ
dti-1371	94	29	.	.	NOUN
dti-1371	94	30	1	1	NUM
dti-1371	94	31	(	(	PUNCT
dti-1371	94	32	hospital	hospital	NOUN
dti-1371	94	33	dia	dia	PROPN
dti-1371	94	34	)	)	PUNCT
dti-1371	94	35	during	during	ADP
dti-1371	94	36	2002–2008	2002–2008	NUM
dti-1371	94	37	.	.	PUNCT
dti-1371	95	1	variable	variable	ADJ
dti-1371	95	2	category	category	NOUN
dti-1371	95	3	n	n	CCONJ
dti-1371	95	4	%	%	NOUN
dti-1371	95	5	initial	initial	ADJ
dti-1371	95	6	viral	viral	ADJ
dti-1371	95	7	load	load	NOUN
dti-1371	95	8	(	(	PUNCT
dti-1371	95	9	treatment	treatment	NOUN
dti-1371	95	10	-	-	PUNCT
dti-1371	95	11	naive	naive	ADJ
dti-1371	95	12	)	)	PUNCT
dti-1371	95	13	,	,	PUNCT
dti-1371	95	14	50	50	NUM
dti-1371	95	15	copies	copy	NOUN
dti-1371	95	16	/	/	SYM
dti-1371	95	17	ml	ml	NOUN
dti-1371	95	18	0	0	NUM
dti-1371	95	19	0	0	NUM
dti-1371	96	1	50.1–400	50.1–400	NUM
dti-1371	96	2	copies	copy	NOUN
dti-1371	96	3	/	/	SYM
dti-1371	96	4	ml	ml	NOUN
dti-1371	96	5	0	0	NUM
dti-1371	96	6	0	0	NUM
dti-1371	96	7	400.1–10,000	400.1–10,000	NUM
dti-1371	96	8	copies	copy	NOUN
dti-1371	96	9	/	/	SYM
dti-1371	96	10	ml	ml	PROPN
dti-1371	96	11	5	5	NUM
dti-1371	96	12	3.6	3.6	NUM
dti-1371	96	13	10,000.1–100,000	10,000.1–100,000	NUM
dti-1371	96	14	copies	copy	NOUN
dti-1371	96	15	/	/	SYM
dti-1371	96	16	ml	ml	PROPN
dti-1371	96	17	57	57	NUM
dti-1371	96	18	41.0	41.0	NUM
dti-1371	96	19	100,0000.1–500,000	100,0000.1–500,000	NUM
dti-1371	96	20	copies	copy	NOUN
dti-1371	96	21	/	/	SYM
dti-1371	96	22	ml	ml	PROPN
dti-1371	96	23	77	77	NUM
dti-1371	96	24	55.4	55.4	NUM
dti-1371	96	25	viral	viral	ADJ
dti-1371	96	26	load	load	NOUN
dti-1371	96	27	after	after	ADP
dti-1371	96	28	haart	haart	PROPN
dti-1371	96	29	,	,	PUNCT
dti-1371	96	30	50	50	NUM
dti-1371	96	31	copies	copy	NOUN
dti-1371	96	32	/	/	SYM
dti-1371	96	33	ml	ml	NOUN
dti-1371	96	34	99	99	NUM
dti-1371	96	35	71.2	71.2	NUM
dti-1371	96	36	50.1–400	50.1–400	NUM
dti-1371	96	37	copies	copy	NOUN
dti-1371	96	38	/	/	SYM
dti-1371	96	39	ml	ml	PROPN
dti-1371	96	40	20	20	NUM
dti-1371	96	41	14.4	14.4	NUM
dti-1371	96	42	400.1–10,000	400.1–10,000	NUM
dti-1371	96	43	copies	copy	NOUN
dti-1371	96	44	/	/	SYM
dti-1371	96	45	ml	ml	PROPN
dti-1371	96	46	10	10	NUM
dti-1371	96	47	7.2	7.2	NUM
dti-1371	96	48	10,000.1–100,000	10,000.1–100,000	NUM
dti-1371	96	49	copies	copy	NOUN
dti-1371	96	50	/	/	SYM
dti-1371	96	51	ml	ml	NUM
dti-1371	96	52	8	8	NUM
dti-1371	96	53	5.8	5.8	NUM
dti-1371	96	54	100,000–500,000	100,000–500,000	NUM
dti-1371	96	55	copies	copy	NOUN
dti-1371	96	56	/	/	SYM
dti-1371	96	57	ml	ml	PROPN
dti-1371	96	58	2	2	NUM
dti-1371	96	59	1.4	1.4	NUM
dti-1371	96	60	initial	initial	ADJ
dti-1371	96	61	t	t	PROPN
dti-1371	96	62	cd4	cd4	PROPN
dti-1371	96	63	+	+	PROPN
dti-1371	96	64	cell	cell	NOUN
dti-1371	96	65	counts	count	NOUN
dti-1371	96	66	(	(	PUNCT
dti-1371	96	67	treatment	treatment	NOUN
dti-1371	96	68	-	-	PUNCT
dti-1371	96	69	naive	naive	ADJ
dti-1371	96	70	)	)	PUNCT
dti-1371	96	71	0–200	0–200	NUM
dti-1371	96	72	cells	cell	NOUN
dti-1371	96	73	/	/	SYM
dti-1371	96	74	mm3	mm3	NOUN
dti-1371	96	75	96	96	NUM
dti-1371	96	76	68.4	68.4	NUM
dti-1371	96	77	200.1–350	200.1–350	NUM
dti-1371	96	78	cells	cell	NOUN
dti-1371	96	79	/	/	SYM
dti-1371	96	80	mm3	mm3	NOUN
dti-1371	96	81	37	37	NUM
dti-1371	96	82	26.6	26.6	NUM
dti-1371	96	83	351–500	351–500	NUM
dti-1371	96	84	cells/	cells/	NUM
dti-1371	96	85	7	7	NUM
dti-1371	96	86	5.0	5.0	NUM
dti-1371	96	87	above	above	ADP
dti-1371	96	88	de	de	X
dti-1371	96	89	500	500	NUM
dti-1371	96	90	cells	cell	NOUN
dti-1371	96	91	/	/	SYM
dti-1371	96	92	mm3	mm3	NOUN
dti-1371	96	93	0	0	NUM
dti-1371	96	94	0	0	NUM
dti-1371	96	95	t	t	PROPN
dti-1371	96	96	cd4	cd4	PROPN
dti-1371	96	97	+	+	NOUN
dti-1371	96	98	cell	cell	NOUN
dti-1371	96	99	counts	count	NOUN
dti-1371	96	100	after	after	ADP
dti-1371	96	101	haart	haart	PROPN
dti-1371	96	102	0–200	0–200	NUM
dti-1371	96	103	cells	cell	NOUN
dti-1371	96	104	/	/	SYM
dti-1371	96	105	mm3	mm3	NOUN
dti-1371	96	106	51	51	NUM
dti-1371	96	107	36.7	36.7	NUM
dti-1371	96	108	200.1–350	200.1–350	NUM
dti-1371	96	109	cells	cell	NOUN
dti-1371	96	110	/	/	SYM
dti-1371	96	111	mm3	mm3	NOUN
dti-1371	96	112	60	60	NUM
dti-1371	96	113	43.2	43.2	NUM
dti-1371	96	114	351–500	351–500	NUM
dti-1371	96	115	cells	cell	NOUN
dti-1371	96	116	/	/	SYM
dti-1371	96	117	mm3	mm3	NOUN
dti-1371	96	118	21	21	NUM
dti-1371	96	119	15.1	15.1	NUM
dti-1371	96	120	above	above	ADP
dti-1371	96	121	de	de	X
dti-1371	96	122	500	500	NUM
dti-1371	96	123	cells	cell	NOUN
dti-1371	96	124	/	/	SYM
dti-1371	96	125	mm3	mm3	NOUN
dti-1371	96	126	7	7	NUM
dti-1371	96	127	5.0	5.0	NUM
dti-1371	96	128	haart	haart	NOUN
dti-1371	96	129	2	2	NUM
dti-1371	96	130	itrn	itrn	NOUN
dti-1371	96	131	+	+	CCONJ
dti-1371	96	132	1	1	NUM
dti-1371	96	133	itrnn	itrnn	VERB
dti-1371	96	134	99	99	NUM
dti-1371	96	135	71.2	71.2	NUM
dti-1371	96	136	2	2	NUM
dti-1371	96	137	itrn	itrn	NOUN
dti-1371	96	138	+	+	CCONJ
dti-1371	96	139	1	1	NUM
dti-1371	96	140	ip	ip	NUM
dti-1371	96	141	39	39	NUM
dti-1371	96	142	28.1	28.1	NUM
dti-1371	96	143	3	3	NUM
dti-1371	96	144	itrn	itrn	NOUN
dti-1371	96	145	1	1	NUM
dti-1371	96	146	0.7	0.7	NUM
dti-1371	96	147	139	139	NUM
dti-1371	96	148	100	100	NUM
dti-1371	96	149	abbreviations	abbreviation	NOUN
dti-1371	96	150	:	:	PUNCT
dti-1371	96	151	haart	haart	PROPN
dti-1371	96	152	,	,	PUNCT
dti-1371	96	153	highly	highly	ADV
dti-1371	96	154	active	active	ADJ
dti-1371	96	155	antiretroviral	antiretroviral	ADJ
dti-1371	96	156	therapy	therapy	NOUN
dti-1371	96	157	;	;	PUNCT
dti-1371	96	158	nrti	nrti	NOUN
dti-1371	96	159	,	,	PUNCT
dti-1371	96	160	nucleoside	nucleoside	ADV
dti-1371	96	161	reverse	reverse	ADJ
dti-1371	96	162	transcriptase	transcriptase	NOUN
dti-1371	96	163	inhibitor	inhibitor	NOUN
dti-1371	96	164	;	;	PUNCT
dti-1371	96	165	nnrti	nnrti	PROPN
dti-1371	96	166	,	,	PUNCT
dti-1371	96	167	non	non	ADJ
dti-1371	96	168	-	-	ADJ
dti-1371	96	169	nucleoside	nucleoside	ADJ
dti-1371	96	170	reverse	reverse	ADJ
dti-1371	96	171	transcriptase	transcriptase	NOUN
dti-1371	96	172	inhibitor	inhibitor	NOUN
dti-1371	96	173	.	.	PUNCT
dti-1371	97	1	http://www.la-press.com	http://www.la-press.com	X
dti-1371	97	2	bello	bello	PROPN
dti-1371	97	3	et	et	PROPN
dti-1371	97	4	al	al	PROPN
dti-1371	97	5	38	38	NUM
dti-1371	97	6	drug	drug	NOUN
dti-1371	97	7	target	target	NOUN
dti-1371	97	8	insights	insight	NOUN
dti-1371	97	9	2011:5	2011:5	NUM
dti-1371	97	10	that	that	PRON
dti-1371	97	11	plasma	plasma	VERB
dti-1371	97	12	viral	viral	ADJ
dti-1371	97	13	load	load	NOUN
dti-1371	97	14	strongly	strongly	ADV
dti-1371	97	15	predicts	predict	VERB
dti-1371	97	16	the	the	DET
dti-1371	97	17	rate	rate	NOUN
dti-1371	97	18	of	of	ADP
dti-1371	97	19	cd4	cd4	PROPN
dti-1371	97	20	+	+	CCONJ
dti-1371	97	21	lymphocyte	lymphocyte	ADJ
dti-1371	97	22	count	count	NOUN
dti-1371	97	23	decrease	decrease	NOUN
dti-1371	97	24	,	,	PUNCT
dti-1371	97	25	progression	progression	NOUN
dti-1371	97	26	to	to	ADP
dti-1371	97	27	aids	aid	NOUN
dti-1371	97	28	and	and	CCONJ
dti-1371	97	29	death	death	NOUN
dti-1371	97	30	.	.	PUNCT
dti-1371	98	1	but	but	CCONJ
dti-1371	98	2	the	the	DET
dti-1371	98	3	prognosis	prognosis	NOUN
dti-1371	98	4	for	for	ADP
dti-1371	98	5	people	people	NOUN
dti-1371	98	6	infected	infect	VERB
dti-1371	98	7	with	with	ADP
dti-1371	98	8	hiv	hiv	PROPN
dti-1371	98	9	is	be	AUX
dti-1371	98	10	more	more	ADV
dti-1371	98	11	strictly	strictly	ADV
dti-1371	98	12	defined	define	VERB
dti-1371	98	13	by	by	ADP
dti-1371	98	14	the	the	DET
dti-1371	98	15	combination	combination	NOUN
dti-1371	98	16	of	of	ADP
dti-1371	98	17	plasma	plasma	NOUN
dti-1371	98	18	viral	viral	ADJ
dti-1371	98	19	load	load	NOUN
dti-1371	98	20	measurement	measurement	NOUN
dti-1371	98	21	and	and	CCONJ
dti-1371	98	22	cd4	cd4	PROPN
dti-1371	98	23	+	+	PROPN
dti-1371	98	24	lymphocytes	lymphocytes	ADJ
dti-1371	98	25	’	'	PUNCT
dti-1371	98	26	counts	count	NOUN
dti-1371	98	27	.	.	PUNCT
dti-1371	99	1	some	some	DET
dti-1371	99	2	patients	patient	NOUN
dti-1371	99	3	with	with	ADP
dti-1371	99	4	viral	viral	ADJ
dti-1371	99	5	load	load	NOUN
dti-1371	99	6	higher	high	ADJ
dti-1371	99	7	than	than	ADP
dti-1371	99	8	100.000	100.000	NUM
dti-1371	99	9	copies	copy	NOUN
dti-1371	99	10	/	/	PUNCT
dti-1371	99	11	ml	ml	VERB
dti-1371	99	12	remained	remain	VERB
dti-1371	99	13	in	in	ADP
dti-1371	99	14	treatment	treatment	NOUN
dti-1371	99	15	failure	failure	NOUN
dti-1371	99	16	after	after	ADP
dti-1371	99	17	haart	haart	PROPN
dti-1371	99	18	regimen	regimen	PROPN
dti-1371	99	19	in	in	ADP
dti-1371	99	20	contrast	contrast	NOUN
dti-1371	99	21	to	to	ADP
dti-1371	99	22	t	t	PROPN
dti-1371	99	23	cd4	cd4	PROPN
dti-1371	99	24	+	+	PROPN
dti-1371	99	25	lymphocyte	lymphocyte	ADJ
dti-1371	99	26	counts	count	NOUN
dti-1371	99	27	decrease	decrease	VERB
dti-1371	99	28	at	at	ADP
dti-1371	99	29	a	a	DET
dti-1371	99	30	slower	slow	ADJ
dti-1371	99	31	pace	pace	NOUN
dti-1371	99	32	,	,	PUNCT
dti-1371	99	33	leaving	leave	VERB
dti-1371	99	34	some	some	PRON
dti-1371	99	35	in	in	ADP
dti-1371	99	36	virologic	virologic	ADJ
dti-1371	99	37	failure	failure	NOUN
dti-1371	99	38	,	,	PUNCT
dti-1371	99	39	probably	probably	ADV
dti-1371	99	40	due	due	ADP
dti-1371	99	41	to	to	ADP
dti-1371	99	42	the	the	DET
dti-1371	99	43	emergence	emergence	NOUN
dti-1371	99	44	of	of	ADP
dti-1371	99	45	hiv	hiv	PROPN
dti-1371	99	46	resistant	resistant	ADJ
dti-1371	99	47	strains	strain	NOUN
dti-1371	99	48	.	.	PUNCT
dti-1371	100	1	cozzi	cozzi	ADJ
dti-1371	100	2	-	-	PUNCT
dti-1371	100	3	lepri	lepri	PROPN
dti-1371	100	4	et	et	NOUN
dti-1371	100	5	al7	al7	NOUN
dti-1371	100	6	advocate	advocate	VERB
dti-1371	100	7	that	that	SCONJ
dti-1371	100	8	patients	patient	NOUN
dti-1371	100	9	who	who	PRON
dti-1371	100	10	remained	remain	VERB
dti-1371	100	11	in	in	ADP
dti-1371	100	12	haart	haart	PROPN
dti-1371	100	13	regimen	regimen	NOUN
dti-1371	100	14	failure	failure	NOUN
dti-1371	100	15	,	,	PUNCT
dti-1371	100	16	the	the	DET
dti-1371	100	17	viral	viral	ADJ
dti-1371	100	18	load	load	NOUN
dti-1371	100	19	in	in	ADP
dti-1371	100	20	the	the	DET
dti-1371	100	21	next	next	ADJ
dti-1371	100	22	twelve	twelve	NUM
dti-1371	100	23	months	month	NOUN
dti-1371	100	24	was	be	AUX
dti-1371	100	25	growing	grow	VERB
dti-1371	100	26	at	at	ADP
dti-1371	100	27	a	a	DET
dti-1371	100	28	relatively	relatively	ADV
dti-1371	100	29	slow	slow	ADJ
dti-1371	100	30	pace	pace	NOUN
dti-1371	100	31	,	,	PUNCT
dti-1371	100	32	the	the	DET
dti-1371	100	33	cd4	cd4	PROPN
dti-1371	100	34	+	+	PROPN
dti-1371	100	35	t	t	NOUN
dti-1371	100	36	cell	cell	NOUN
dti-1371	100	37	count	count	NOUN
dti-1371	100	38	was	be	AUX
dti-1371	100	39	stable	stable	ADJ
dti-1371	100	40	and	and	CCONJ
dti-1371	100	41	the	the	DET
dti-1371	100	42	time	time	NOUN
dti-1371	100	43	course	course	NOUN
dti-1371	100	44	of	of	ADP
dti-1371	100	45	viral	viral	ADJ
dti-1371	100	46	replication	replication	NOUN
dti-1371	100	47	in	in	ADP
dti-1371	100	48	patients	patient	NOUN
dti-1371	100	49	with	with	ADP
dti-1371	100	50	virological	virological	ADJ
dti-1371	100	51	failure	failure	NOUN
dti-1371	100	52	table	table	NOUN
dti-1371	100	53	3	3	NUM
dti-1371	100	54	.	.	PUNCT
dti-1371	100	55	distribution	distribution	NOUN
dti-1371	100	56	of	of	ADP
dti-1371	100	57	variables	variable	NOUN
dti-1371	100	58	,	,	PUNCT
dti-1371	100	59	viral	viral	ADJ
dti-1371	100	60	load	load	NOUN
dti-1371	100	61	,	,	PUNCT
dti-1371	100	62	t	t	PROPN
dti-1371	100	63	cd4	cd4	PROPN
dti-1371	100	64	+	+	PROPN
dti-1371	100	65	cell	cell	NOUN
dti-1371	100	66	counts	count	NOUN
dti-1371	100	67	,	,	PUNCT
dti-1371	100	68	haart	haart	PROPN
dti-1371	100	69	and	and	CCONJ
dti-1371	100	70	comorbidity	comorbidity	NOUN
dti-1371	100	71	in	in	ADP
dti-1371	100	72	relation	relation	NOUN
dti-1371	100	73	to	to	ADP
dti-1371	100	74	the	the	DET
dti-1371	100	75	significance	significance	NOUN
dti-1371	100	76	of	of	ADP
dti-1371	100	77	virologic	virologic	ADJ
dti-1371	100	78	failure	failure	NOUN
dti-1371	100	79	in	in	ADP
dti-1371	100	80	patients	patient	NOUN
dti-1371	100	81	treated	treat	VERB
dti-1371	100	82	at	at	ADP
dti-1371	100	83	the	the	DET
dti-1371	100	84	health	health	NOUN
dti-1371	100	85	centre	centre	NOUN
dti-1371	100	86	no	no	INTJ
dti-1371	100	87	.	.	NOUN
dti-1371	100	88	1	1	NUM
dti-1371	100	89	(	(	PUNCT
dti-1371	100	90	hospital	hospital	NOUN
dti-1371	100	91	dia	dia	PROPN
dti-1371	100	92	)	)	PUNCT
dti-1371	100	93	during	during	ADP
dti-1371	100	94	2002–2008	2002–2008	NUM
dti-1371	100	95	.	.	PUNCT
dti-1371	101	1	variable	variable	ADJ
dti-1371	101	2	category	category	NOUN
dti-1371	101	3	vf	vf	NOUN
dti-1371	101	4	n	n	NUM
dti-1371	101	5	ci%	ci%	ADJ
dti-1371	101	6	rr	rr	NOUN
dti-1371	102	1	ci95	ci95	PROPN
dti-1371	102	2	%	%	NOUN
dti-1371	102	3	p	p	NOUN
dti-1371	102	4	sex	sex	NOUN
dti-1371	102	5	male	male	NOUN
dti-1371	102	6	103	103	NUM
dti-1371	102	7	14	14	NUM
dti-1371	102	8	13.6	13.6	NUM
dti-1371	102	9	1.63	1.63	NUM
dti-1371	102	10	0.49–5.35	0.49–5.35	NUM
dti-1371	102	11	0.407	0.407	NUM
dti-1371	102	12	female	female	ADJ
dti-1371	102	13	36	36	NUM
dti-1371	102	14	3	3	NUM
dti-1371	102	15	8.3	8.3	NUM
dti-1371	102	16	age	age	NOUN
dti-1371	102	17	41–65	41–65	NUM
dti-1371	102	18	60	60	NUM
dti-1371	102	19	10	10	NUM
dti-1371	102	20	16.7	16.7	NUM
dti-1371	102	21	1.88	1.88	NUM
dti-1371	102	22	0.76–4.75	0.76–4.75	NUM
dti-1371	102	23	0.164	0.164	NUM
dti-1371	102	24	20–40	20–40	NUM
dti-1371	102	25	79	79	NUM
dti-1371	102	26	7	7	NUM
dti-1371	102	27	8.9	8.9	NUM
dti-1371	102	28	race	race	NOUN
dti-1371	102	29	mestizo	mestizo	NOUN
dti-1371	102	30	79	79	NUM
dti-1371	102	31	10	10	NUM
dti-1371	102	32	12.7	12.7	NUM
dti-1371	102	33	1.08	1.08	NUM
dti-1371	102	34	0.43–2.68	0.43–2.68	NUM
dti-1371	102	35	0.860	0.860	NUM
dti-1371	102	36	white	white	ADJ
dti-1371	102	37	60	60	NUM
dti-1371	102	38	7	7	NUM
dti-1371	102	39	11.7	11.7	NUM
dti-1371	102	40	marital	marital	ADJ
dti-1371	102	41	status	status	NOUN
dti-1371	102	42	single	single	ADJ
dti-1371	102	43	/	/	SYM
dti-1371	102	44	separate	separate	ADJ
dti-1371	102	45	80	80	NUM
dti-1371	102	46	11	11	NUM
dti-1371	102	47	13.8	13.8	NUM
dti-1371	102	48	1.35	1.35	NUM
dti-1371	102	49	0.53–3.44	0.53–3.44	NUM
dti-1371	102	50	0.524	0.524	NUM
dti-1371	102	51	married	married	ADJ
dti-1371	102	52	/	/	SYM
dti-1371	102	53	stable	stable	ADJ
dti-1371	102	54	union	union	NOUN
dti-1371	102	55	59	59	NUM
dti-1371	102	56	6	6	NUM
dti-1371	102	57	10.2	10.2	NUM
dti-1371	102	58	education	education	NOUN
dti-1371	102	59	nf	nf	NOUN
dti-1371	102	60	incomplete	incomplete	ADJ
dti-1371	102	61	/	/	SYM
dti-1371	102	62	illiterate	illiterate	ADJ
dti-1371	102	63	38	38	NUM
dti-1371	102	64	6	6	NUM
dti-1371	102	65	15.8	15.8	NUM
dti-1371	102	66	1.45	1.45	NUM
dti-1371	102	67	0.57–3.64	0.57–3.64	NUM
dti-1371	102	68	0.432	0.432	NUM
dti-1371	102	69	other	other	ADJ
dti-1371	102	70	school	school	NOUN
dti-1371	102	71	levels	level	NOUN
dti-1371	102	72	101	101	NUM
dti-1371	102	73	11	11	NUM
dti-1371	102	74	10.9	10.9	NUM
dti-1371	102	75	residence	residence	NOUN
dti-1371	102	76	brasilia	brasilia	PROPN
dti-1371	102	77	suroundings	surounding	NOUN
dti-1371	102	78	19	19	NUM
dti-1371	102	79	3	3	NUM
dti-1371	102	80	15.8	15.8	NUM
dti-1371	102	81	1.35	1.35	NUM
dti-1371	102	82	0.42–4.27	0.42–4.27	NUM
dti-1371	102	83	0.610	0.610	NUM
dti-1371	102	84	pilot	pilot	NOUN
dti-1371	102	85	plan	plan	PROPN
dti-1371	102	86	/	/	SYM
dti-1371	102	87	satellite	satellite	PROPN
dti-1371	102	88	city	city	NOUN
dti-1371	102	89	120	120	NUM
dti-1371	102	90	14	14	NUM
dti-1371	102	91	11.7	11.7	NUM
dti-1371	102	92	birthplace	birthplace	NOUN
dti-1371	102	93	midwest	midwest	NOUN
dti-1371	102	94	56	56	NUM
dti-1371	102	95	11	11	NUM
dti-1371	102	96	19.6	19.6	NUM
dti-1371	102	97	2.71	2.71	NUM
dti-1371	102	98	1.06–6.92	1.06–6.92	NUM
dti-1371	102	99	0.028	0.028	NUM
dti-1371	102	100	north	north	NOUN
dti-1371	102	101	,	,	PUNCT
dti-1371	102	102	northeast	northeast	ADV
dti-1371	102	103	,	,	PUNCT
dti-1371	102	104	south	south	NOUN
dti-1371	102	105	,	,	PUNCT
dti-1371	102	106	southeast	southeast	NOUN
dti-1371	102	107	83	83	NUM
dti-1371	102	108	6	6	NUM
dti-1371	102	109	7.2	7.2	NUM
dti-1371	102	110	exposury	exposury	NOUN
dti-1371	102	111	category	category	NOUN
dti-1371	102	112	heterosexual	heterosexual	ADJ
dti-1371	102	113	83	83	NUM
dti-1371	102	114	11	11	NUM
dti-1371	102	115	13.3	13.3	NUM
dti-1371	102	116	1.23	1.23	NUM
dti-1371	102	117	0.48–3.15	0.48–3.15	NUM
dti-1371	102	118	0.654	0.654	NUM
dti-1371	102	119	homosexual	homosexual	NOUN
dti-1371	102	120	56	56	NUM
dti-1371	102	121	6	6	NUM
dti-1371	102	122	10.7	10.7	NUM
dti-1371	102	123	abbreviations	abbreviation	NOUN
dti-1371	102	124	:	:	PUNCT
dti-1371	102	125	n	n	CCONJ
dti-1371	102	126	,	,	PUNCT
dti-1371	102	127	patients	patient	NOUN
dti-1371	102	128	number	number	NOUN
dti-1371	102	129	;	;	PUNCT
dti-1371	102	130	vf	vf	X
dti-1371	102	131	,	,	PUNCT
dti-1371	102	132	virological	virological	ADJ
dti-1371	102	133	failure	failure	NOUN
dti-1371	102	134	;	;	PUNCT
dti-1371	102	135	ci	ci	NOUN
dti-1371	102	136	,	,	PUNCT
dti-1371	102	137	incidence	incidence	NOUN
dti-1371	102	138	coefficient	coefficient	NOUN
dti-1371	102	139	;	;	PUNCT
dti-1371	102	140	rr	rr	NOUN
dti-1371	102	141	,	,	PUNCT
dti-1371	102	142	relative	relative	ADJ
dti-1371	102	143	risk	risk	NOUN
dti-1371	102	144	;	;	PUNCT
dti-1371	102	145	ic95	ic95	PROPN
dti-1371	102	146	%	%	NOUN
dti-1371	102	147	,	,	PUNCT
dti-1371	102	148	interval	interval	NOUN
dti-1371	102	149	confidence	confidence	NOUN
dti-1371	102	150	;	;	PUNCT
dti-1371	102	151	p	p	X
dti-1371	102	152	,	,	PUNCT
dti-1371	102	153	significance	significance	NOUN
dti-1371	102	154	:	:	PUNCT
dti-1371	102	155	nf	nf	ADJ
dti-1371	102	156	,	,	PUNCT
dti-1371	102	157	uninformed	uninformed	ADJ
dti-1371	102	158	.	.	PUNCT
dti-1371	103	1	table	table	NOUN
dti-1371	103	2	4	4	NUM
dti-1371	103	3	.	.	PUNCT
dti-1371	104	1	distribution	distribution	NOUN
dti-1371	104	2	of	of	ADP
dti-1371	104	3	association	association	NOUN
dti-1371	104	4	of	of	ADP
dti-1371	104	5	viral	viral	ADJ
dti-1371	104	6	load	load	NOUN
dti-1371	104	7	,	,	PUNCT
dti-1371	104	8	t	t	PROPN
dti-1371	104	9	cd4	cd4	PROPN
dti-1371	104	10	+	+	PROPN
dti-1371	104	11	cell	cell	NOUN
dti-1371	104	12	count	count	NOUN
dti-1371	104	13	,	,	PUNCT
dti-1371	104	14	haart	haart	PROPN
dti-1371	104	15	and	and	CCONJ
dti-1371	104	16	comorbidities	comorbiditie	NOUN
dti-1371	104	17	in	in	ADP
dti-1371	104	18	terms	term	NOUN
dti-1371	104	19	of	of	ADP
dti-1371	104	20	the	the	DET
dti-1371	104	21	significance	significance	NOUN
dti-1371	104	22	of	of	ADP
dti-1371	104	23	virologic	virologic	ADJ
dti-1371	104	24	failure	failure	NOUN
dti-1371	104	25	in	in	ADP
dti-1371	104	26	patients	patient	NOUN
dti-1371	104	27	treated	treat	VERB
dti-1371	104	28	at	at	ADP
dti-1371	104	29	the	the	DET
dti-1371	104	30	health	health	NOUN
dti-1371	104	31	centre	centre	NOUN
dti-1371	104	32	no	no	INTJ
dti-1371	104	33	.	.	NOUN
dti-1371	104	34	1	1	NUM
dti-1371	104	35	during	during	ADP
dti-1371	104	36	the	the	DET
dti-1371	104	37	years	year	NOUN
dti-1371	104	38	2002	2002	NUM
dti-1371	104	39	to	to	ADP
dti-1371	104	40	2008	2008	NUM
dti-1371	104	41	.	.	PUNCT
dti-1371	105	1	variable	variable	ADJ
dti-1371	105	2	category	category	NOUN
dti-1371	105	3	n	n	PART
dti-1371	105	4	vf	vf	X
dti-1371	105	5	ic%	ic%	NUM
dti-1371	105	6	rr	rr	NOUN
dti-1371	105	7	ic95	ic95	PROPN
dti-1371	105	8	%	%	NOUN
dti-1371	105	9	p	p	ADJ
dti-1371	105	10	viral	viral	ADJ
dti-1371	105	11	load	load	NOUN
dti-1371	105	12	after	after	ADP
dti-1371	105	13	haart	haart	PROPN
dti-1371	105	14	.100.000	.100.000	PROPN
dti-1371	106	1	77	77	NUM
dti-1371	106	2	10	10	NUM
dti-1371	106	3	13.0	13.0	NUM
dti-1371	106	4	1.15	1.15	NUM
dti-1371	106	5	0.46–2.84	0.46–2.84	ADV
dti-1371	106	6	0.762	0.762	NUM
dti-1371	106	7	#	#	SYM
dti-1371	106	8	100.000	100.000	NUM
dti-1371	106	9	62	62	NUM
dti-1371	106	10	7	7	NUM
dti-1371	106	11	11.3	11.3	NUM
dti-1371	106	12	t	t	PROPN
dti-1371	106	13	cd4	cd4	PROPN
dti-1371	106	14	+	+	PROPN
dti-1371	106	15	cell	cell	NOUN
dti-1371	106	16	after	after	ADP
dti-1371	106	17	haart	haart	PROPN
dti-1371	106	18	.200	.200	NUM
dti-1371	106	19	95	95	NUM
dti-1371	106	20	8	8	NUM
dti-1371	106	21	10.5	10.5	NUM
dti-1371	106	22	0.66	0.66	NUM
dti-1371	106	23	0.27–1.63	0.27–1.63	NUM
dti-1371	106	24	0.368	0.368	NUM
dti-1371	106	25	#	#	SYM
dti-1371	106	26	200	200	NUM
dti-1371	106	27	44	44	NUM
dti-1371	106	28	9	9	NUM
dti-1371	106	29	15.9	15.9	NUM
dti-1371	106	30	haart	haart	NOUN
dti-1371	106	31	2	2	NUM
dti-1371	106	32	itrn	itrn	NOUN
dti-1371	106	33	+	+	CCONJ
dti-1371	106	34	1	1	NUM
dti-1371	106	35	itrnn	itrnn	VERB
dti-1371	106	36	100	100	NUM
dti-1371	106	37	12	12	NUM
dti-1371	106	38	12.0	12.0	NUM
dti-1371	106	39	0.93	0.93	NUM
dti-1371	106	40	0.35–2.48	0.35–2.48	NUM
dti-1371	106	41	0.804	0.804	NUM
dti-1371	106	42	2	2	NUM
dti-1371	106	43	itrnn	itrnn	NOUN
dti-1371	106	44	+	+	X
dti-1371	106	45	1	1	NUM
dti-1371	106	46	ip	ip	NUM
dti-1371	106	47	39	39	NUM
dti-1371	106	48	5	5	NUM
dti-1371	106	49	12.8	12.8	NUM
dti-1371	106	50	hcv	hcv	NOUN
dti-1371	106	51	(	(	PUNCT
dti-1371	106	52	hcv	hcv	NOUN
dti-1371	106	53	-	-	PUNCT
dti-1371	106	54	anti	anti	NOUN
dti-1371	106	55	)	)	PUNCT
dti-1371	106	56	positive	positive	ADJ
dti-1371	106	57	10	10	NUM
dti-1371	106	58	1	1	NUM
dti-1371	106	59	10.0	10.0	NUM
dti-1371	106	60	0.80	0.80	NUM
dti-1371	106	61	0.11–3.47	0.11–3.47	NUM
dti-1371	106	62	0.823	0.823	NUM
dti-1371	106	63	negative	negative	ADJ
dti-1371	106	64	129	129	NUM
dti-1371	106	65	16	16	NUM
dti-1371	106	66	12.4	12.4	NUM
dti-1371	106	67	hbv	hbv	NOUN
dti-1371	106	68	(	(	PUNCT
dti-1371	106	69	hbsag	hbsag	NOUN
dti-1371	106	70	)	)	PUNCT
dti-1371	106	71	positive	positive	ADJ
dti-1371	106	72	31	31	NUM
dti-1371	106	73	3	3	NUM
dti-1371	106	74	9.7	9.7	NUM
dti-1371	106	75	0.74	0.74	NUM
dti-1371	106	76	0.22–2.43	0.22–2.43	NUM
dti-1371	106	77	0.623	0.623	NUM
dti-1371	106	78	negative	negative	ADJ
dti-1371	106	79	108	108	NUM
dti-1371	106	80	14	14	NUM
dti-1371	106	81	13.9	13.9	NUM
dti-1371	106	82	tb	tb	X
dti-1371	106	83	(	(	PUNCT
dti-1371	106	84	baar	baar	PROPN
dti-1371	106	85	)	)	PUNCT
dti-1371	106	86	positive	positive	ADJ
dti-1371	106	87	22	22	NUM
dti-1371	106	88	6	6	NUM
dti-1371	106	89	27.3	27.3	NUM
dti-1371	106	90	2.90	2.90	NUM
dti-1371	106	91	1.19–7.02	1.19–7.02	NUM
dti-1371	106	92	0.019	0.019	NUM
dti-1371	106	93	negative	negative	ADJ
dti-1371	106	94	117	117	NUM
dti-1371	106	95	11	11	NUM
dti-1371	106	96	10.3	10.3	NUM
dti-1371	106	97	total	total	NOUN
dti-1371	106	98	139	139	NUM
dti-1371	106	99	17	17	NUM
dti-1371	106	100	abbreviations	abbreviation	NOUN
dti-1371	106	101	:	:	PUNCT
dti-1371	106	102	haart	haart	PROPN
dti-1371	106	103	,	,	PUNCT
dti-1371	106	104	antiretroviral	antiretroviral	ADJ
dti-1371	106	105	therapy	therapy	NOUN
dti-1371	106	106	;	;	PUNCT
dti-1371	106	107	t	t	PROPN
dti-1371	106	108	cd4	cd4	PROPN
dti-1371	106	109	+	+	PROPN
dti-1371	106	110	,	,	PUNCT
dti-1371	106	111	lymphocyte	lymphocyte	ADJ
dti-1371	106	112	count	count	NOUN
dti-1371	106	113	;	;	PUNCT
dti-1371	106	114	n	n	CCONJ
dti-1371	106	115	,	,	PUNCT
dti-1371	106	116	number	number	NOUN
dti-1371	106	117	of	of	ADP
dti-1371	106	118	patients	patient	NOUN
dti-1371	106	119	;	;	PUNCT
dti-1371	106	120	vf	vf	X
dti-1371	106	121	,	,	PUNCT
dti-1371	106	122	virologic	virologic	ADJ
dti-1371	106	123	failure	failure	NOUN
dti-1371	106	124	values	value	NOUN
dti-1371	106	125	;	;	PUNCT
dti-1371	106	126	ci	ci	NOUN
dti-1371	106	127	,	,	PUNCT
dti-1371	106	128	incidence	incidence	NOUN
dti-1371	106	129	rate	rate	NOUN
dti-1371	106	130	;	;	PUNCT
dti-1371	106	131	rr	rr	NOUN
dti-1371	106	132	,	,	PUNCT
dti-1371	106	133	relative	relative	ADJ
dti-1371	106	134	risk	risk	NOUN
dti-1371	106	135	;	;	PUNCT
dti-1371	106	136	ic95	ic95	PROPN
dti-1371	106	137	%	%	NOUN
dti-1371	106	138	,	,	PUNCT
dti-1371	106	139	confidence	confidence	NOUN
dti-1371	106	140	interval	interval	NOUN
dti-1371	106	141	;	;	PUNCT
dti-1371	106	142	p	p	X
dti-1371	106	143	,	,	PUNCT
dti-1371	106	144	significance	significance	NOUN
dti-1371	106	145	;	;	PUNCT
dti-1371	106	146	hcv	hcv	NOUN
dti-1371	106	147	,	,	PUNCT
dti-1371	106	148	antibody	antibody	NOUN
dti-1371	106	149	to	to	ADP
dti-1371	106	150	the	the	DET
dti-1371	106	151	hepatitis	hepatitis	NOUN
dti-1371	106	152	“	"	PUNCT
dti-1371	106	153	c”virus	c”virus	PROPN
dti-1371	106	154	;	;	PUNCT
dti-1371	106	155	hbv	hbv	NOUN
dti-1371	106	156	,	,	PUNCT
dti-1371	106	157	antibody	antibody	NOUN
dti-1371	106	158	against	against	ADP
dti-1371	106	159	hepatitis	hepatitis	NOUN
dti-1371	106	160	“	"	PUNCT
dti-1371	106	161	b	b	PROPN
dti-1371	106	162	”	"	PUNCT
dti-1371	106	163	virus	virus	NOUN
dti-1371	106	164	antigens	antigen	NOUN
dti-1371	106	165	;	;	PUNCT
dti-1371	106	166	tb	tb	NOUN
dti-1371	106	167	,	,	PUNCT
dti-1371	106	168	tuberculosis	tuberculosis	NOUN
dti-1371	106	169	;	;	PUNCT
dti-1371	106	170	baar	baar	NOUN
dti-1371	106	171	,	,	PUNCT
dti-1371	106	172	alcohol	alcohol	NOUN
dti-1371	106	173	acid	acid	NOUN
dti-1371	106	174	resistant	resistant	ADJ
dti-1371	106	175	bacilli	bacilli	NOUN
dti-1371	106	176	.	.	PUNCT
dti-1371	107	1	http://www.la-press.com	http://www.la-press.com	X
dti-1371	108	1	antiretroviral	antiretroviral	ADJ
dti-1371	108	2	treatment	treatment	NOUN
dti-1371	108	3	in	in	ADP
dti-1371	108	4	the	the	DET
dti-1371	108	5	federal	federal	ADJ
dti-1371	108	6	district	district	PROPN
dti-1371	108	7	,	,	PUNCT
dti-1371	108	8	brazil	brazil	PROPN
dti-1371	108	9	,	,	PUNCT
dti-1371	108	10	federal	federal	ADJ
dti-1371	108	11	district	district	NOUN
dti-1371	108	12	drug	drug	NOUN
dti-1371	108	13	target	target	NOUN
dti-1371	108	14	insights	insight	NOUN
dti-1371	108	15	2011:5	2011:5	NUM
dti-1371	108	16	39	39	NUM
dti-1371	108	17	had	have	AUX
dti-1371	108	18	not	not	PART
dti-1371	108	19	been	be	AUX
dti-1371	108	20	fully	fully	ADV
dti-1371	108	21	elucidated	elucidated	ADJ
dti-1371	108	22	.	.	PUNCT
dti-1371	109	1	asjo	asjo	PROPN
dti-1371	109	2	and	and	CCONJ
dti-1371	109	3	langeland20	langeland20	NOUN
dti-1371	109	4	suggest	suggest	VERB
dti-1371	109	5	that	that	SCONJ
dti-1371	109	6	the	the	DET
dti-1371	109	7	lack	lack	NOUN
dti-1371	109	8	of	of	ADP
dti-1371	109	9	complete	complete	ADJ
dti-1371	109	10	suppression	suppression	NOUN
dti-1371	109	11	of	of	ADP
dti-1371	109	12	viral	viral	ADJ
dti-1371	109	13	replication	replication	NOUN
dti-1371	109	14	allows	allow	VERB
dti-1371	109	15	the	the	DET
dti-1371	109	16	continued	continue	VERB
dti-1371	109	17	development	development	NOUN
dti-1371	109	18	of	of	ADP
dti-1371	109	19	hiv	hiv	PROPN
dti-1371	109	20	variants	variant	NOUN
dti-1371	109	21	with	with	ADP
dti-1371	109	22	different	different	ADJ
dti-1371	109	23	degrees	degree	NOUN
dti-1371	109	24	of	of	ADP
dti-1371	109	25	resistance	resistance	NOUN
dti-1371	109	26	.	.	PUNCT
dti-1371	110	1	it	it	PRON
dti-1371	110	2	results	result	VERB
dti-1371	110	3	not	not	PART
dti-1371	110	4	only	only	ADV
dti-1371	110	5	in	in	ADP
dti-1371	110	6	treatment	treatment	NOUN
dti-1371	110	7	failure	failure	NOUN
dti-1371	110	8	,	,	PUNCT
dti-1371	110	9	but	but	CCONJ
dti-1371	110	10	it	it	PRON
dti-1371	110	11	also	also	ADV
dti-1371	110	12	increases	increase	VERB
dti-1371	110	13	the	the	DET
dti-1371	110	14	risk	risk	NOUN
dti-1371	110	15	of	of	ADP
dti-1371	110	16	hiv	hiv	PROPN
dti-1371	110	17	primary	primary	ADJ
dti-1371	110	18	resistance	resistance	NOUN
dti-1371	110	19	and	and	CCONJ
dti-1371	110	20	dissemination	dissemination	NOUN
dti-1371	110	21	.	.	PUNCT
dti-1371	111	1	patients	patient	NOUN
dti-1371	111	2	with	with	ADP
dti-1371	111	3	initial	initial	ADJ
dti-1371	111	4	cd4	cd4	PROPN
dti-1371	111	5	+	+	PROPN
dti-1371	111	6	t	t	NOUN
dti-1371	111	7	cell	cell	NOUN
dti-1371	111	8	count	count	NOUN
dti-1371	111	9	#	#	NOUN
dti-1371	111	10	200	200	NUM
dti-1371	111	11	cells	cell	NOUN
dti-1371	111	12	/	/	SYM
dti-1371	111	13	mm3	mm3	NOUN
dti-1371	111	14	had	have	VERB
dti-1371	111	15	a	a	DET
dti-1371	111	16	tendency	tendency	NOUN
dti-1371	111	17	to	to	PART
dti-1371	111	18	virologic	virologic	ADJ
dti-1371	111	19	failure	failure	NOUN
dti-1371	111	20	,	,	PUNCT
dti-1371	111	21	however	however	ADV
dti-1371	111	22	,	,	PUNCT
dti-1371	111	23	there	there	PRON
dti-1371	111	24	was	be	VERB
dti-1371	111	25	not	not	PART
dti-1371	111	26	any	any	DET
dti-1371	111	27	statistical	statistical	ADJ
dti-1371	111	28	significance	significance	NOUN
dti-1371	111	29	.	.	PUNCT
dti-1371	112	1	tuberculosis	tuberculosis	NOUN
dti-1371	112	2	coinfection	coinfection	NOUN
dti-1371	112	3	was	be	AUX
dti-1371	112	4	associated	associate	VERB
dti-1371	112	5	with	with	ADP
dti-1371	112	6	virologic	virologic	ADJ
dti-1371	112	7	failure	failure	NOUN
dti-1371	112	8	demonstrated	demonstrate	VERB
dti-1371	112	9	with	with	ADP
dti-1371	112	10	statistical	statistical	ADJ
dti-1371	112	11	significance	significance	NOUN
dti-1371	112	12	,	,	PUNCT
dti-1371	112	13	p	p	X
dti-1371	112	14	=	=	NOUN
dti-1371	112	15	0.019	0.019	NUM
dti-1371	112	16	.	.	PUNCT
dti-1371	113	1	patients	patient	NOUN
dti-1371	113	2	with	with	ADP
dti-1371	113	3	a	a	DET
dti-1371	113	4	previous	previous	ADJ
dti-1371	113	5	diagnosis	diagnosis	NOUN
dti-1371	113	6	of	of	ADP
dti-1371	113	7	tuberculosis	tuberculosis	NOUN
dti-1371	113	8	infection	infection	NOUN
dti-1371	113	9	had	have	VERB
dti-1371	113	10	2.9	2.9	NUM
dti-1371	113	11	times	time	NOUN
dti-1371	113	12	great	great	ADJ
dti-1371	113	13	risk	risk	NOUN
dti-1371	113	14	of	of	ADP
dti-1371	113	15	virologic	virologic	ADJ
dti-1371	113	16	failure	failure	NOUN
dti-1371	113	17	.	.	PUNCT
dti-1371	114	1	it	it	PRON
dti-1371	114	2	is	be	AUX
dti-1371	114	3	observed	observe	VERB
dti-1371	114	4	that	that	SCONJ
dti-1371	114	5	the	the	DET
dti-1371	114	6	t	t	PROPN
dti-1371	114	7	cd4	cd4	PROPN
dti-1371	114	8	+	+	PROPN
dti-1371	114	9	cell	cell	NOUN
dti-1371	114	10	count	count	NOUN
dti-1371	114	11	baseline	baseline	NOUN
dti-1371	114	12	above	above	ADP
dti-1371	114	13	200	200	NUM
dti-1371	114	14	cells	cell	NOUN
dti-1371	114	15	/	/	SYM
dti-1371	114	16	mm3	mm3	NOUN
dti-1371	114	17	was	be	AUX
dti-1371	114	18	not	not	PART
dti-1371	114	19	statistically	statistically	ADV
dti-1371	114	20	associated	associate	VERB
dti-1371	114	21	with	with	ADP
dti-1371	114	22	virological	virological	ADJ
dti-1371	114	23	failure	failure	NOUN
dti-1371	114	24	,	,	PUNCT
dti-1371	114	25	but	but	CCONJ
dti-1371	114	26	the	the	DET
dti-1371	114	27	incidence	incidence	NOUN
dti-1371	114	28	of	of	ADP
dti-1371	114	29	failure	failure	NOUN
dti-1371	114	30	in	in	ADP
dti-1371	114	31	this	this	DET
dti-1371	114	32	group	group	NOUN
dti-1371	114	33	was	be	AUX
dti-1371	114	34	noticeably	noticeably	ADV
dti-1371	114	35	lower	low	ADJ
dti-1371	114	36	than	than	ADP
dti-1371	114	37	in	in	ADP
dti-1371	114	38	those	those	PRON
dti-1371	114	39	with	with	ADP
dti-1371	114	40	initial	initial	ADJ
dti-1371	114	41	t	t	PROPN
dti-1371	114	42	cd4	cd4	PROPN
dti-1371	114	43	+	+	PROPN
dti-1371	114	44	less	less	ADJ
dti-1371	114	45	than	than	ADP
dti-1371	114	46	200	200	NUM
dti-1371	114	47	cells	cell	NOUN
dti-1371	114	48	/	/	SYM
dti-1371	114	49	mm3	mm3	NOUN
dti-1371	114	50	.	.	PUNCT
dti-1371	115	1	studies	study	NOUN
dti-1371	115	2	conducted	conduct	VERB
dti-1371	115	3	by	by	ADP
dti-1371	115	4	skowron	skowron	ADJ
dti-1371	115	5	et	et	PROPN
dti-1371	116	1	al21	al21	PROPN
dti-1371	116	2	demonstrated	demonstrate	VERB
dti-1371	116	3	that	that	SCONJ
dti-1371	116	4	t	t	PROPN
dti-1371	116	5	cd4	cd4	PROPN
dti-1371	116	6	+	+	PROPN
dti-1371	116	7	cell	cell	NOUN
dti-1371	116	8	count	count	NOUN
dti-1371	116	9	is	be	AUX
dti-1371	116	10	a	a	DET
dti-1371	116	11	better	well	ADJ
dti-1371	116	12	predictor	predictor	NOUN
dti-1371	116	13	of	of	ADP
dti-1371	116	14	viral	viral	ADJ
dti-1371	116	15	suppression	suppression	NOUN
dti-1371	116	16	.	.	PUNCT
dti-1371	117	1	however	however	ADV
dti-1371	117	2	,	,	PUNCT
dti-1371	117	3	in	in	ADP
dti-1371	117	4	order	order	NOUN
dti-1371	117	5	to	to	PART
dti-1371	117	6	achieve	achieve	VERB
dti-1371	117	7	viral	viral	ADJ
dti-1371	117	8	load	load	NOUN
dti-1371	117	9	suppression	suppression	NOUN
dti-1371	117	10	to	to	ADP
dti-1371	117	11	undetectable	undetectable	ADJ
dti-1371	117	12	levels	level	NOUN
dti-1371	117	13	,	,	PUNCT
dti-1371	117	14	it	it	PRON
dti-1371	117	15	is	be	AUX
dti-1371	117	16	necessary	necessary	ADJ
dti-1371	117	17	to	to	PART
dti-1371	117	18	have	have	VERB
dti-1371	117	19	an	an	DET
dti-1371	117	20	optimal	optimal	ADJ
dti-1371	117	21	response	response	NOUN
dti-1371	117	22	of	of	ADP
dti-1371	117	23	t	t	PROPN
dti-1371	117	24	cd4	cd4	PROPN
dti-1371	117	25	+	+	PROPN
dti-1371	117	26	cell	cell	NOUN
dti-1371	117	27	count	count	NOUN
dti-1371	117	28	in	in	ADP
dti-1371	117	29	patients	patient	NOUN
dti-1371	117	30	under	under	ADP
dti-1371	117	31	antiretroviral	antiretroviral	ADJ
dti-1371	117	32	therapy	therapy	NOUN
dti-1371	117	33	.	.	PUNCT
dti-1371	118	1	piliero22	piliero22	PROPN
dti-1371	118	2	comments	comment	NOUN
dti-1371	118	3	that	that	SCONJ
dti-1371	118	4	the	the	DET
dti-1371	118	5	maximum	maximum	ADJ
dti-1371	118	6	suppression	suppression	NOUN
dti-1371	118	7	of	of	ADP
dti-1371	118	8	viral	viral	ADJ
dti-1371	118	9	replication	replication	NOUN
dti-1371	118	10	remains	remain	VERB
dti-1371	118	11	the	the	DET
dti-1371	118	12	primary	primary	ADJ
dti-1371	118	13	goal	goal	NOUN
dti-1371	118	14	of	of	ADP
dti-1371	118	15	therapy	therapy	NOUN
dti-1371	118	16	after	after	ADP
dti-1371	118	17	haart	haart	PROPN
dti-1371	118	18	regimen	regimen	PROPN
dti-1371	118	19	,	,	PUNCT
dti-1371	118	20	therefore	therefore	ADV
dti-1371	118	21	t	t	PROPN
dti-1371	118	22	cd4	cd4	PROPN
dti-1371	118	23	+	+	PROPN
dti-1371	118	24	cell	cell	NOUN
dti-1371	118	25	count	count	NOUN
dti-1371	118	26	and	and	CCONJ
dti-1371	118	27	hiv	hiv	PROPN
dti-1371	118	28	plasma	plasma	NOUN
dti-1371	118	29	viral	viral	ADJ
dti-1371	118	30	load	load	NOUN
dti-1371	118	31	values	value	NOUN
dti-1371	118	32	are	be	AUX
dti-1371	118	33	the	the	DET
dti-1371	118	34	prognostic	prognostic	ADJ
dti-1371	118	35	markers	marker	NOUN
dti-1371	118	36	for	for	ADP
dti-1371	118	37	treatment	treatment	NOUN
dti-1371	118	38	success	success	NOUN
dti-1371	118	39	after	after	ADP
dti-1371	118	40	four	four	NUM
dti-1371	118	41	,	,	PUNCT
dti-1371	118	42	eight	eight	NUM
dti-1371	118	43	or	or	CCONJ
dti-1371	118	44	twelve	twelve	NUM
dti-1371	118	45	weeks	week	NOUN
dti-1371	118	46	post	post	NOUN
dti-1371	118	47	treatment	treatment	NOUN
dti-1371	118	48	,	,	PUNCT
dti-1371	118	49	as	as	SCONJ
dti-1371	118	50	the	the	DET
dti-1371	118	51	changes	change	NOUN
dti-1371	118	52	are	be	AUX
dti-1371	118	53	predictive	predictive	ADJ
dti-1371	118	54	of	of	ADP
dti-1371	118	55	favorable	favorable	ADJ
dti-1371	118	56	longterm	longterm	ADJ
dti-1371	118	57	success	success	NOUN
dti-1371	118	58	in	in	ADP
dti-1371	118	59	six	six	NUM
dti-1371	118	60	months	month	NOUN
dti-1371	118	61	or	or	CCONJ
dti-1371	118	62	more	more	ADJ
dti-1371	118	63	.	.	PUNCT
dti-1371	119	1	according	accord	VERB
dti-1371	119	2	to	to	ADP
dti-1371	119	3	moreno	moreno	PROPN
dti-1371	119	4	et	et	PROPN
dti-1371	119	5	al23	al23	PROPN
dti-1371	119	6	in	in	ADP
dti-1371	119	7	multifailed	multifailed	ADJ
dti-1371	119	8	patients	patient	NOUN
dti-1371	119	9	,	,	PUNCT
dti-1371	119	10	at	at	ADP
dti-1371	119	11	least	least	ADV
dti-1371	119	12	two	two	NUM
dti-1371	119	13	active	active	ADJ
dti-1371	119	14	drugs	drug	NOUN
dti-1371	119	15	can	can	AUX
dti-1371	119	16	not	not	PART
dti-1371	119	17	be	be	AUX
dti-1371	119	18	used	use	VERB
dti-1371	119	19	,	,	PUNCT
dti-1371	119	20	the	the	DET
dti-1371	119	21	therapeutic	therapeutic	ADJ
dti-1371	119	22	scheme	scheme	NOUN
dti-1371	119	23	should	should	AUX
dti-1371	119	24	be	be	AUX
dti-1371	119	25	kept	keep	VERB
dti-1371	119	26	in	in	ADP
dti-1371	119	27	use	use	NOUN
dti-1371	119	28	until	until	SCONJ
dti-1371	119	29	new	new	ADJ
dti-1371	119	30	drugs	drug	NOUN
dti-1371	119	31	become	become	VERB
dti-1371	119	32	available	available	ADJ
dti-1371	119	33	,	,	PUNCT
dti-1371	119	34	assuming	assume	VERB
dti-1371	119	35	that	that	SCONJ
dti-1371	119	36	there	there	PRON
dti-1371	119	37	is	be	VERB
dti-1371	119	38	an	an	DET
dti-1371	119	39	immunologic	immunologic	ADJ
dti-1371	119	40	and	and	CCONJ
dti-1371	119	41	clinical	clinical	ADJ
dti-1371	119	42	stability	stability	NOUN
dti-1371	119	43	in	in	ADP
dti-1371	119	44	order	order	NOUN
dti-1371	119	45	to	to	PART
dti-1371	119	46	avoid	avoid	VERB
dti-1371	119	47	the	the	DET
dti-1371	119	48	use	use	NOUN
dti-1371	119	49	of	of	ADP
dti-1371	119	50	a	a	DET
dti-1371	119	51	drug	drug	NOUN
dti-1371	119	52	from	from	ADP
dti-1371	119	53	a	a	DET
dti-1371	119	54	common	common	ADJ
dti-1371	119	55	chemical	chemical	NOUN
dti-1371	119	56	group	group	NOUN
dti-1371	119	57	which	which	PRON
dti-1371	119	58	usually	usually	ADV
dti-1371	119	59	leads	lead	VERB
dti-1371	119	60	to	to	ADP
dti-1371	119	61	a	a	DET
dti-1371	119	62	rapid	rapid	ADJ
dti-1371	119	63	viral	viral	ADJ
dti-1371	119	64	resistance	resistance	NOUN
dti-1371	119	65	development	development	NOUN
dti-1371	119	66	,	,	PUNCT
dti-1371	119	67	further	far	ADV
dti-1371	119	68	limiting	limit	VERB
dti-1371	119	69	future	future	ADJ
dti-1371	119	70	treatment	treatment	NOUN
dti-1371	119	71	options	option	NOUN
dti-1371	119	72	.	.	PUNCT
dti-1371	120	1	geretti	geretti	INTJ
dti-1371	120	2	et	et	PROPN
dti-1371	121	1	al24	al24	PROPN
dti-1371	121	2	stated	state	VERB
dti-1371	121	3	that	that	SCONJ
dti-1371	121	4	patients	patient	NOUN
dti-1371	121	5	in	in	ADP
dti-1371	121	6	first	first	ADJ
dti-1371	121	7	haart	haart	PROPN
dti-1371	121	8	line	line	NOUN
dti-1371	121	9	who	who	PRON
dti-1371	121	10	maintained	maintain	VERB
dti-1371	121	11	consistently	consistently	ADV
dti-1371	121	12	undetectable	undetectable	ADJ
dti-1371	121	13	plasma	plasma	NOUN
dti-1371	121	14	viral	viral	ADJ
dti-1371	121	15	load	load	NOUN
dti-1371	121	16	for	for	ADP
dti-1371	121	17	a	a	DET
dti-1371	121	18	year	year	NOUN
dti-1371	121	19	,	,	PUNCT
dti-1371	121	20	had	have	VERB
dti-1371	121	21	a	a	DET
dti-1371	121	22	low	low	ADJ
dti-1371	121	23	risk	risk	NOUN
dti-1371	121	24	of	of	ADP
dti-1371	121	25	virologic	virologic	ADJ
dti-1371	121	26	failure	failure	NOUN
dti-1371	121	27	.	.	PUNCT
dti-1371	122	1	in	in	ADP
dti-1371	122	2	this	this	DET
dti-1371	122	3	study	study	NOUN
dti-1371	122	4	,	,	PUNCT
dti-1371	122	5	the	the	DET
dti-1371	122	6	tuberculosis	tuberculosis	NOUN
dti-1371	122	7	comorbidity	comorbidity	NOUN
dti-1371	122	8	had	have	VERB
dti-1371	122	9	significant	significant	ADJ
dti-1371	122	10	influence	influence	NOUN
dti-1371	122	11	on	on	ADP
dti-1371	122	12	the	the	DET
dti-1371	122	13	occurrence	occurrence	NOUN
dti-1371	122	14	of	of	ADP
dti-1371	122	15	virologic	virologic	ADJ
dti-1371	122	16	failure	failure	NOUN
dti-1371	122	17	.	.	PUNCT
dti-1371	123	1	special	special	ADJ
dti-1371	123	2	attention	attention	NOUN
dti-1371	123	3	should	should	AUX
dti-1371	123	4	be	be	AUX
dti-1371	123	5	given	give	VERB
dti-1371	123	6	to	to	ADP
dti-1371	123	7	early	early	ADJ
dti-1371	123	8	tuberculosis	tuberculosis	NOUN
dti-1371	123	9	diagnosis	diagnosis	NOUN
dti-1371	123	10	during	during	ADP
dti-1371	123	11	the	the	DET
dti-1371	123	12	early	early	ADJ
dti-1371	123	13	haart	haart	PROPN
dti-1371	123	14	table	table	NOUN
dti-1371	123	15	5	5	NUM
dti-1371	123	16	.	.	PUNCT
dti-1371	123	17	logistic	logistic	ADJ
dti-1371	123	18	regresion	regresion	NOUN
dti-1371	123	19	in	in	ADP
dti-1371	123	20	patients	patient	NOUN
dti-1371	123	21	attended	attend	VERB
dti-1371	123	22	in	in	ADP
dti-1371	123	23	the	the	DET
dti-1371	123	24	health	health	NOUN
dti-1371	123	25	center	center	NOUN
dti-1371	123	26	no	no	INTJ
dti-1371	123	27	.	.	NOUN
dti-1371	123	28	1	1	NUM
dti-1371	123	29	(	(	PUNCT
dti-1371	123	30	hospital	hospital	NOUN
dti-1371	123	31	dia	dia	PROPN
dti-1371	123	32	)	)	PUNCT
dti-1371	123	33	from	from	ADP
dti-1371	123	34	2002	2002	NUM
dti-1371	123	35	to	to	ADP
dti-1371	123	36	2008	2008	NUM
dti-1371	123	37	.	.	PUNCT
dti-1371	124	1	step	step	NOUN
dti-1371	124	2	variable	variable	ADJ
dti-1371	124	3	β	β	X
dti-1371	124	4	wald	wald	X
dti-1371	124	5	test	test	NOUN
dti-1371	124	6	p	p	NOUN
dti-1371	124	7	-	-	PUNCT
dti-1371	124	8	value	value	NOUN
dti-1371	124	9	odds	odd	NOUN
dti-1371	124	10	ratio	ratio	NOUN
dti-1371	124	11	ic95	ic95	PROPN
dti-1371	124	12	%	%	NOUN
dti-1371	124	13	step	step	NOUN
dti-1371	124	14	1	1	NUM
dti-1371	124	15	gender	gender	NOUN
dti-1371	124	16	1.142	1.142	NUM
dti-1371	124	17	1.718	1.718	NUM
dti-1371	124	18	0.182	0.182	NUM
dti-1371	124	19	3.132	3.132	NUM
dti-1371	124	20	0.586–16.746	0.586–16.746	NOUN
dti-1371	124	21	age	age	VERB
dti-1371	124	22	0.894	0.894	NUM
dti-1371	124	23	1.906	1.906	NUM
dti-1371	124	24	0.167	0.167	NUM
dti-1371	124	25	2.444	2.444	NUM
dti-1371	124	26	0.687–8.692	0.687–8.692	NOUN
dti-1371	124	27	skin	skin	NOUN
dti-1371	124	28	colour	colour	NOUN
dti-1371	124	29	0.059	0.059	NUM
dti-1371	124	30	0.007	0.007	NUM
dti-1371	124	31	0.932	0.932	NUM
dti-1371	124	32	1.061	1.061	NUM
dti-1371	124	33	0.274–4.107	0.274–4.107	NOUN
dti-1371	124	34	marital	marital	ADJ
dti-1371	124	35	status	status	NOUN
dti-1371	124	36	0.512	0.512	NUM
dti-1371	124	37	0.588	0.588	NUM
dti-1371	124	38	0.443	0.443	NUM
dti-1371	124	39	1.668	1.668	NUM
dti-1371	124	40	0.451–6.170	0.451–6.170	NUM
dti-1371	125	1	education	education	NOUN
dti-1371	125	2	0.745	0.745	NUM
dti-1371	125	3	1.129	1.129	NUM
dti-1371	125	4	0.288	0.288	NUM
dti-1371	125	5	2.106	2.106	NUM
dti-1371	125	6	0.533–8.319	0.533–8.319	PROPN
dti-1371	125	7	zone	zone	NOUN
dti-1371	125	8	0.149	0.149	NUM
dti-1371	125	9	0.034	0.034	NUM
dti-1371	125	10	0.854	0.854	NUM
dti-1371	125	11	1.160	1.160	NUM
dti-1371	125	12	0.237–5.683	0.237–5.683	NUM
dti-1371	125	13	birthplace	birthplace	NOUN
dti-1371	125	14	1.240	1.240	NUM
dti-1371	125	15	3.656	3.656	NUM
dti-1371	125	16	0.056	0.056	NUM
dti-1371	125	17	3.454	3.454	NUM
dti-1371	125	18	0.969–12.310	0.969–12.310	PROPN
dti-1371	125	19	expsosure	expsosure	NOUN
dti-1371	125	20	category	category	NOUN
dti-1371	125	21	0.580	0.580	NUM
dti-1371	125	22	0.475	0.475	NUM
dti-1371	125	23	0.491	0.491	NUM
dti-1371	125	24	1.786	1.786	NUM
dti-1371	125	25	0.343–9.301	0.343–9.301	NUM
dti-1371	125	26	viral	viral	ADJ
dti-1371	125	27	load	load	NOUN
dti-1371	125	28	after	after	ADP
dti-1371	125	29	haart	haart	PROPN
dti-1371	125	30	21.291	21.291	NUM
dti-1371	125	31	0.000	0.000	NUM
dti-1371	125	32	1.000	1.000	NUM
dti-1371	125	33	0.000	0.000	NUM
dti-1371	125	34	0.000–0.000	0.000–0.000	NOUN
dti-1371	126	1	t	t	PROPN
dti-1371	126	2	cd4	cd4	PROPN
dti-1371	126	3	+	+	PROPN
dti-1371	126	4	after	after	ADP
dti-1371	126	5	haart	haart	PROPN
dti-1371	126	6	0.451	0.451	NUM
dti-1371	126	7	0.417	0.417	NUM
dti-1371	126	8	0.518	0.518	NUM
dti-1371	126	9	1.569	1.569	NUM
dti-1371	126	10	0.400–6.156	0.400–6.156	NOUN
dti-1371	126	11	haart	haart	PROPN
dti-1371	126	12	-0.112	-0.112	PUNCT
dti-1371	126	13	0.023	0.023	NUM
dti-1371	126	14	0.880	0.880	NUM
dti-1371	126	15	0.894	0.894	NUM
dti-1371	126	16	0.207–3.851	0.207–3.851	NOUN
dti-1371	126	17	hbv	hbv	NOUN
dti-1371	126	18	(	(	PUNCT
dti-1371	126	19	hbsag	hbsag	NOUN
dti-1371	126	20	)	)	PUNCT
dti-1371	126	21	-0,539	-0,539	PROPN
dti-1371	126	22	0,210	0,210	NUM
dti-1371	126	23	0,647	0,647	NUM
dti-1371	126	24	0,583	0,583	NOUN
dti-1371	126	25	0,058–5,859	0,058–5,859	NUM
dti-1371	127	1	hcv	hcv	X
dti-1371	127	2	(	(	PUNCT
dti-1371	127	3	anti	anti	X
dti-1371	127	4	hcv	hcv	PROPN
dti-1371	127	5	)	)	PUNCT
dti-1371	127	6	-0.356	-0.356	VERB
dti-1371	127	7	0.191	0.191	NUM
dti-1371	127	8	0.662	0.662	NUM
dti-1371	127	9	0.701	0.701	NUM
dti-1371	127	10	0.142–3.450	0.142–3.450	X
dti-1371	127	11	tb	tb	X
dti-1371	127	12	(	(	PUNCT
dti-1371	127	13	b.a.a.r	b.a.a.r	PROPN
dti-1371	127	14	.	.	PUNCT
dti-1371	127	15	)	)	PUNCT
dti-1371	128	1	1.107	1.107	NUM
dti-1371	128	2	2.536	2.536	NUM
dti-1371	128	3	0.111	0.111	NUM
dti-1371	128	4	3.025	3.025	NUM
dti-1371	128	5	0.775–11.810	0.775–11.810	NOUN
dti-1371	128	6	constant	constant	ADJ
dti-1371	128	7	-48.150	-48.150	ADP
dti-1371	128	8	0.000	0.000	NUM
dti-1371	128	9	1.000	1.000	NUM
dti-1371	128	10	0.000	0.000	NUM
dti-1371	128	11	0.000–0.000	0.000–0.000	NUM
dti-1371	128	12	step	step	NOUN
dti-1371	128	13	14	14	NUM
dti-1371	128	14	age	age	NOUN
dti-1371	128	15	0.812	0.812	NUM
dti-1371	128	16	2.125	2.125	NUM
dti-1371	128	17	0.145	0.145	NUM
dti-1371	128	18	2.252	2.252	NUM
dti-1371	128	19	0.756–6.707	0.756–6.707	NUM
dti-1371	128	20	birthplace	birthplace	NOUN
dti-1371	128	21	1.308	1.308	NUM
dti-1371	128	22	5.247	5.247	NUM
dti-1371	128	23	0.022	0.022	NUM
dti-1371	128	24	3.698	3.698	NUM
dti-1371	128	25	1.208–11.322	1.208–11.322	PROPN
dti-1371	128	26	tb	tb	X
dti-1371	128	27	(	(	PUNCT
dti-1371	128	28	b.a.a.r	b.a.a.r	PROPN
dti-1371	128	29	.	.	PUNCT
dti-1371	128	30	)	)	PUNCT
dti-1371	129	1	1.311	1.311	NUM
dti-1371	129	2	4.786	4.786	NUM
dti-1371	129	3	0.029	0.029	NUM
dti-1371	129	4	3.710	3.710	NUM
dti-1371	129	5	1.146–12.008	1.146–12.008	PROPN
dti-1371	129	6	constant	constant	ADJ
dti-1371	129	7	-3.508	-3.508	NUM
dti-1371	129	8	4.353	4.353	NUM
dti-1371	129	9	0.037	0.037	NUM
dti-1371	129	10	0.030	0.030	NUM
dti-1371	129	11	0.000–0.000	0.000–0.000	NUM
dti-1371	129	12	paso	paso	PROPN
dti-1371	129	13	15	15	NUM
dti-1371	129	14	birthplace	birthplace	NOUN
dti-1371	129	15	1.188	1.188	NUM
dti-1371	129	16	4.584	4.584	NUM
dti-1371	129	17	0.032	0.032	NUM
dti-1371	129	18	3.280	3.280	NUM
dti-1371	129	19	1.106–9.731	1.106–9.731	NOUN
dti-1371	129	20	tb	tb	X
dti-1371	129	21	(	(	PUNCT
dti-1371	129	22	b.a.a.r	b.a.a.r	PROPN
dti-1371	129	23	.	.	PUNCT
dti-1371	129	24	)	)	PUNCT
dti-1371	129	25	1.340	1.340	NUM
dti-1371	129	26	5.098	5.098	NUM
dti-1371	129	27	0.024	0.024	NUM
dti-1371	129	28	3.820	3.820	NUM
dti-1371	129	29	1.194–12.229	1.194–12.229	NUM
dti-1371	129	30	constant	constant	ADJ
dti-1371	129	31	-2.173	-2.173	ADP
dti-1371	129	32	2.567	2.567	NUM
dti-1371	129	33	0.109	0.109	NUM
dti-1371	129	34	0.114	0.114	NUM
dti-1371	129	35	0.000–0.000	0.000–0.000	NUM
dti-1371	129	36	abbreviations	abbreviation	NOUN
dti-1371	129	37	:	:	PUNCT
dti-1371	129	38	β	β	X
dti-1371	129	39	,	,	PUNCT
dti-1371	129	40	maximum	maximum	PROPN
dti-1371	129	41	likehood	likehood	NOUN
dti-1371	129	42	values	value	NOUN
dti-1371	129	43	;	;	PUNCT
dti-1371	129	44	haart	haart	PROPN
dti-1371	129	45	,	,	PUNCT
dti-1371	129	46	antiretroviral	antiretroviral	ADJ
dti-1371	129	47	therapy	therapy	NOUN
dti-1371	129	48	;	;	PUNCT
dti-1371	129	49	cd4	cd4	PROPN
dti-1371	129	50	+	+	PROPN
dti-1371	129	51	,	,	PUNCT
dti-1371	129	52	lymphocyte	lymphocyte	ADJ
dti-1371	129	53	count	count	NOUN
dti-1371	129	54	;	;	PUNCT
dti-1371	129	55	ic95	ic95	PROPN
dti-1371	129	56	%	%	NOUN
dti-1371	129	57	,	,	PUNCT
dti-1371	129	58	confidence	confidence	NOUN
dti-1371	129	59	interval	interval	NOUN
dti-1371	129	60	;	;	PUNCT
dti-1371	129	61	hcv	hcv	PROPN
dti-1371	129	62	,	,	PUNCT
dti-1371	129	63	hepatitis	hepatitis	PROPN
dti-1371	129	64	c	c	PROPN
dti-1371	129	65	virus	virus	NOUN
dti-1371	129	66	;	;	PUNCT
dti-1371	129	67	anti	anti	X
dti-1371	129	68	hcv	hcv	PROPN
dti-1371	129	69	,	,	PUNCT
dti-1371	129	70	antibody	antibody	NOUN
dti-1371	129	71	to	to	ADP
dti-1371	129	72	the	the	DET
dti-1371	129	73	hepatitis	hepatitis	NOUN
dti-1371	129	74	“	"	PUNCT
dti-1371	129	75	c	c	NOUN
dti-1371	129	76	”	"	PUNCT
dti-1371	129	77	virus	virus	NOUN
dti-1371	129	78	;	;	PUNCT
dti-1371	129	79	hbv	hbv	NOUN
dti-1371	129	80	,	,	PUNCT
dti-1371	129	81	hepatitis	hepatitis	PROPN
dti-1371	129	82	b	b	PROPN
dti-1371	129	83	virus	virus	NOUN
dti-1371	129	84	;	;	PUNCT
dti-1371	129	85	hbsag	hbsag	NOUN
dti-1371	129	86	,	,	PUNCT
dti-1371	129	87	hepatitis	hepatitis	PROPN
dti-1371	129	88	b	b	PROPN
dti-1371	129	89	virus	virus	NOUN
dti-1371	129	90	surface	surface	VERB
dti-1371	129	91	antigen	antigen	ADV
dti-1371	129	92	;	;	PUNCT
dti-1371	129	93	tb	tb	NOUN
dti-1371	129	94	,	,	PUNCT
dti-1371	129	95	tuberculosis	tuberculosis	NOUN
dti-1371	129	96	;	;	PUNCT
dti-1371	129	97	b.a.a.r	b.a.a.r	PROPN
dti-1371	129	98	,	,	PUNCT
dti-1371	129	99	alcohol	alcohol	NOUN
dti-1371	129	100	acid	acid	NOUN
dti-1371	129	101	resistant	resistant	ADJ
dti-1371	129	102	bacilli	bacilli	NOUN
dti-1371	129	103	.	.	PUNCT
dti-1371	130	1	http://www.la-press.com	http://www.la-press.com	X
dti-1371	131	1	bello	bello	PROPN
dti-1371	131	2	et	et	PROPN
dti-1371	131	3	al	al	PROPN
dti-1371	131	4	40	40	NUM
dti-1371	131	5	drug	drug	NOUN
dti-1371	131	6	target	target	NOUN
dti-1371	131	7	insights	insight	NOUN
dti-1371	131	8	2011:5	2011:5	NUM
dti-1371	131	9	regimen	regiman	NOUN
dti-1371	131	10	prescription	prescription	NOUN
dti-1371	131	11	.	.	PUNCT
dti-1371	132	1	studies	study	NOUN
dti-1371	132	2	reported	report	VERB
dti-1371	132	3	by	by	ADP
dti-1371	132	4	bekker	bekker	PROPN
dti-1371	132	5	et	et	PROPN
dti-1371	132	6	al25	al25	PROPN
dti-1371	132	7	and	and	CCONJ
dti-1371	132	8	von	von	PROPN
dti-1371	132	9	reyn	reyn	PROPN
dti-1371	132	10	et	et	PROPN
dti-1371	132	11	al26	al26	PROPN
dti-1371	132	12	showed	show	VERB
dti-1371	132	13	that	that	SCONJ
dti-1371	132	14	the	the	DET
dti-1371	132	15	mycobacterial	mycobacterial	ADJ
dti-1371	132	16	disease	disease	NOUN
dti-1371	132	17	was	be	AUX
dti-1371	132	18	a	a	DET
dti-1371	132	19	major	major	ADJ
dti-1371	132	20	contributor	contributor	NOUN
dti-1371	132	21	to	to	ADP
dti-1371	132	22	hiv	hiv	PROPN
dti-1371	132	23	mortality	mortality	NOUN
dti-1371	132	24	.	.	PUNCT
dti-1371	133	1	in	in	ADP
dti-1371	133	2	addition	addition	NOUN
dti-1371	133	3	,	,	PUNCT
dti-1371	133	4	the	the	DET
dti-1371	133	5	infection	infection	NOUN
dti-1371	133	6	increases	increase	VERB
dti-1371	133	7	the	the	DET
dti-1371	133	8	risk	risk	NOUN
dti-1371	133	9	of	of	ADP
dti-1371	133	10	latent	latent	NOUN
dti-1371	133	11	tuberculosis	tuberculosis	NOUN
dti-1371	133	12	reactivation	reactivation	NOUN
dti-1371	133	13	,	,	PUNCT
dti-1371	133	14	a	a	DET
dti-1371	133	15	new	new	ADJ
dti-1371	133	16	infection	infection	NOUN
dti-1371	133	17	progression	progression	NOUN
dti-1371	133	18	or	or	CCONJ
dti-1371	133	19	re	re	NOUN
dti-1371	133	20	-	-	NOUN
dti-1371	133	21	infection	infection	NOUN
dti-1371	133	22	to	to	ADP
dti-1371	133	23	active	active	ADJ
dti-1371	133	24	disease	disease	NOUN
dti-1371	133	25	,	,	PUNCT
dti-1371	133	26	increasing	increase	VERB
dti-1371	133	27	the	the	DET
dti-1371	133	28	risk	risk	NOUN
dti-1371	133	29	of	of	ADP
dti-1371	133	30	the	the	DET
dti-1371	133	31	emergence	emergence	NOUN
dti-1371	133	32	of	of	ADP
dti-1371	133	33	hiv	hiv	PROPN
dti-1371	133	34	resistant	resistant	ADJ
dti-1371	133	35	strains	strain	NOUN
dti-1371	133	36	to	to	ADP
dti-1371	133	37	the	the	DET
dti-1371	133	38	usual	usual	ADJ
dti-1371	133	39	antiretroviral	antiretroviral	ADJ
dti-1371	133	40	therapy	therapy	NOUN
dti-1371	133	41	.	.	PUNCT
dti-1371	134	1	tuberculosis	tuberculosis	NOUN
dti-1371	134	2	also	also	ADV
dti-1371	134	3	accelerates	accelerate	VERB
dti-1371	134	4	the	the	DET
dti-1371	134	5	course	course	NOUN
dti-1371	134	6	of	of	ADP
dti-1371	134	7	hiv	hiv	PROPN
dti-1371	134	8	induced	induce	VERB
dti-1371	134	9	disease	disease	NOUN
dti-1371	134	10	by	by	ADP
dti-1371	134	11	activating	activate	VERB
dti-1371	134	12	viral	viral	ADJ
dti-1371	134	13	replication	replication	NOUN
dti-1371	134	14	and	and	CCONJ
dti-1371	134	15	accentuating	accentuate	VERB
dti-1371	134	16	the	the	DET
dti-1371	134	17	decline	decline	NOUN
dti-1371	134	18	of	of	ADP
dti-1371	134	19	t	t	PROPN
dti-1371	134	20	cd4	cd4	PROPN
dti-1371	134	21	+	+	PROPN
dti-1371	134	22	cells	cell	NOUN
dti-1371	134	23	.	.	PUNCT
dti-1371	135	1	in	in	ADP
dti-1371	135	2	the	the	DET
dti-1371	135	3	logistic	logistic	ADJ
dti-1371	135	4	regresion	regresion	NOUN
dti-1371	135	5	analysis	analysis	NOUN
dti-1371	135	6	the	the	DET
dti-1371	135	7	best	good	ADJ
dti-1371	135	8	model	model	NOUN
dti-1371	135	9	to	to	PART
dti-1371	135	10	explain	explain	VERB
dti-1371	135	11	the	the	DET
dti-1371	135	12	event	event	NOUN
dti-1371	135	13	of	of	ADP
dti-1371	135	14	virological	virological	ADJ
dti-1371	135	15	failure	failure	NOUN
dti-1371	135	16	is	be	AUX
dti-1371	135	17	the	the	DET
dti-1371	135	18	one	one	NOUN
dti-1371	135	19	that	that	PRON
dti-1371	135	20	includes	include	VERB
dti-1371	135	21	variables	variable	NOUN
dti-1371	135	22	such	such	ADJ
dti-1371	135	23	as	as	ADP
dti-1371	135	24	origin	origin	NOUN
dti-1371	135	25	and	and	CCONJ
dti-1371	135	26	infection	infection	NOUN
dti-1371	135	27	by	by	ADP
dti-1371	135	28	m.	m.	NOUN
dti-1371	135	29	tuberculosis	tuberculosis	NOUN
dti-1371	135	30	,	,	PUNCT
dti-1371	135	31	yielding	yield	VERB
dti-1371	135	32	or	or	CCONJ
dti-1371	135	33	values	value	NOUN
dti-1371	135	34	of	of	ADP
dti-1371	135	35	3.2	3.2	NUM
dti-1371	135	36	and	and	CCONJ
dti-1371	135	37	3.8	3.8	NUM
dti-1371	135	38	respectively	respectively	ADV
dti-1371	135	39	.	.	PUNCT
dti-1371	136	1	conclusion	conclusion	NOUN
dti-1371	136	2	despite	despite	SCONJ
dti-1371	136	3	the	the	DET
dti-1371	136	4	enormous	enormous	ADJ
dti-1371	136	5	progress	progress	NOUN
dti-1371	136	6	as	as	ADP
dti-1371	136	7	a	a	DET
dti-1371	136	8	result	result	NOUN
dti-1371	136	9	of	of	ADP
dti-1371	136	10	the	the	DET
dti-1371	136	11	impact	impact	NOUN
dti-1371	136	12	of	of	ADP
dti-1371	136	13	haart	haart	PROPN
dti-1371	136	14	-	-	PUNCT
dti-1371	136	15	related	relate	VERB
dti-1371	136	16	morbidity	morbidity	NOUN
dti-1371	136	17	and	and	CCONJ
dti-1371	136	18	mortality	mortality	NOUN
dti-1371	136	19	in	in	ADP
dti-1371	136	20	patients	patient	NOUN
dti-1371	136	21	with	with	ADP
dti-1371	136	22	hiv	hiv	PROPN
dti-1371	136	23	/	/	SYM
dti-1371	136	24	aids	aids	PROPN
dti-1371	136	25	continue	continue	VERB
dti-1371	136	26	and	and	CCONJ
dti-1371	136	27	will	will	AUX
dti-1371	136	28	continue	continue	VERB
dti-1371	136	29	to	to	PART
dti-1371	136	30	fail	fail	VERB
dti-1371	136	31	in	in	ADP
dti-1371	136	32	the	the	DET
dti-1371	136	33	face	face	NOUN
dti-1371	136	34	of	of	ADP
dti-1371	136	35	the	the	DET
dti-1371	136	36	therapeutic	therapeutic	ADJ
dti-1371	136	37	classes	class	NOUN
dti-1371	136	38	of	of	ADP
dti-1371	136	39	haart	haart	PROPN
dti-1371	136	40	currently	currently	ADV
dti-1371	136	41	available	available	ADJ
dti-1371	136	42	.	.	PUNCT
dti-1371	137	1	the	the	DET
dti-1371	137	2	presented	present	VERB
dti-1371	137	3	results	result	NOUN
dti-1371	137	4	reinforce	reinforce	VERB
dti-1371	137	5	the	the	DET
dti-1371	137	6	importance	importance	NOUN
dti-1371	137	7	of	of	ADP
dti-1371	137	8	monitoring	monitor	VERB
dti-1371	137	9	the	the	DET
dti-1371	137	10	biological	biological	ADJ
dti-1371	137	11	markers	marker	NOUN
dti-1371	137	12	t	t	PROPN
dti-1371	137	13	cd4	cd4	PROPN
dti-1371	137	14	+	+	PROPN
dti-1371	137	15	cells	cell	NOUN
dti-1371	137	16	and	and	CCONJ
dti-1371	137	17	viral	viral	ADJ
dti-1371	137	18	load	load	NOUN
dti-1371	137	19	in	in	ADP
dti-1371	137	20	patients	patient	NOUN
dti-1371	137	21	living	live	VERB
dti-1371	137	22	with	with	ADP
dti-1371	137	23	and	and	CCONJ
dti-1371	137	24	without	without	ADP
dti-1371	137	25	aids	aid	NOUN
dti-1371	137	26	,	,	PUNCT
dti-1371	137	27	both	both	PRON
dti-1371	137	28	to	to	PART
dti-1371	137	29	ensure	ensure	VERB
dti-1371	137	30	that	that	SCONJ
dti-1371	137	31	viral	viral	ADJ
dti-1371	137	32	replication	replication	NOUN
dti-1371	137	33	is	be	AUX
dti-1371	137	34	under	under	ADP
dti-1371	137	35	control	control	NOUN
dti-1371	137	36	and	and	CCONJ
dti-1371	137	37	to	to	PART
dti-1371	137	38	reassure	reassure	VERB
dti-1371	137	39	the	the	DET
dti-1371	137	40	maintenance	maintenance	NOUN
dti-1371	137	41	of	of	ADP
dti-1371	137	42	immune	immune	ADJ
dti-1371	137	43	reconstitution	reconstitution	NOUN
dti-1371	137	44	compatible	compatible	ADJ
dti-1371	137	45	with	with	ADP
dti-1371	137	46	life	life	NOUN
dti-1371	137	47	,	,	PUNCT
dti-1371	137	48	and	and	CCONJ
dti-1371	137	49	to	to	PART
dti-1371	137	50	predict	predict	VERB
dti-1371	137	51	the	the	DET
dti-1371	137	52	risk	risk	NOUN
dti-1371	137	53	of	of	ADP
dti-1371	137	54	developing	develop	VERB
dti-1371	137	55	resistance	resistance	NOUN
dti-1371	137	56	and	and	CCONJ
dti-1371	137	57	therapeutic	therapeutic	ADJ
dti-1371	137	58	failures	failure	NOUN
dti-1371	137	59	in	in	ADP
dti-1371	137	60	the	the	DET
dti-1371	137	61	course	course	NOUN
dti-1371	137	62	of	of	ADP
dti-1371	137	63	the	the	DET
dti-1371	137	64	treatment	treatment	NOUN
dti-1371	137	65	of	of	ADP
dti-1371	137	66	hiv	hiv	PROPN
dti-1371	137	67	-	-	PUNCT
dti-1371	137	68	infected	infect	VERB
dti-1371	137	69	people	people	NOUN
dti-1371	137	70	.	.	PUNCT
dti-1371	138	1	it	it	PRON
dti-1371	138	2	should	should	AUX
dti-1371	138	3	be	be	AUX
dti-1371	138	4	noted	note	VERB
dti-1371	138	5	that	that	SCONJ
dti-1371	138	6	the	the	DET
dti-1371	138	7	sample	sample	NOUN
dti-1371	138	8	size	size	NOUN
dti-1371	138	9	limited	limit	VERB
dti-1371	138	10	the	the	DET
dti-1371	138	11	analysis	analysis	NOUN
dti-1371	138	12	of	of	ADP
dti-1371	138	13	this	this	DET
dti-1371	138	14	study	study	NOUN
dti-1371	138	15	,	,	PUNCT
dti-1371	138	16	as	as	SCONJ
dti-1371	138	17	the	the	DET
dti-1371	138	18	retrospective	retrospective	ADJ
dti-1371	138	19	information	information	NOUN
dti-1371	138	20	taken	take	VERB
dti-1371	138	21	from	from	ADP
dti-1371	138	22	the	the	DET
dti-1371	138	23	medical	medical	ADJ
dti-1371	138	24	records	record	NOUN
dti-1371	138	25	,	,	PUNCT
dti-1371	138	26	excluded	exclude	VERB
dti-1371	138	27	some	some	DET
dti-1371	138	28	data	datum	NOUN
dti-1371	138	29	from	from	ADP
dti-1371	138	30	the	the	DET
dti-1371	138	31	laboratory	laboratory	NOUN
dti-1371	138	32	and	and	CCONJ
dti-1371	138	33	the	the	DET
dti-1371	138	34	clinical	clinical	ADJ
dti-1371	138	35	follow	follow	NOUN
dti-1371	138	36	up	up	ADP
dti-1371	138	37	.	.	PUNCT
dti-1371	139	1	the	the	DET
dti-1371	139	2	sample	sample	NOUN
dti-1371	139	3	obtained	obtain	VERB
dti-1371	139	4	in	in	ADP
dti-1371	139	5	this	this	DET
dti-1371	139	6	way	way	NOUN
dti-1371	139	7	may	may	AUX
dti-1371	139	8	have	have	AUX
dti-1371	139	9	had	have	VERB
dti-1371	139	10	a	a	DET
dti-1371	139	11	limited	limited	ADJ
dti-1371	139	12	ability	ability	NOUN
dti-1371	139	13	to	to	PART
dti-1371	139	14	highlight	highlight	VERB
dti-1371	139	15	the	the	DET
dti-1371	139	16	predictive	predictive	ADJ
dti-1371	139	17	differences	difference	NOUN
dti-1371	139	18	of	of	ADP
dti-1371	139	19	risk	risk	NOUN
dti-1371	139	20	for	for	ADP
dti-1371	139	21	both	both	DET
dti-1371	139	22	t	t	PROPN
dti-1371	139	23	cd4	cd4	PROPN
dti-1371	139	24	+	+	PROPN
dti-1371	139	25	cell	cell	NOUN
dti-1371	139	26	count	count	NOUN
dti-1371	139	27	and	and	CCONJ
dti-1371	139	28	viral	viral	ADJ
dti-1371	139	29	load	load	NOUN
dti-1371	139	30	in	in	ADP
dti-1371	139	31	naive	naive	ADJ
dti-1371	139	32	patients	patient	NOUN
dti-1371	139	33	.	.	PUNCT
dti-1371	140	1	it	it	PRON
dti-1371	140	2	is	be	AUX
dti-1371	140	3	possible	possible	ADJ
dti-1371	140	4	that	that	SCONJ
dti-1371	140	5	working	work	VERB
dti-1371	140	6	with	with	ADP
dti-1371	140	7	a	a	DET
dti-1371	140	8	larger	large	ADJ
dti-1371	140	9	cohort	cohort	NOUN
dti-1371	140	10	of	of	ADP
dti-1371	140	11	patients	patient	NOUN
dti-1371	140	12	and	and	CCONJ
dti-1371	140	13	longer	long	ADV
dti-1371	140	14	follow	follow	VERB
dti-1371	140	15	-	-	PUNCT
dti-1371	140	16	up	up	NOUN
dti-1371	140	17	of	of	ADP
dti-1371	140	18	these	these	DET
dti-1371	140	19	predictors	predictor	NOUN
dti-1371	140	20	probably	probably	ADV
dti-1371	140	21	would	would	AUX
dti-1371	140	22	show	show	VERB
dti-1371	140	23	more	more	ADV
dti-1371	140	24	consistent	consistent	ADJ
dti-1371	140	25	evidence	evidence	NOUN
dti-1371	140	26	that	that	PRON
dti-1371	140	27	is	be	AUX
dti-1371	140	28	statistically	statistically	ADV
dti-1371	140	29	supported	support	VERB
dti-1371	140	30	.	.	PUNCT
dti-1371	141	1	initial	initial	ADJ
dti-1371	141	2	treatment	treatment	NOUN
dti-1371	141	3	with	with	ADP
dti-1371	141	4	any	any	DET
dti-1371	141	5	nnrti	nnrti	NOUN
dti-1371	141	6	-	-	PUNCT
dti-1371	141	7	based	base	VERB
dti-1371	141	8	regimen	regiman	NOUN
dti-1371	141	9	or	or	CCONJ
dti-1371	141	10	an	an	DET
dti-1371	141	11	ip	ip	NOUN
dti-1371	141	12	,	,	PUNCT
dti-1371	141	13	but	but	CCONJ
dti-1371	141	14	not	not	PART
dti-1371	141	15	both	both	PRON
dti-1371	141	16	,	,	PUNCT
dti-1371	141	17	is	be	AUX
dti-1371	141	18	a	a	DET
dti-1371	141	19	good	good	ADJ
dti-1371	141	20	strategy	strategy	NOUN
dti-1371	141	21	for	for	ADP
dti-1371	141	22	managing	manage	VERB
dti-1371	141	23	the	the	DET
dti-1371	141	24	long	long	ADJ
dti-1371	141	25	-	-	PUNCT
dti-1371	141	26	term	term	NOUN
dti-1371	141	27	antiretroviral	antiretroviral	ADJ
dti-1371	141	28	treatment	treatment	NOUN
dti-1371	141	29	in	in	ADP
dti-1371	141	30	naive	naive	ADJ
dti-1371	141	31	hiv	hiv	PROPN
dti-1371	141	32	patients	patient	NOUN
dti-1371	141	33	.	.	PUNCT
dti-1371	142	1	moreover	moreover	ADV
dti-1371	142	2	,	,	PUNCT
dti-1371	142	3	the	the	DET
dti-1371	142	4	recent	recent	ADJ
dti-1371	142	5	availability	availability	NOUN
dti-1371	142	6	of	of	ADP
dti-1371	142	7	new	new	ADJ
dti-1371	142	8	antiretroviral	antiretroviral	ADJ
dti-1371	142	9	agents	agent	NOUN
dti-1371	142	10	for	for	ADP
dti-1371	142	11	the	the	DET
dti-1371	142	12	treatment	treatment	NOUN
dti-1371	142	13	of	of	ADP
dti-1371	142	14	hiv	hiv	PROPN
dti-1371	142	15	has	have	AUX
dti-1371	142	16	increased	increase	VERB
dti-1371	142	17	treatment	treatment	NOUN
dti-1371	142	18	options	option	NOUN
dti-1371	142	19	and	and	CCONJ
dti-1371	142	20	improved	improve	VERB
dti-1371	142	21	durability	durability	NOUN
dti-1371	142	22	,	,	PUNCT
dti-1371	142	23	tolerability	tolerability	NOUN
dti-1371	142	24	and	and	CCONJ
dti-1371	142	25	efficacy	efficacy	NOUN
dti-1371	142	26	in	in	ADP
dti-1371	142	27	the	the	DET
dti-1371	142	28	long	long	ADJ
dti-1371	142	29	-	-	PUNCT
dti-1371	142	30	term	term	NOUN
dti-1371	142	31	haart	haart	PROPN
dti-1371	142	32	regimen	regiman	NOUN
dti-1371	142	33	.	.	PUNCT
dti-1371	143	1	other	other	ADJ
dti-1371	143	2	limitations	limitation	NOUN
dti-1371	143	3	that	that	PRON
dti-1371	143	4	should	should	AUX
dti-1371	143	5	be	be	AUX
dti-1371	143	6	highlighted	highlight	VERB
dti-1371	143	7	refer	refer	NOUN
dti-1371	143	8	to	to	ADP
dti-1371	143	9	the	the	DET
dti-1371	143	10	possibility	possibility	NOUN
dti-1371	143	11	of	of	ADP
dti-1371	143	12	verifying	verify	VERB
dti-1371	143	13	the	the	DET
dti-1371	143	14	association	association	NOUN
dti-1371	143	15	of	of	ADP
dti-1371	143	16	hbv	hbv	NOUN
dti-1371	143	17	and	and	CCONJ
dti-1371	143	18	hcv	hcv	PROPN
dti-1371	143	19	coinfections	coinfection	NOUN
dti-1371	143	20	which	which	PRON
dti-1371	143	21	do	do	AUX
dti-1371	143	22	not	not	PART
dti-1371	143	23	have	have	VERB
dti-1371	143	24	evolutionary	evolutionary	ADJ
dti-1371	143	25	studies	study	NOUN
dti-1371	143	26	of	of	ADP
dti-1371	143	27	these	these	DET
dti-1371	143	28	hiv	hiv	PROPN
dti-1371	143	29	comorbidities	comorbiditie	NOUN
dti-1371	143	30	.	.	PUNCT
dti-1371	144	1	it	it	PRON
dti-1371	144	2	is	be	AUX
dti-1371	144	3	possible	possible	ADJ
dti-1371	144	4	that	that	SCONJ
dti-1371	144	5	if	if	SCONJ
dti-1371	144	6	we	we	PRON
dti-1371	144	7	had	have	VERB
dti-1371	144	8	a	a	DET
dti-1371	144	9	homogeneous	homogeneous	ADJ
dti-1371	144	10	group	group	NOUN
dti-1371	144	11	of	of	ADP
dti-1371	144	12	patients	patient	NOUN
dti-1371	144	13	already	already	ADV
dti-1371	144	14	in	in	ADP
dti-1371	144	15	advanced	advanced	ADJ
dti-1371	144	16	stages	stage	NOUN
dti-1371	144	17	of	of	ADP
dti-1371	144	18	these	these	DET
dti-1371	144	19	pathologies	pathology	NOUN
dti-1371	144	20	,	,	PUNCT
dti-1371	144	21	the	the	DET
dti-1371	144	22	risk	risk	NOUN
dti-1371	144	23	of	of	ADP
dti-1371	144	24	virologic	virologic	ADJ
dti-1371	144	25	failure	failure	NOUN
dti-1371	144	26	would	would	AUX
dti-1371	144	27	be	be	AUX
dti-1371	144	28	high	high	ADJ
dti-1371	144	29	.	.	PUNCT
dti-1371	145	1	the	the	DET
dti-1371	145	2	sociodemographic	sociodemographic	ADJ
dti-1371	145	3	data	datum	NOUN
dti-1371	145	4	were	be	AUX
dti-1371	145	5	collected	collect	VERB
dti-1371	145	6	from	from	ADP
dti-1371	145	7	medical	medical	ADJ
dti-1371	145	8	records	record	NOUN
dti-1371	145	9	and	and	CCONJ
dti-1371	145	10	not	not	PART
dti-1371	145	11	through	through	ADP
dti-1371	145	12	interviews	interview	NOUN
dti-1371	145	13	,	,	PUNCT
dti-1371	145	14	this	this	DET
dti-1371	145	15	fact	fact	NOUN
dti-1371	145	16	may	may	AUX
dti-1371	145	17	also	also	ADV
dti-1371	145	18	have	have	AUX
dti-1371	145	19	skewed	skew	VERB
dti-1371	145	20	the	the	DET
dti-1371	145	21	results	result	NOUN
dti-1371	145	22	of	of	ADP
dti-1371	145	23	the	the	DET
dti-1371	145	24	analysis	analysis	NOUN
dti-1371	145	25	of	of	ADP
dti-1371	145	26	association	association	NOUN
dti-1371	145	27	between	between	ADP
dti-1371	145	28	these	these	DET
dti-1371	145	29	variables	variable	NOUN
dti-1371	145	30	and	and	CCONJ
dti-1371	145	31	treatment	treatment	NOUN
dti-1371	145	32	failure	failure	NOUN
dti-1371	145	33	.	.	PUNCT
dti-1371	146	1	however	however	ADV
dti-1371	146	2	,	,	PUNCT
dti-1371	146	3	this	this	DET
dti-1371	146	4	service	service	NOUN
dti-1371	146	5	data	datum	NOUN
dti-1371	146	6	and	and	CCONJ
dti-1371	146	7	variables	variable	NOUN
dti-1371	146	8	accounted	account	VERB
dti-1371	146	9	are	be	AUX
dti-1371	146	10	limitations	limitation	NOUN
dti-1371	146	11	imposed	impose	VERB
dti-1371	146	12	by	by	ADP
dti-1371	146	13	real	real	ADJ
dti-1371	146	14	situations	situation	NOUN
dti-1371	146	15	in	in	ADP
dti-1371	146	16	nosocomial	nosocomial	ADJ
dti-1371	146	17	institutions	institution	NOUN
dti-1371	146	18	in	in	ADP
dti-1371	146	19	the	the	DET
dti-1371	146	20	federal	federal	ADJ
dti-1371	146	21	district	district	NOUN
dti-1371	146	22	in	in	ADP
dti-1371	146	23	brazil	brazil	PROPN
dti-1371	146	24	.	.	PUNCT
dti-1371	147	1	it	it	PRON
dti-1371	147	2	is	be	AUX
dti-1371	147	3	of	of	ADP
dti-1371	147	4	great	great	ADJ
dti-1371	147	5	relevance	relevance	NOUN
dti-1371	147	6	to	to	ADP
dti-1371	147	7	the	the	DET
dti-1371	147	8	findings	finding	NOUN
dti-1371	147	9	in	in	ADP
dti-1371	147	10	this	this	DET
dti-1371	147	11	study	study	NOUN
dti-1371	147	12	considering	consider	VERB
dti-1371	147	13	the	the	DET
dti-1371	147	14	limitations	limitation	NOUN
dti-1371	147	15	and	and	CCONJ
dti-1371	147	16	difficulties	difficulty	NOUN
dti-1371	147	17	of	of	ADP
dti-1371	147	18	conducting	conduct	VERB
dti-1371	147	19	studies	study	NOUN
dti-1371	147	20	in	in	ADP
dti-1371	147	21	routine	routine	ADJ
dti-1371	147	22	service	service	NOUN
dti-1371	147	23	,	,	PUNCT
dti-1371	147	24	as	as	SCONJ
dti-1371	147	25	it	it	PRON
dti-1371	147	26	can	can	AUX
dti-1371	147	27	be	be	AUX
dti-1371	147	28	concluded	conclude	VERB
dti-1371	147	29	that	that	SCONJ
dti-1371	147	30	even	even	ADV
dti-1371	147	31	in	in	ADP
dti-1371	147	32	the	the	DET
dti-1371	147	33	non	non	ADJ
dti-1371	147	34	-	-	ADJ
dti-1371	147	35	ideal	ideal	ADJ
dti-1371	147	36	conditions	condition	NOUN
dti-1371	147	37	of	of	ADP
dti-1371	147	38	a	a	DET
dti-1371	147	39	clinical	clinical	ADJ
dti-1371	147	40	trial	trial	NOUN
dti-1371	147	41	,	,	PUNCT
dti-1371	147	42	patients	patient	NOUN
dti-1371	147	43	treated	treat	VERB
dti-1371	147	44	in	in	ADP
dti-1371	147	45	this	this	DET
dti-1371	147	46	unit	unit	NOUN
dti-1371	147	47	had	have	VERB
dti-1371	147	48	virological	virological	ADJ
dti-1371	147	49	success	success	NOUN
dti-1371	147	50	of	of	ADP
dti-1371	147	51	12.2	12.2	NUM
dti-1371	147	52	%	%	NOUN
dti-1371	147	53	up	up	ADP
dti-1371	147	54	to	to	ADP
dti-1371	147	55	one	one	NUM
dti-1371	147	56	year	year	NOUN
dti-1371	147	57	of	of	ADP
dti-1371	147	58	treatment	treatment	NOUN
dti-1371	147	59	,	,	PUNCT
dti-1371	147	60	a	a	DET
dti-1371	147	61	fact	fact	NOUN
dti-1371	147	62	that	that	PRON
dti-1371	147	63	can	can	AUX
dti-1371	147	64	predict	predict	VERB
dti-1371	147	65	the	the	DET
dti-1371	147	66	durability	durability	NOUN
dti-1371	147	67	of	of	ADP
dti-1371	147	68	the	the	DET
dti-1371	147	69	first	first	ADJ
dti-1371	147	70	scheme	scheme	NOUN
dti-1371	147	71	which	which	PRON
dti-1371	147	72	is	be	AUX
dti-1371	147	73	better	well	ADJ
dti-1371	147	74	than	than	SCONJ
dti-1371	147	75	expected	expect	VERB
dti-1371	147	76	in	in	ADP
dti-1371	147	77	many	many	ADJ
dti-1371	147	78	other	other	ADJ
dti-1371	147	79	international	international	ADJ
dti-1371	147	80	centers.17	centers.17	NOUN
dti-1371	147	81	also	also	ADV
dti-1371	147	82	tuberculosis	tuberculosis	PRON
dti-1371	147	83	infection	infection	NOUN
dti-1371	147	84	should	should	AUX
dti-1371	147	85	be	be	AUX
dti-1371	147	86	traced	trace	VERB
dti-1371	147	87	as	as	ADP
dti-1371	147	88	a	a	DET
dti-1371	147	89	priority	priority	NOUN
dti-1371	147	90	as	as	ADV
dti-1371	147	91	early	early	ADV
dti-1371	147	92	as	as	ADP
dti-1371	147	93	possible	possible	ADJ
dti-1371	147	94	.	.	PUNCT
dti-1371	148	1	as	as	SCONJ
dti-1371	148	2	the	the	DET
dti-1371	148	3	low	low	ADJ
dti-1371	148	4	values	value	NOUN
dti-1371	148	5	of	of	ADP
dti-1371	148	6	t	t	PROPN
dti-1371	148	7	cd4	cd4	PROPN
dti-1371	148	8	+	+	PROPN
dti-1371	148	9	cell	cell	NOUN
dti-1371	148	10	counts	count	NOUN
dti-1371	148	11	and	and	CCONJ
dti-1371	148	12	high	high	ADJ
dti-1371	148	13	viral	viral	ADJ
dti-1371	148	14	load	load	NOUN
dti-1371	148	15	pre	pre	NOUN
dti-1371	148	16	-	-	NOUN
dti-1371	148	17	treatment	treatment	NOUN
dti-1371	148	18	should	should	AUX
dti-1371	148	19	be	be	AUX
dti-1371	148	20	considered	consider	VERB
dti-1371	148	21	to	to	PART
dti-1371	148	22	implement	implement	VERB
dti-1371	148	23	the	the	DET
dti-1371	148	24	prescribed	prescribed	ADJ
dti-1371	148	25	antiretroviral	antiretroviral	ADJ
dti-1371	148	26	therapy	therapy	NOUN
dti-1371	148	27	,	,	PUNCT
dti-1371	148	28	especially	especially	ADV
dti-1371	148	29	when	when	SCONJ
dti-1371	148	30	new	new	ADJ
dti-1371	148	31	classes	class	NOUN
dti-1371	148	32	are	be	AUX
dti-1371	148	33	available	available	ADJ
dti-1371	148	34	and	and	CCONJ
dti-1371	148	35	have	have	VERB
dti-1371	148	36	superior	superior	ADJ
dti-1371	148	37	performance	performance	NOUN
dti-1371	148	38	,	,	PUNCT
dti-1371	148	39	as	as	SCONJ
dti-1371	148	40	much	much	ADJ
dti-1371	148	41	viral	viral	ADJ
dti-1371	148	42	suppression	suppression	NOUN
dti-1371	148	43	and	and	CCONJ
dti-1371	148	44	immune	immune	ADJ
dti-1371	148	45	reconstitution	reconstitution	NOUN
dti-1371	148	46	could	could	AUX
dti-1371	148	47	be	be	AUX
dti-1371	148	48	achieved	achieve	VERB
dti-1371	148	49	.	.	PUNCT
dti-1371	149	1	disclosures	disclosure	NOUN
dti-1371	149	2	author(s	author(s	PROPN
dti-1371	149	3	)	)	PUNCT
dti-1371	149	4	have	have	AUX
dti-1371	149	5	provided	provide	VERB
dti-1371	149	6	signed	sign	VERB
dti-1371	149	7	confirmations	confirmation	NOUN
dti-1371	149	8	to	to	ADP
dti-1371	149	9	the	the	DET
dti-1371	149	10	publisher	publisher	NOUN
dti-1371	149	11	of	of	ADP
dti-1371	149	12	their	their	PRON
dti-1371	149	13	compliance	compliance	NOUN
dti-1371	149	14	with	with	ADP
dti-1371	149	15	all	all	DET
dti-1371	149	16	applicable	applicable	ADJ
dti-1371	149	17	legal	legal	ADJ
dti-1371	149	18	and	and	CCONJ
dti-1371	149	19	ethical	ethical	ADJ
dti-1371	149	20	obligations	obligation	NOUN
dti-1371	149	21	in	in	ADP
dti-1371	149	22	respect	respect	NOUN
dti-1371	149	23	to	to	ADP
dti-1371	149	24	declaration	declaration	NOUN
dti-1371	149	25	of	of	ADP
dti-1371	149	26	conflicts	conflict	NOUN
dti-1371	149	27	of	of	ADP
dti-1371	149	28	interest	interest	NOUN
dti-1371	149	29	,	,	PUNCT
dti-1371	149	30	funding	funding	NOUN
dti-1371	149	31	,	,	PUNCT
dti-1371	149	32	authorship	authorship	NOUN
dti-1371	149	33	and	and	CCONJ
dti-1371	149	34	contributorship	contributorship	NOUN
dti-1371	149	35	,	,	PUNCT
dti-1371	149	36	and	and	CCONJ
dti-1371	149	37	compliance	compliance	NOUN
dti-1371	149	38	with	with	ADP
dti-1371	149	39	ethical	ethical	ADJ
dti-1371	149	40	requirements	requirement	NOUN
dti-1371	149	41	in	in	ADP
dti-1371	149	42	respect	respect	NOUN
dti-1371	149	43	to	to	ADP
dti-1371	149	44	treatment	treatment	NOUN
dti-1371	149	45	of	of	ADP
dti-1371	149	46	human	human	ADJ
dti-1371	149	47	and	and	CCONJ
dti-1371	149	48	animal	animal	NOUN
dti-1371	149	49	test	test	NOUN
dti-1371	149	50	subjects	subject	NOUN
dti-1371	149	51	.	.	PUNCT
dti-1371	150	1	if	if	SCONJ
dti-1371	150	2	this	this	DET
dti-1371	150	3	article	article	NOUN
dti-1371	150	4	contains	contain	VERB
dti-1371	150	5	identifiable	identifiable	ADJ
dti-1371	150	6	human	human	NOUN
dti-1371	150	7	subject(s	subject(s	PROPN
dti-1371	150	8	)	)	PUNCT
dti-1371	150	9	author(s	author(s	NOUN
dti-1371	150	10	)	)	PUNCT
dti-1371	150	11	were	be	AUX
dti-1371	150	12	required	require	VERB
dti-1371	150	13	to	to	PART
dti-1371	150	14	supply	supply	VERB
dti-1371	150	15	signed	sign	VERB
dti-1371	150	16	patient	patient	ADJ
dti-1371	150	17	consent	consent	NOUN
dti-1371	150	18	prior	prior	ADV
dti-1371	150	19	to	to	ADP
dti-1371	150	20	publication	publication	NOUN
dti-1371	150	21	.	.	PUNCT
dti-1371	151	1	author(s	author(s	NOUN
dti-1371	151	2	)	)	PUNCT
dti-1371	151	3	have	have	AUX
dti-1371	151	4	confirmed	confirm	VERB
dti-1371	151	5	that	that	SCONJ
dti-1371	151	6	the	the	DET
dti-1371	151	7	published	publish	VERB
dti-1371	151	8	article	article	NOUN
dti-1371	151	9	is	be	AUX
dti-1371	151	10	unique	unique	ADJ
dti-1371	151	11	and	and	CCONJ
dti-1371	151	12	not	not	PART
dti-1371	151	13	under	under	ADP
dti-1371	151	14	consideration	consideration	NOUN
dti-1371	151	15	nor	nor	CCONJ
dti-1371	151	16	published	publish	VERB
dti-1371	151	17	by	by	ADP
dti-1371	151	18	any	any	DET
dti-1371	151	19	other	other	ADJ
dti-1371	151	20	publication	publication	NOUN
dti-1371	151	21	and	and	CCONJ
dti-1371	151	22	that	that	SCONJ
dti-1371	151	23	they	they	PRON
dti-1371	151	24	have	have	VERB
dti-1371	151	25	consent	consent	NOUN
dti-1371	151	26	to	to	PART
dti-1371	151	27	reproduce	reproduce	VERB
dti-1371	151	28	any	any	DET
dti-1371	151	29	copyrighted	copyright	VERB
dti-1371	151	30	material	material	NOUN
dti-1371	151	31	.	.	PUNCT
dti-1371	152	1	the	the	DET
dti-1371	152	2	peer	peer	NOUN
dti-1371	152	3	reviewers	reviewer	NOUN
dti-1371	152	4	declared	declare	VERB
dti-1371	152	5	no	no	DET
dti-1371	152	6	conflicts	conflict	NOUN
dti-1371	152	7	of	of	ADP
dti-1371	152	8	interest	interest	NOUN
dti-1371	152	9	.	.	PUNCT
dti-1371	153	1	http://www.la-press.com	http://www.la-press.com	X
dti-1371	153	2	publish	publish	VERB
dti-1371	153	3	with	with	ADP
dti-1371	153	4	libertas	liberta	NOUN
dti-1371	153	5	academica	academica	PROPN
dti-1371	153	6	and	and	CCONJ
dti-1371	153	7	every	every	DET
dti-1371	153	8	scientist	scientist	NOUN
dti-1371	153	9	working	work	VERB
dti-1371	153	10	in	in	ADP
dti-1371	153	11	your	your	PRON
dti-1371	153	12	field	field	NOUN
dti-1371	153	13	can	can	AUX
dti-1371	153	14	read	read	VERB
dti-1371	153	15	your	your	PRON
dti-1371	153	16	article	article	NOUN
dti-1371	153	17	“	"	PUNCT
dti-1371	153	18	i	i	PRON
dti-1371	153	19	would	would	AUX
dti-1371	153	20	like	like	VERB
dti-1371	153	21	to	to	PART
dti-1371	153	22	say	say	VERB
dti-1371	153	23	that	that	SCONJ
dti-1371	153	24	this	this	PRON
dti-1371	153	25	is	be	AUX
dti-1371	153	26	the	the	DET
dti-1371	153	27	most	most	ADV
dti-1371	153	28	author	author	NOUN
dti-1371	153	29	-	-	PUNCT
dti-1371	153	30	friendly	friendly	ADJ
dti-1371	153	31	editing	editing	NOUN
dti-1371	153	32	process	process	NOUN
dti-1371	153	33	i	i	PRON
dti-1371	153	34	have	have	AUX
dti-1371	153	35	experienced	experience	VERB
dti-1371	153	36	in	in	ADP
dti-1371	153	37	over	over	ADP
dti-1371	153	38	150	150	NUM
dti-1371	153	39	publications	publication	NOUN
dti-1371	153	40	.	.	PUNCT
dti-1371	154	1	thank	thank	VERB
dti-1371	154	2	you	you	PRON
dti-1371	154	3	most	most	ADV
dti-1371	154	4	sincerely	sincerely	ADV
dti-1371	154	5	.	.	PUNCT
dti-1371	154	6	”	"	PUNCT
dti-1371	155	1	“	"	PUNCT
dti-1371	155	2	the	the	DET
dti-1371	155	3	communication	communication	NOUN
dti-1371	155	4	between	between	ADP
dti-1371	155	5	your	your	PRON
dti-1371	155	6	staff	staff	NOUN
dti-1371	155	7	and	and	CCONJ
dti-1371	155	8	me	i	PRON
dti-1371	155	9	has	have	AUX
dti-1371	155	10	been	be	AUX
dti-1371	155	11	terrific	terrific	ADJ
dti-1371	155	12	.	.	PUNCT
dti-1371	156	1	whenever	whenever	SCONJ
dti-1371	156	2	progress	progress	NOUN
dti-1371	156	3	is	be	AUX
dti-1371	156	4	made	make	VERB
dti-1371	156	5	with	with	ADP
dti-1371	156	6	the	the	DET
dti-1371	156	7	manuscript	manuscript	NOUN
dti-1371	156	8	,	,	PUNCT
dti-1371	156	9	i	i	PRON
dti-1371	156	10	receive	receive	VERB
dti-1371	156	11	notice	notice	NOUN
dti-1371	156	12	.	.	PUNCT
dti-1371	157	1	quite	quite	ADV
dti-1371	157	2	honestly	honestly	ADV
dti-1371	157	3	,	,	PUNCT
dti-1371	157	4	i	i	PRON
dti-1371	157	5	’ve	’ve	AUX
dti-1371	157	6	never	never	ADV
dti-1371	157	7	had	have	VERB
dti-1371	157	8	such	such	ADJ
dti-1371	157	9	complete	complete	ADJ
dti-1371	157	10	communication	communication	NOUN
dti-1371	157	11	with	with	ADP
dti-1371	157	12	a	a	DET
dti-1371	157	13	journal	journal	NOUN
dti-1371	157	14	.	.	PUNCT
dti-1371	157	15	”	"	PUNCT
dti-1371	158	1	“	"	PUNCT
dti-1371	158	2	la	la	X
dti-1371	158	3	is	be	AUX
dti-1371	158	4	different	different	ADJ
dti-1371	158	5	,	,	PUNCT
dti-1371	158	6	and	and	CCONJ
dti-1371	158	7	hopefully	hopefully	ADV
dti-1371	158	8	represents	represent	VERB
dti-1371	158	9	a	a	DET
dti-1371	158	10	kind	kind	NOUN
dti-1371	158	11	of	of	ADP
dti-1371	158	12	scientific	scientific	ADJ
dti-1371	158	13	publication	publication	NOUN
dti-1371	158	14	machinery	machinery	NOUN
dti-1371	158	15	that	that	PRON
dti-1371	158	16	removes	remove	VERB
dti-1371	158	17	the	the	DET
dti-1371	158	18	hurdles	hurdle	NOUN
dti-1371	158	19	from	from	ADP
dti-1371	158	20	free	free	ADJ
dti-1371	158	21	flow	flow	NOUN
dti-1371	158	22	of	of	ADP
dti-1371	158	23	scientific	scientific	ADJ
dti-1371	158	24	thought	thought	NOUN
dti-1371	158	25	.	.	PUNCT
dti-1371	158	26	”	"	PUNCT
dti-1371	159	1	your	your	PRON
dti-1371	159	2	paper	paper	NOUN
dti-1371	159	3	will	will	AUX
dti-1371	159	4	be	be	AUX
dti-1371	159	5	:	:	PUNCT
dti-1371	159	6	•	•	ADV
dti-1371	159	7	available	available	ADJ
dti-1371	159	8	to	to	ADP
dti-1371	159	9	your	your	PRON
dti-1371	159	10	entire	entire	ADJ
dti-1371	159	11	community	community	NOUN
dti-1371	159	12	free	free	ADJ
dti-1371	159	13	of	of	ADP
dti-1371	159	14	charge	charge	NOUN
dti-1371	159	15	•	•	ADV
dti-1371	159	16	fairly	fairly	ADV
dti-1371	159	17	and	and	CCONJ
dti-1371	159	18	quickly	quickly	ADV
dti-1371	159	19	peer	peer	NOUN
dti-1371	159	20	reviewed	review	VERB
dti-1371	159	21	•	•	NOUN
dti-1371	159	22	yours	yours	PRON
dti-1371	159	23	!	!	PUNCT
dti-1371	160	1	you	you	PRON
dti-1371	160	2	retain	retain	VERB
dti-1371	160	3	copyright	copyright	NOUN
dti-1371	160	4	http://www.la-press.com	http://www.la-press.com	X
dti-1371	160	5	antiretroviral	antiretroviral	ADJ
dti-1371	160	6	treatment	treatment	NOUN
dti-1371	160	7	in	in	ADP
dti-1371	160	8	the	the	DET
dti-1371	160	9	federal	federal	ADJ
dti-1371	160	10	district	district	PROPN
dti-1371	160	11	,	,	PUNCT
dti-1371	160	12	brazil	brazil	PROPN
dti-1371	160	13	,	,	PUNCT
dti-1371	160	14	federal	federal	ADJ
dti-1371	160	15	district	district	NOUN
dti-1371	160	16	drug	drug	NOUN
dti-1371	160	17	target	target	NOUN
dti-1371	160	18	insights	insight	NOUN
dti-1371	160	19	2011:5	2011:5	NUM
dti-1371	160	20	41	41	NUM
dti-1371	160	21	references	reference	NOUN
dti-1371	160	22	1	1	NUM
dti-1371	160	23	.	.	PUNCT
dti-1371	160	24	mellors	mellors	PROPN
dti-1371	160	25	jw	jw	PROPN
dti-1371	160	26	,	,	PUNCT
dti-1371	160	27	munoz	munoz	PROPN
dti-1371	160	28	a	a	PROPN
dti-1371	160	29	,	,	PUNCT
dti-1371	160	30	giorgi	giorgi	NOUN
dti-1371	160	31	jv	jv	PROPN
dti-1371	160	32	,	,	PUNCT
dti-1371	160	33	margolick	margolick	PROPN
dti-1371	160	34	jb	jb	PROPN
dti-1371	160	35	,	,	PUNCT
dti-1371	160	36	tassoni	tassoni	PROPN
dti-1371	160	37	cj	cj	PROPN
dti-1371	160	38	,	,	PUNCT
dti-1371	160	39	gupta	gupta	PROPN
dti-1371	160	40	p.	p.	PROPN
dti-1371	160	41	plasma	plasma	NOUN
dti-1371	160	42	viral	viral	ADJ
dti-1371	160	43	load	load	NOUN
dti-1371	160	44	and	and	CCONJ
dti-1371	160	45	cd4	cd4	PROPN
dti-1371	160	46	+	+	PROPN
dti-1371	160	47	lymphocytes	lymphocyte	NOUN
dti-1371	160	48	as	as	ADP
dti-1371	160	49	prognostic	prognostic	ADJ
dti-1371	160	50	markers	marker	NOUN
dti-1371	160	51	of	of	ADP
dti-1371	160	52	hiv-1	hiv-1	ADJ
dti-1371	160	53	infection	infection	NOUN
dti-1371	160	54	.	.	PUNCT
dti-1371	161	1	ann	ann	PROPN
dti-1371	161	2	intern	intern	PROPN
dti-1371	161	3	med	med	PROPN
dti-1371	161	4	.	.	PUNCT
dti-1371	162	1	jun	jun	PROPN
dti-1371	162	2	15	15	NUM
dti-1371	162	3	,	,	PUNCT
dti-1371	162	4	1997;126(12):946–54	1997;126(12):946–54	NUM
dti-1371	162	5	.	.	NOUN
dti-1371	162	6	2	2	NUM
dti-1371	162	7	.	.	PUNCT
dti-1371	162	8	kantor	kantor	PROPN
dti-1371	162	9	r	r	PROPN
dti-1371	162	10	,	,	PUNCT
dti-1371	162	11	diero	diero	NOUN
dti-1371	162	12	l	l	PROPN
dti-1371	162	13	,	,	PUNCT
dti-1371	162	14	delong	delong	PROPN
dti-1371	162	15	a	a	X
dti-1371	162	16	,	,	PUNCT
dti-1371	162	17	kamle	kamle	PROPN
dti-1371	162	18	l	l	PROPN
dti-1371	162	19	,	,	PUNCT
dti-1371	162	20	muyonga	muyonga	ADV
dti-1371	162	21	s	s	PART
dti-1371	162	22	,	,	PUNCT
dti-1371	162	23	mambo	mambo	PROPN
dti-1371	162	24	f.	f.	PROPN
dti-1371	162	25	misclassification	misclassification	NOUN
dti-1371	162	26	of	of	ADP
dti-1371	162	27	first	first	ADJ
dti-1371	162	28	-	-	PUNCT
dti-1371	162	29	line	line	NOUN
dti-1371	162	30	antiretroviral	antiretroviral	ADJ
dti-1371	162	31	treatment	treatment	NOUN
dti-1371	162	32	failure	failure	NOUN
dti-1371	162	33	based	base	VERB
dti-1371	162	34	on	on	ADP
dti-1371	162	35	immunological	immunological	ADJ
dti-1371	162	36	monitoring	monitoring	NOUN
dti-1371	162	37	of	of	ADP
dti-1371	162	38	hiv	hiv	PROPN
dti-1371	162	39	infection	infection	NOUN
dti-1371	162	40	in	in	ADP
dti-1371	162	41	resource	resource	NOUN
dti-1371	162	42	-	-	PUNCT
dti-1371	162	43	limited	limit	VERB
dti-1371	162	44	settings	setting	NOUN
dti-1371	162	45	.	.	PUNCT
dti-1371	163	1	clin	clin	PROPN
dti-1371	163	2	infect	infect	PROPN
dti-1371	163	3	dis	dis	PROPN
dti-1371	163	4	.	.	PUNCT
dti-1371	164	1	aug	aug	PROPN
dti-1371	164	2	1	1	NUM
dti-1371	164	3	,	,	PUNCT
dti-1371	164	4	2009;49(3):454–62	2009;49(3):454–62	NUM
dti-1371	164	5	.	.	NOUN
dti-1371	164	6	3	3	X
dti-1371	164	7	.	.	X
dti-1371	164	8	pasternak	pasternak	PROPN
dti-1371	164	9	ao	ao	PROPN
dti-1371	164	10	,	,	PUNCT
dti-1371	164	11	adema	adema	PROPN
dti-1371	164	12	kw	kw	PROPN
dti-1371	164	13	,	,	PUNCT
dti-1371	164	14	bakker	bakker	PROPN
dti-1371	164	15	m	m	PROPN
dti-1371	164	16	,	,	PUNCT
dti-1371	164	17	jurriaans	jurriaans	PROPN
dti-1371	164	18	s	s	PROPN
dti-1371	164	19	,	,	PUNCT
dti-1371	164	20	berkhout	berkhout	PROPN
dti-1371	164	21	b	b	PROPN
dti-1371	164	22	,	,	PUNCT
dti-1371	164	23	cornelissen	cornelissen	NOUN
dti-1371	164	24	m.	m.	NOUN
dti-1371	164	25	highly	highly	ADV
dti-1371	164	26	sensitive	sensitive	ADJ
dti-1371	164	27	methods	method	NOUN
dti-1371	164	28	based	base	VERB
dti-1371	164	29	on	on	ADP
dti-1371	164	30	seminested	semineste	VERB
dti-1371	164	31	real	real	ADJ
dti-1371	164	32	-	-	PUNCT
dti-1371	164	33	time	time	NOUN
dti-1371	164	34	reverse	reverse	ADJ
dti-1371	164	35	transcription	transcription	NOUN
dti-1371	164	36	-	-	PUNCT
dti-1371	164	37	pcr	pcr	NOUN
dti-1371	164	38	for	for	ADP
dti-1371	164	39	quantitation	quantitation	NOUN
dti-1371	164	40	of	of	ADP
dti-1371	164	41	human	human	ADJ
dti-1371	164	42	immunodeficiency	immunodeficiency	NOUN
dti-1371	164	43	virus	virus	NOUN
dti-1371	164	44	type	type	NOUN
dti-1371	164	45	1	1	NUM
dti-1371	164	46	unspliced	unspliced	ADJ
dti-1371	164	47	and	and	CCONJ
dti-1371	164	48	multiply	multiply	ADV
dti-1371	164	49	spliced	splice	VERB
dti-1371	164	50	rna	rna	NOUN
dti-1371	164	51	and	and	CCONJ
dti-1371	164	52	proviral	proviral	PROPN
dti-1371	164	53	dna	dna	PROPN
dti-1371	164	54	.	.	PUNCT
dti-1371	165	1	j	j	PROPN
dti-1371	165	2	clin	clin	PROPN
dti-1371	165	3	microbiol	microbiol	PROPN
dti-1371	165	4	.	.	PUNCT
dti-1371	166	1	jul	jul	PROPN
dti-1371	166	2	2008;46(7):2206–11	2008;46(7):2206–11	PROPN
dti-1371	166	3	.	.	PUNCT
dti-1371	167	1	4	4	X
dti-1371	167	2	.	.	X
dti-1371	167	3	pinganaud	pinganaud	NOUN
dti-1371	167	4	c	c	NOUN
dti-1371	167	5	,	,	PUNCT
dti-1371	167	6	goujard	goujard	ADJ
dti-1371	167	7	c.	c.	PROPN
dti-1371	167	8	management	management	NOUN
dti-1371	167	9	of	of	ADP
dti-1371	167	10	antiretroviral	antiretroviral	ADJ
dti-1371	167	11	treatment	treatment	NOUN
dti-1371	167	12	in	in	ADP
dti-1371	167	13	hiv	hiv	PROPN
dti-1371	167	14	-	-	PUNCT
dti-1371	167	15	infected	infect	VERB
dti-1371	167	16	patients	patient	NOUN
dti-1371	167	17	exhibiting	exhibit	VERB
dti-1371	167	18	virologic	virologic	ADJ
dti-1371	167	19	failure	failure	NOUN
dti-1371	167	20	.	.	PUNCT
dti-1371	168	1	presse	presse	PROPN
dti-1371	168	2	med	med	PROPN
dti-1371	168	3	.	.	PUNCT
dti-1371	169	1	jun	jun	PROPN
dti-1371	169	2	22	22	NUM
dti-1371	169	3	,	,	PUNCT
dti-1371	169	4	2002;31(22):1034–40	2002;31(22):1034–40	NUM
dti-1371	169	5	.	.	PUNCT
dti-1371	170	1	5	5	NUM
dti-1371	170	2	.	.	X
dti-1371	170	3	gallant	gallant	PROPN
dti-1371	170	4	je	je	PROPN
dti-1371	170	5	.	.	PROPN
dti-1371	170	6	drug	drug	PROPN
dti-1371	170	7	resistance	resistance	NOUN
dti-1371	170	8	after	after	ADP
dti-1371	170	9	failure	failure	NOUN
dti-1371	170	10	of	of	ADP
dti-1371	170	11	initial	initial	ADJ
dti-1371	170	12	antiretroviral	antiretroviral	ADJ
dti-1371	170	13	therapy	therapy	NOUN
dti-1371	170	14	in	in	ADP
dti-1371	170	15	resource	resource	NOUN
dti-1371	170	16	-	-	PUNCT
dti-1371	170	17	limited	limit	VERB
dti-1371	170	18	countries	country	NOUN
dti-1371	170	19	.	.	PUNCT
dti-1371	171	1	clin	clin	PROPN
dti-1371	171	2	infect	infect	PROPN
dti-1371	171	3	dis	dis	PROPN
dti-1371	171	4	.	.	PUNCT
dti-1371	171	5	feb	feb	PROPN
dti-1371	171	6	1	1	NUM
dti-1371	171	7	,	,	PUNCT
dti-1371	171	8	2007;44(3):453–5	2007;44(3):453–5	NUM
dti-1371	171	9	.	.	PUNCT
dti-1371	172	1	6	6	NUM
dti-1371	172	2	.	.	X
dti-1371	172	3	turner	turner	PROPN
dti-1371	172	4	bj	bj	PROPN
dti-1371	172	5	,	,	PUNCT
dti-1371	172	6	hecht	hecht	PROPN
dti-1371	172	7	fm	fm	PROPN
dti-1371	172	8	,	,	PUNCT
dti-1371	172	9	ismail	ismail	PROPN
dti-1371	172	10	rb	rb	PROPN
dti-1371	172	11	.	.	PUNCT
dti-1371	173	1	cd4	cd4	PROPN
dti-1371	173	2	+	+	PROPN
dti-1371	173	3	t	t	PROPN
dti-1371	173	4	-	-	PUNCT
dti-1371	173	5	lymphocyte	lymphocyte	NOUN
dti-1371	173	6	measures	measure	NOUN
dti-1371	173	7	in	in	ADP
dti-1371	173	8	the	the	DET
dti-1371	173	9	treatment	treatment	NOUN
dti-1371	173	10	of	of	ADP
dti-1371	173	11	individuals	individual	NOUN
dti-1371	173	12	infected	infect	VERB
dti-1371	173	13	with	with	ADP
dti-1371	173	14	human	human	ADJ
dti-1371	173	15	immunodeficiency	immunodeficiency	NOUN
dti-1371	173	16	virus	virus	NOUN
dti-1371	173	17	type	type	NOUN
dti-1371	173	18	1	1	NUM
dti-1371	173	19	.	.	PUNCT
dti-1371	174	1	a	a	DET
dti-1371	174	2	review	review	NOUN
dti-1371	174	3	for	for	ADP
dti-1371	174	4	clinical	clinical	ADJ
dti-1371	174	5	practitioners	practitioner	NOUN
dti-1371	174	6	.	.	PUNCT
dti-1371	175	1	arch	arch	ADJ
dti-1371	175	2	intern	intern	PROPN
dti-1371	175	3	med	med	PROPN
dti-1371	175	4	.	.	PUNCT
dti-1371	176	1	jul	jul	PROPN
dti-1371	176	2	25	25	NUM
dti-1371	176	3	,	,	PUNCT
dti-1371	176	4	1994;154(14):1561–73	1994;154(14):1561–73	NUM
dti-1371	176	5	.	.	NOUN
dti-1371	176	6	7	7	NUM
dti-1371	176	7	.	.	X
dti-1371	176	8	cozzi	cozzi	NOUN
dti-1371	176	9	-	-	PUNCT
dti-1371	176	10	lepri	lepri	PROPN
dti-1371	176	11	a	a	NOUN
dti-1371	176	12	,	,	PUNCT
dti-1371	176	13	phillips	phillips	PROPN
dti-1371	176	14	an	an	PROPN
dti-1371	176	15	,	,	PUNCT
dti-1371	176	16	miller	miller	PROPN
dti-1371	176	17	v	v	PROPN
dti-1371	176	18	,	,	PUNCT
dti-1371	176	19	katlama	katlama	NOUN
dti-1371	176	20	c	c	NOUN
dti-1371	176	21	,	,	PUNCT
dti-1371	176	22	ledergerber	ledergerber	NOUN
dti-1371	176	23	b	b	PROPN
dti-1371	176	24	,	,	PUNCT
dti-1371	176	25	vella	vella	PROPN
dti-1371	176	26	s.	s.	PROPN
dti-1371	176	27	changes	change	VERB
dti-1371	176	28	in	in	ADP
dti-1371	176	29	viral	viral	ADJ
dti-1371	176	30	load	load	NOUN
dti-1371	176	31	in	in	ADP
dti-1371	176	32	people	people	NOUN
dti-1371	176	33	with	with	ADP
dti-1371	176	34	virological	virological	ADJ
dti-1371	176	35	failure	failure	NOUN
dti-1371	176	36	who	who	PRON
dti-1371	176	37	remain	remain	VERB
dti-1371	176	38	on	on	ADP
dti-1371	176	39	the	the	DET
dti-1371	176	40	same	same	ADJ
dti-1371	176	41	haart	haart	PROPN
dti-1371	176	42	regimen	regiman	NOUN
dti-1371	176	43	.	.	PUNCT
dti-1371	177	1	antivir	antivir	PROPN
dti-1371	177	2	ther	ther	PROPN
dti-1371	177	3	.	.	PUNCT
dti-1371	178	1	apr	apr	VERB
dti-1371	178	2	2003;8(2):127–36	2003;8(2):127–36	NUM
dti-1371	178	3	.	.	PUNCT
dti-1371	179	1	8	8	NUM
dti-1371	179	2	.	.	X
dti-1371	179	3	resino	resino	PROPN
dti-1371	179	4	s	s	PROPN
dti-1371	179	5	,	,	PUNCT
dti-1371	179	6	bellon	bellon	NOUN
dti-1371	179	7	jm	jm	PROPN
dti-1371	179	8	,	,	PUNCT
dti-1371	179	9	ramos	ramos	PROPN
dti-1371	179	10	jt	jt	PROPN
dti-1371	179	11	,	,	PUNCT
dti-1371	179	12	resino	resino	PROPN
dti-1371	179	13	r	r	PROPN
dti-1371	179	14	,	,	PUNCT
dti-1371	179	15	gurbindo	gurbindo	PROPN
dti-1371	179	16	md	md	PROPN
dti-1371	179	17	,	,	PUNCT
dti-1371	179	18	mellado	mellado	PROPN
dti-1371	179	19	mj	mj	PROPN
dti-1371	179	20	.	.	PROPN
dti-1371	179	21	impact	impact	NOUN
dti-1371	179	22	of	of	ADP
dti-1371	179	23	highly	highly	ADV
dti-1371	179	24	active	active	ADJ
dti-1371	179	25	antiretroviral	antiretroviral	ADJ
dti-1371	179	26	therapy	therapy	NOUN
dti-1371	179	27	on	on	ADP
dti-1371	179	28	cd4	cd4	PROPN
dti-1371	179	29	+	+	PROPN
dti-1371	179	30	t	t	NOUN
dti-1371	179	31	cells	cell	NOUN
dti-1371	179	32	and	and	CCONJ
dti-1371	179	33	viral	viral	ADJ
dti-1371	179	34	load	load	NOUN
dti-1371	179	35	of	of	ADP
dti-1371	179	36	children	child	NOUN
dti-1371	179	37	with	with	ADP
dti-1371	179	38	aids	aids	PROPN
dti-1371	179	39	:	:	PUNCT
dti-1371	179	40	a	a	DET
dti-1371	179	41	population	population	NOUN
dti-1371	179	42	-	-	PUNCT
dti-1371	179	43	based	base	VERB
dti-1371	179	44	study	study	NOUN
dti-1371	179	45	.	.	PUNCT
dti-1371	180	1	aids	aids	PROPN
dti-1371	180	2	res	re	NOUN
dti-1371	180	3	hum	hum	ADJ
dti-1371	180	4	retroviruses	retrovirus	NOUN
dti-1371	180	5	.	.	PUNCT
dti-1371	181	1	sep	sep	PROPN
dti-1371	181	2	2004;20(9):927–31	2004;20(9):927–31	NUM
dti-1371	181	3	.	.	PROPN
dti-1371	182	1	9	9	NUM
dti-1371	182	2	.	.	X
dti-1371	182	3	battegay	battegay	PROPN
dti-1371	182	4	m	m	PROPN
dti-1371	182	5	,	,	PUNCT
dti-1371	182	6	fehr	fehr	PROPN
dti-1371	182	7	j	j	PROPN
dti-1371	182	8	,	,	PUNCT
dti-1371	182	9	fluckiger	fluckiger	ADV
dti-1371	182	10	u	u	NOUN
dti-1371	182	11	,	,	PUNCT
dti-1371	182	12	elzi	elzi	PROPN
dti-1371	182	13	l.	l.	PROPN
dti-1371	182	14	antiretroviral	antiretroviral	ADJ
dti-1371	182	15	therapy	therapy	NOUN
dti-1371	182	16	of	of	ADP
dti-1371	182	17	late	late	ADJ
dti-1371	182	18	presenters	presenter	NOUN
dti-1371	182	19	with	with	ADP
dti-1371	182	20	advanced	advanced	ADJ
dti-1371	182	21	hiv	hiv	PROPN
dti-1371	182	22	disease	disease	NOUN
dti-1371	182	23	.	.	PUNCT
dti-1371	183	1	j	j	PROPN
dti-1371	183	2	antimicrob	antimicrob	PROPN
dti-1371	183	3	chemother	chemother	PROPN
dti-1371	183	4	.	.	PUNCT
dti-1371	184	1	jul	jul	PROPN
dti-1371	184	2	2008	2008	NUM
dti-1371	184	3	;	;	PUNCT
dti-1371	184	4	62(1):41–4	62(1):41–4	NOUN
dti-1371	184	5	.	.	PUNCT
dti-1371	185	1	10	10	NUM
dti-1371	185	2	.	.	PUNCT
dti-1371	186	1	melchior	melchior	PROPN
dti-1371	186	2	r	r	PROPN
dti-1371	186	3	,	,	PUNCT
dti-1371	186	4	nemes	nemes	PROPN
dti-1371	186	5	mi	mi	PROPN
dti-1371	186	6	,	,	PUNCT
dti-1371	186	7	alencar	alencar	PROPN
dti-1371	186	8	tm	tm	PROPN
dti-1371	186	9	,	,	PUNCT
dti-1371	186	10	buchalla	buchalla	PROPN
dti-1371	186	11	cm	cm	PROPN
dti-1371	186	12	.	.	PUNCT
dti-1371	187	1	challenges	challenge	NOUN
dti-1371	187	2	of	of	ADP
dti-1371	187	3	treatment	treatment	NOUN
dti-1371	187	4	adherence	adherence	NOUN
dti-1371	187	5	by	by	ADP
dti-1371	187	6	people	people	NOUN
dti-1371	187	7	living	live	VERB
dti-1371	187	8	with	with	ADP
dti-1371	187	9	hiv	hiv	PROPN
dti-1371	187	10	/	/	SYM
dti-1371	187	11	aids	aids	PROPN
dti-1371	187	12	in	in	ADP
dti-1371	187	13	brazil	brazil	PROPN
dti-1371	187	14	.	.	PUNCT
dti-1371	188	1	rev	rev	PROPN
dti-1371	188	2	saude	saude	PROPN
dti-1371	188	3	publica	publica	PROPN
dti-1371	188	4	.	.	PUNCT
dti-1371	189	1	dec	dec	PROPN
dti-1371	189	2	2007;41	2007;41	NUM
dti-1371	189	3	suppl	suppl	ADJ
dti-1371	189	4	2:87–93	2:87–93	NUM
dti-1371	189	5	.	.	PROPN
dti-1371	190	1	11	11	NUM
dti-1371	190	2	.	.	PUNCT
dti-1371	191	1	cdc	cdc	PROPN
dti-1371	191	2	revises	revise	VERB
dti-1371	191	3	hiv	hiv	PROPN
dti-1371	191	4	classification	classification	NOUN
dti-1371	191	5	system	system	NOUN
dti-1371	191	6	,	,	PUNCT
dti-1371	191	7	aids	aid	VERB
dti-1371	191	8	definition	definition	NOUN
dti-1371	191	9	.	.	PUNCT
dti-1371	192	1	w	w	PROPN
dti-1371	192	2	v	v	NUM
dti-1371	192	3	med	med	PROPN
dti-1371	192	4	j.	j.	PROPN
dti-1371	192	5	feb	feb	PROPN
dti-1371	192	6	1993;89(2):74	1993;89(2):74	PROPN
dti-1371	192	7	.	.	PROPN
dti-1371	192	8	12	12	NUM
dti-1371	192	9	.	.	PUNCT
dti-1371	193	1	brazil	brazil	PROPN
dti-1371	193	2	moh	moh	PROPN
dti-1371	193	3	,	,	PUNCT
dti-1371	193	4	secretariat	secretariat	NOUN
dti-1371	193	5	of	of	ADP
dti-1371	193	6	health	health	NOUN
dti-1371	193	7	surveillance	surveillance	NOUN
dti-1371	193	8	,	,	PUNCT
dti-1371	193	9	national	national	ADJ
dti-1371	193	10	std	std	NOUN
dti-1371	193	11	and	and	CCONJ
dti-1371	193	12	aids	aid	NOUN
dti-1371	193	13	.	.	PUNCT
dti-1371	194	1	recommendations	recommendation	NOUN
dti-1371	194	2	for	for	ADP
dti-1371	194	3	antiretroviral	antiretroviral	ADJ
dti-1371	194	4	therapy	therapy	NOUN
dti-1371	194	5	in	in	ADP
dti-1371	194	6	adults	adult	NOUN
dti-1371	194	7	and	and	CCONJ
dti-1371	194	8	adolescents	adolescent	NOUN
dti-1371	194	9	infected	infect	VERB
dti-1371	194	10	with	with	ADP
dti-1371	194	11	hiv	hiv	PROPN
dti-1371	194	12	.	.	PUNCT
dti-1371	194	13	2008	2008	NUM
dti-1371	194	14	.	.	PUNCT
dti-1371	195	1	available	available	ADJ
dti-1371	195	2	:	:	PUNCT
dti-1371	195	3	http://bvsms.saude.gov.br/bvs/	http://bvsms.saude.gov.br/bvs/	PROPN
dti-1371	195	4	publicacoes	publicacoe	VERB
dti-1371	195	5	/	/	SYM
dti-1371	195	6	recomendacao_terapia.pdf	recomendacao_terapia.pdf	NOUN
dti-1371	195	7	access	access	NOUN
dti-1371	195	8	:	:	PUNCT
dti-1371	195	9	28/05/2011	28/05/2011	NUM
dti-1371	195	10	.	.	NOUN
dti-1371	195	11	13	13	NUM
dti-1371	195	12	.	.	PUNCT
dti-1371	196	1	brazil	brazil	PROPN
dti-1371	196	2	mohssoh	mohssoh	PROPN
dti-1371	196	3	,	,	PUNCT
dti-1371	196	4	national	national	ADJ
dti-1371	196	5	std	std	X
dti-1371	196	6	aids	aids	PROPN
dti-1371	196	7	.	.	PUNCT
dti-1371	197	1	quick	quick	ADJ
dti-1371	197	2	reference	reference	NOUN
dti-1371	197	3	for	for	ADP
dti-1371	197	4	the	the	DET
dti-1371	197	5	arv	arv	NOUN
dti-1371	197	6	drug	drug	NOUN
dti-1371	197	7	dispensing	dispense	VERB
dti-1371	197	8	siclom	siclom	NOUN
dti-1371	197	9	.	.	PUNCT
dti-1371	198	1	2007	2007	NUM
dti-1371	198	2	.	.	PUNCT
dti-1371	199	1	available	available	ADJ
dti-1371	199	2	:	:	PUNCT
dti-1371	199	3	http://siclom.aids.gov.br	http://siclom.aids.gov.br	ADJ
dti-1371	199	4	access	access	NOUN
dti-1371	199	5	:	:	PUNCT
dti-1371	199	6	28.05.2011	28.05.2011	NUM
dti-1371	199	7	.	.	NOUN
dti-1371	199	8	14	14	NUM
dti-1371	199	9	.	.	PUNCT
dti-1371	200	1	brazil	brazil	PROPN
dti-1371	200	2	npfpacovh	npfpacovh	NOUN
dti-1371	200	3	.	.	PUNCT
dti-1371	201	1	national	national	ADJ
dti-1371	201	2	program	program	NOUN
dti-1371	201	3	for	for	ADP
dti-1371	201	4	prevention	prevention	NOUN
dti-1371	201	5	and	and	CCONJ
dti-1371	201	6	control	control	NOUN
dti-1371	201	7	of	of	ADP
dti-1371	201	8	viral	viral	ADJ
dti-1371	201	9	hepatitis	hepatitis	NOUN
dti-1371	201	10	.	.	PUNCT
dti-1371	202	1	2005	2005	NUM
dti-1371	202	2	.	.	PUNCT
dti-1371	203	1	national	national	ADJ
dti-1371	203	2	program	program	NOUN
dti-1371	203	3	for	for	ADP
dti-1371	203	4	prevention	prevention	NOUN
dti-1371	203	5	and	and	CCONJ
dti-1371	203	6	control	control	NOUN
dti-1371	203	7	of	of	ADP
dti-1371	203	8	viral	viral	ADJ
dti-1371	203	9	hepatitis	hepatitis	NOUN
dti-1371	203	10	http://bvsms.saude.gov.br/bvs/politicas/hepatites_aconselhamento.pdf	http://bvsms.saude.gov.br/bvs/politicas/hepatites_aconselhamento.pdf	NOUN
dti-1371	203	11	access	access	NOUN
dti-1371	203	12	:	:	PUNCT
dti-1371	203	13	28.05.2011	28.05.2011	NUM
dti-1371	203	14	.	.	NOUN
dti-1371	203	15	15	15	NUM
dti-1371	203	16	.	.	PUNCT
dti-1371	204	1	brazil	brazil	PROPN
dti-1371	204	2	moh	moh	PROPN
dti-1371	204	3	,	,	PUNCT
dti-1371	204	4	department	department	NOUN
dti-1371	204	5	of	of	ADP
dti-1371	204	6	health	health	NOUN
dti-1371	204	7	policy	policy	NOUN
dti-1371	204	8	,	,	PUNCT
dti-1371	204	9	department	department	NOUN
dti-1371	204	10	of	of	ADP
dti-1371	204	11	primary	primary	ADJ
dti-1371	204	12	care	care	NOUN
dti-1371	204	13	.	.	PUNCT
dti-1371	205	1	technical	technical	ADJ
dti-1371	205	2	manual	manual	NOUN
dti-1371	205	3	for	for	ADP
dti-1371	205	4	the	the	DET
dti-1371	205	5	control	control	NOUN
dti-1371	205	6	of	of	ADP
dti-1371	205	7	tuberculosis	tuberculosis	NOUN
dti-1371	205	8	.	.	PUNCT
dti-1371	206	1	2002	2002	NUM
dti-1371	206	2	.	.	PUNCT
dti-1371	207	1	available	available	ADJ
dti-1371	207	2	to	to	ADP
dti-1371	207	3	:	:	PUNCT
dti-1371	207	4	http://	http://	PROPN
dti-1371	207	5	bvsms.saude.gov.br/bvs/publicacoes/guia_controle_tuberculose.pdf	bvsms.saude.gov.br/bvs/publicacoes/guia_controle_tuberculose.pdf	PROPN
dti-1371	207	6	access	access	NOUN
dti-1371	207	7	:	:	PUNCT
dti-1371	207	8	28.05.2011	28.05.2011	NUM
dti-1371	207	9	.	.	NOUN
dti-1371	207	10	16	16	NUM
dti-1371	207	11	.	.	PUNCT
dti-1371	208	1	faucher	faucher	PROPN
dti-1371	208	2	jf	jf	PROPN
dti-1371	208	3	,	,	PUNCT
dti-1371	208	4	challier	challier	NOUN
dti-1371	208	5	b	b	NOUN
dti-1371	208	6	,	,	PUNCT
dti-1371	208	7	chirouze	chirouze	ADJ
dti-1371	208	8	c	c	NOUN
dti-1371	208	9	,	,	PUNCT
dti-1371	208	10	drobacheff	drobacheff	NOUN
dti-1371	208	11	c	c	NOUN
dti-1371	208	12	,	,	PUNCT
dti-1371	208	13	fischer	fischer	PROPN
dti-1371	208	14	p	p	PROPN
dti-1371	208	15	,	,	PUNCT
dti-1371	209	1	lang	lang	PROPN
dti-1371	209	2	jm	jm	PROPN
dti-1371	209	3	.	.	PROPN
dti-1371	209	4	predictive	predictive	ADJ
dti-1371	209	5	factors	factor	NOUN
dti-1371	209	6	of	of	ADP
dti-1371	209	7	virological	virological	ADJ
dti-1371	209	8	response	response	NOUN
dti-1371	209	9	to	to	ADP
dti-1371	209	10	primary	primary	ADJ
dti-1371	209	11	antiretroviral	antiretroviral	ADJ
dti-1371	209	12	treatment	treatment	NOUN
dti-1371	209	13	.	.	PUNCT
dti-1371	210	1	presse	presse	PROPN
dti-1371	210	2	med	med	PROPN
dti-1371	210	3	.	.	PUNCT
dti-1371	211	1	mar	mar	PROPN
dti-1371	211	2	13	13	NUM
dti-1371	211	3	,	,	PUNCT
dti-1371	211	4	2004;33(5):310–5	2004;33(5):310–5	NUM
dti-1371	211	5	.	.	PUNCT
dti-1371	211	6	17	17	NUM
dti-1371	211	7	.	.	PUNCT
dti-1371	212	1	johnson	johnson	PROPN
dti-1371	212	2	k	k	PROPN
dti-1371	212	3	,	,	PUNCT
dti-1371	212	4	way	way	NOUN
dti-1371	212	5	a.	a.	NOUN
dti-1371	212	6	risk	risk	NOUN
dti-1371	212	7	factors	factor	NOUN
dti-1371	212	8	for	for	ADP
dti-1371	212	9	hiv	hiv	PROPN
dti-1371	212	10	infection	infection	NOUN
dti-1371	212	11	in	in	ADP
dti-1371	212	12	a	a	DET
dti-1371	212	13	national	national	ADJ
dti-1371	212	14	adult	adult	NOUN
dti-1371	212	15	population	population	NOUN
dti-1371	212	16	:	:	PUNCT
dti-1371	212	17	evidence	evidence	NOUN
dti-1371	212	18	from	from	ADP
dti-1371	212	19	the	the	DET
dti-1371	212	20	2003	2003	NUM
dti-1371	212	21	kenya	kenya	PROPN
dti-1371	212	22	demographic	demographic	ADJ
dti-1371	212	23	and	and	CCONJ
dti-1371	212	24	health	health	NOUN
dti-1371	212	25	survey	survey	NOUN
dti-1371	212	26	.	.	PUNCT
dti-1371	213	1	j	j	PROPN
dti-1371	213	2	acquir	acquir	PROPN
dti-1371	213	3	immune	immune	VERB
dti-1371	213	4	defic	defic	ADJ
dti-1371	213	5	syndr	syndr	NOUN
dti-1371	213	6	.	.	PUNCT
dti-1371	214	1	aug	aug	PROPN
dti-1371	214	2	15	15	NUM
dti-1371	214	3	,	,	PUNCT
dti-1371	214	4	2006;42(5):627–36	2006;42(5):627–36	NUM
dti-1371	214	5	.	.	PROPN
dti-1371	214	6	18	18	NUM
dti-1371	214	7	.	.	PUNCT
dti-1371	214	8	cole	cole	PROPN
dti-1371	214	9	sr	sr	PROPN
dti-1371	214	10	,	,	PUNCT
dti-1371	214	11	hernan	hernan	PROPN
dti-1371	214	12	ma	ma	PROPN
dti-1371	214	13	,	,	PUNCT
dti-1371	214	14	anastos	anasto	VERB
dti-1371	214	15	k	k	PROPN
dti-1371	214	16	,	,	PUNCT
dti-1371	214	17	jamieson	jamieson	PROPN
dti-1371	214	18	bd	bd	PROPN
dti-1371	214	19	,	,	PUNCT
dti-1371	214	20	robins	robins	PROPN
dti-1371	214	21	jm	jm	PROPN
dti-1371	214	22	.	.	PROPN
dti-1371	215	1	determining	determine	VERB
dti-1371	215	2	the	the	DET
dti-1371	215	3	effect	effect	NOUN
dti-1371	215	4	of	of	ADP
dti-1371	215	5	highly	highly	ADV
dti-1371	215	6	active	active	ADJ
dti-1371	215	7	antiretroviral	antiretroviral	ADJ
dti-1371	215	8	therapy	therapy	NOUN
dti-1371	215	9	on	on	ADP
dti-1371	215	10	changes	change	NOUN
dti-1371	215	11	in	in	ADP
dti-1371	215	12	human	human	ADJ
dti-1371	215	13	immunodeficiency	immunodeficiency	NOUN
dti-1371	215	14	virus	virus	NOUN
dti-1371	215	15	type	type	NOUN
dti-1371	215	16	1	1	NUM
dti-1371	215	17	rna	rna	NOUN
dti-1371	215	18	viral	viral	ADJ
dti-1371	215	19	load	load	NOUN
dti-1371	215	20	using	use	VERB
dti-1371	215	21	a	a	DET
dti-1371	215	22	marginal	marginal	ADJ
dti-1371	215	23	structural	structural	ADJ
dti-1371	215	24	leftcensored	leftcensore	VERB
dti-1371	215	25	mean	mean	NOUN
dti-1371	215	26	model	model	NOUN
dti-1371	215	27	.	.	PUNCT
dti-1371	216	1	am	be	AUX
dti-1371	216	2	j	j	PROPN
dti-1371	216	3	epidemiol	epidemiol	PROPN
dti-1371	216	4	.	.	PUNCT
dti-1371	217	1	jul	jul	PROPN
dti-1371	217	2	15	15	NUM
dti-1371	217	3	,	,	PUNCT
dti-1371	217	4	2007;166(2):219–27	2007;166(2):219–27	NUM
dti-1371	217	5	.	.	NOUN
dti-1371	217	6	19	19	NUM
dti-1371	217	7	.	.	PUNCT
dti-1371	217	8	phillips	phillips	PROPN
dti-1371	217	9	an	an	PROPN
dti-1371	217	10	,	,	PUNCT
dti-1371	217	11	staszewski	staszewski	NOUN
dti-1371	217	12	s	s	PROPN
dti-1371	217	13	,	,	PUNCT
dti-1371	217	14	weber	weber	PROPN
dti-1371	217	15	r	r	PROPN
dti-1371	217	16	,	,	PUNCT
dti-1371	217	17	kirk	kirk	PROPN
dti-1371	217	18	o	o	PROPN
dti-1371	217	19	,	,	PUNCT
dti-1371	217	20	francioli	francioli	NOUN
dti-1371	217	21	p	p	NOUN
dti-1371	217	22	,	,	PUNCT
dti-1371	217	23	miller	miller	PROPN
dti-1371	217	24	v.	v.	ADP
dti-1371	217	25	hiv	hiv	PROPN
dti-1371	217	26	viral	viral	ADJ
dti-1371	217	27	load	load	NOUN
dti-1371	217	28	response	response	NOUN
dti-1371	217	29	to	to	ADP
dti-1371	217	30	antiretroviral	antiretroviral	ADJ
dti-1371	217	31	therapy	therapy	NOUN
dti-1371	217	32	according	accord	VERB
dti-1371	217	33	to	to	ADP
dti-1371	217	34	the	the	DET
dti-1371	217	35	baseline	baseline	NOUN
dti-1371	217	36	cd4	cd4	PROPN
dti-1371	217	37	cell	cell	NOUN
dti-1371	217	38	count	count	NOUN
dti-1371	217	39	and	and	CCONJ
dti-1371	217	40	viral	viral	ADJ
dti-1371	217	41	load	load	NOUN
dti-1371	217	42	.	.	PUNCT
dti-1371	218	1	jama	jama	PROPN
dti-1371	218	2	.	.	PUNCT
dti-1371	219	1	nov	nov	PROPN
dti-1371	219	2	28	28	NUM
dti-1371	219	3	,	,	PUNCT
dti-1371	219	4	2001;286(20):2560–7	2001;286(20):2560–7	NUM
dti-1371	219	5	.	.	PUNCT
dti-1371	219	6	20	20	NUM
dti-1371	219	7	.	.	PUNCT
dti-1371	219	8	asjo	asjo	PROPN
dti-1371	219	9	b	b	PROPN
dti-1371	219	10	,	,	PUNCT
dti-1371	219	11	langeland	langeland	NOUN
dti-1371	219	12	n.	n.	PROPN
dti-1371	219	13	drug	drug	PROPN
dti-1371	219	14	resistance	resistance	NOUN
dti-1371	219	15	in	in	ADP
dti-1371	219	16	hiv	hiv	PROPN
dti-1371	219	17	infection	infection	NOUN
dti-1371	219	18	.	.	PUNCT
dti-1371	220	1	tidsskr	tidsskr	NOUN
dti-1371	220	2	nor	nor	CCONJ
dti-1371	220	3	laegeforen	laegeforen	PROPN
dti-1371	220	4	.	.	PUNCT
dti-1371	221	1	nov	nov	PROPN
dti-1371	221	2	20	20	NUM
dti-1371	221	3	,	,	PUNCT
dti-1371	221	4	2008;128(22):2593–6	2008;128(22):2593–6	NUM
dti-1371	221	5	.	.	PUNCT
dti-1371	221	6	21	21	NUM
dti-1371	221	7	.	.	PUNCT
dti-1371	222	1	skowron	skowron	PROPN
dti-1371	222	2	g	g	PROPN
dti-1371	222	3	,	,	PUNCT
dti-1371	222	4	street	street	PROPN
dti-1371	222	5	jc	jc	PROPN
dti-1371	222	6	,	,	PUNCT
dti-1371	222	7	obee	obee	VERB
dti-1371	222	8	em	em	PRON
dti-1371	222	9	.	.	PUNCT
dti-1371	223	1	baseline	baseline	PROPN
dti-1371	223	2	cd4(+	cd4(+	NOUN
dti-1371	223	3	)	)	PUNCT
dti-1371	223	4	cell	cell	NOUN
dti-1371	223	5	count	count	NOUN
dti-1371	223	6	,	,	PUNCT
dti-1371	223	7	not	not	PART
dti-1371	223	8	viral	viral	ADJ
dti-1371	223	9	load	load	NOUN
dti-1371	223	10	,	,	PUNCT
dti-1371	223	11	correlates	correlate	VERB
dti-1371	223	12	with	with	ADP
dti-1371	223	13	virologic	virologic	ADJ
dti-1371	223	14	suppression	suppression	NOUN
dti-1371	223	15	induced	induce	VERB
dti-1371	223	16	by	by	ADP
dti-1371	223	17	potent	potent	ADJ
dti-1371	223	18	antiretroviral	antiretroviral	ADJ
dti-1371	223	19	therapy	therapy	NOUN
dti-1371	223	20	.	.	PUNCT
dti-1371	224	1	j	j	PROPN
dti-1371	224	2	acquir	acquir	PROPN
dti-1371	224	3	immune	immune	VERB
dti-1371	224	4	defic	defic	ADJ
dti-1371	224	5	syndr	syndr	NOUN
dti-1371	224	6	.	.	PUNCT
dti-1371	225	1	dec	dec	PROPN
dti-1371	225	2	1	1	NUM
dti-1371	225	3	,	,	PUNCT
dti-1371	225	4	2001;28(4):313–9	2001;28(4):313–9	NUM
dti-1371	225	5	.	.	PUNCT
dti-1371	226	1	22	22	NUM
dti-1371	226	2	.	.	PUNCT
dti-1371	227	1	piliero	piliero	PROPN
dti-1371	227	2	pj	pj	PROPN
dti-1371	227	3	.	.	PUNCT
dti-1371	228	1	early	early	ADJ
dti-1371	228	2	factors	factor	NOUN
dti-1371	228	3	in	in	ADP
dti-1371	228	4	successful	successful	ADJ
dti-1371	228	5	anti	anti	ADJ
dti-1371	228	6	-	-	ADJ
dti-1371	228	7	hiv	hiv	ADJ
dti-1371	228	8	treatment	treatment	NOUN
dti-1371	228	9	.	.	PUNCT
dti-1371	229	1	j	j	PROPN
dti-1371	229	2	int	int	PROPN
dti-1371	229	3	assoc	assoc	PROPN
dti-1371	229	4	physicians	physicians	PROPN
dti-1371	229	5	aids	aids	PROPN
dti-1371	229	6	care	care	PROPN
dti-1371	229	7	(	(	PUNCT
dti-1371	229	8	chic	chic	ADJ
dti-1371	229	9	ill	ill	ADJ
dti-1371	229	10	)	)	PUNCT
dti-1371	229	11	.	.	PUNCT
dti-1371	230	1	jan	jan	PROPN
dti-1371	230	2	–	–	PROPN
dti-1371	230	3	mar	mar	PROPN
dti-1371	230	4	2003;2(1):10–20	2003;2(1):10–20	NUM
dti-1371	230	5	.	.	PROPN
dti-1371	230	6	23	23	NUM
dti-1371	230	7	.	.	PUNCT
dti-1371	231	1	moreno	moreno	PROPN
dti-1371	231	2	cuerda	cuerda	PROPN
dti-1371	231	3	vj	vj	PROPN
dti-1371	231	4	,	,	PUNCT
dti-1371	231	5	rubio	rubio	PROPN
dti-1371	231	6	garcia	garcia	PROPN
dti-1371	231	7	r	r	PROPN
dti-1371	231	8	,	,	PUNCT
dti-1371	231	9	morales	morales	PROPN
dti-1371	231	10	conejo	conejo	PROPN
dti-1371	231	11	m.	m.	PROPN
dti-1371	231	12	new	new	ADJ
dti-1371	231	13	therapeutic	therapeutic	ADJ
dti-1371	231	14	options	option	NOUN
dti-1371	231	15	in	in	ADP
dti-1371	231	16	protracted	protract	VERB
dti-1371	231	17	hiv	hiv	PROPN
dti-1371	231	18	-	-	PUNCT
dti-1371	231	19	infected	infect	VERB
dti-1371	231	20	patients	patient	NOUN
dti-1371	231	21	with	with	ADP
dti-1371	231	22	virological	virological	ADJ
dti-1371	231	23	failure	failure	NOUN
dti-1371	231	24	.	.	PUNCT
dti-1371	232	1	med	med	PROPN
dti-1371	232	2	clin	clin	PROPN
dti-1371	232	3	(	(	PUNCT
dti-1371	232	4	barc	barc	PROPN
dti-1371	232	5	)	)	PUNCT
dti-1371	232	6	.	.	PUNCT
dti-1371	233	1	jan	jan	PROPN
dti-1371	233	2	26	26	NUM
dti-1371	233	3	,	,	PUNCT
dti-1371	233	4	2008;130(2):66–70	2008;130(2):66–70	NUM
dti-1371	233	5	.	.	NOUN
dti-1371	233	6	24	24	NUM
dti-1371	233	7	.	.	PUNCT
dti-1371	234	1	geretti	geretti	PROPN
dti-1371	234	2	am	am	PROPN
dti-1371	234	3	,	,	PUNCT
dti-1371	234	4	smith	smith	PROPN
dti-1371	234	5	c	c	PROPN
dti-1371	234	6	,	,	PUNCT
dti-1371	234	7	haberl	haberl	VERB
dti-1371	234	8	a	a	PRON
dti-1371	234	9	,	,	PUNCT
dti-1371	234	10	garcia	garcia	PROPN
dti-1371	234	11	-	-	PUNCT
dti-1371	234	12	diaz	diaz	PROPN
dti-1371	234	13	a	a	X
dti-1371	234	14	,	,	PUNCT
dti-1371	234	15	nebbia	nebbia	NOUN
dti-1371	234	16	g	g	PROPN
dti-1371	234	17	,	,	PUNCT
dti-1371	234	18	johnson	johnson	PROPN
dti-1371	234	19	m.	m.	NOUN
dti-1371	234	20	determinants	determinant	NOUN
dti-1371	234	21	of	of	ADP
dti-1371	234	22	virological	virological	ADJ
dti-1371	234	23	failure	failure	NOUN
dti-1371	234	24	after	after	ADP
dti-1371	234	25	successful	successful	ADJ
dti-1371	234	26	viral	viral	ADJ
dti-1371	234	27	load	load	NOUN
dti-1371	234	28	suppression	suppression	NOUN
dti-1371	234	29	in	in	ADP
dti-1371	234	30	first	first	ADJ
dti-1371	234	31	-	-	PUNCT
dti-1371	234	32	line	line	NOUN
dti-1371	234	33	highly	highly	ADV
dti-1371	234	34	active	active	ADJ
dti-1371	234	35	antiretroviral	antiretroviral	ADJ
dti-1371	234	36	therapy	therapy	NOUN
dti-1371	234	37	.	.	PUNCT
dti-1371	235	1	antivir	antivir	PROPN
dti-1371	235	2	ther	ther	ADV
dti-1371	235	3	.	.	PUNCT
dti-1371	236	1	2008;13(7	2008;13(7	NUM
dti-1371	236	2	):	):	PUNCT
dti-1371	236	3	927–36	927–36	NUM
dti-1371	236	4	.	.	PUNCT
dti-1371	237	1	25	25	NUM
dti-1371	237	2	.	.	PUNCT
dti-1371	238	1	bekker	bekker	PROPN
dti-1371	238	2	lg	lg	PROPN
dti-1371	238	3	,	,	PUNCT
dti-1371	238	4	orrell	orrell	ADJ
dti-1371	238	5	c	c	NOUN
dti-1371	238	6	,	,	PUNCT
dti-1371	238	7	reader	reader	PROPN
dti-1371	238	8	l	l	PROPN
dti-1371	238	9	,	,	PUNCT
dti-1371	238	10	matoti	matoti	PROPN
dti-1371	238	11	k	k	PROPN
dti-1371	238	12	,	,	PUNCT
dti-1371	238	13	cohen	cohen	PROPN
dti-1371	238	14	k	k	PROPN
dti-1371	238	15	,	,	PUNCT
dti-1371	238	16	martell	martell	PROPN
dti-1371	238	17	r.	r.	PROPN
dti-1371	238	18	antiretroviral	antiretroviral	PROPN
dti-1371	238	19	therapy	therapy	NOUN
dti-1371	238	20	in	in	ADP
dti-1371	238	21	a	a	DET
dti-1371	238	22	community	community	NOUN
dti-1371	238	23	clinic	clinic	NOUN
dti-1371	238	24	—	—	PUNCT
dti-1371	238	25	early	early	ADJ
dti-1371	238	26	lessons	lesson	NOUN
dti-1371	238	27	from	from	ADP
dti-1371	238	28	a	a	DET
dti-1371	238	29	pilot	pilot	NOUN
dti-1371	238	30	project	project	NOUN
dti-1371	238	31	.	.	PUNCT
dti-1371	239	1	s	s	PROPN
dti-1371	239	2	afr	afr	PROPN
dti-1371	239	3	med	med	PROPN
dti-1371	239	4	j.	j.	PROPN
dti-1371	239	5	jun	jun	PROPN
dti-1371	239	6	2003;93(6):458–62	2003;93(6):458–62	PROPN
dti-1371	239	7	.	.	PROPN
dti-1371	239	8	26	26	NUM
dti-1371	239	9	.	.	PUNCT
dti-1371	240	1	von	von	PROPN
dti-1371	240	2	reyn	reyn	PROPN
dti-1371	240	3	cf	cf	PROPN
dti-1371	240	4	,	,	PUNCT
dti-1371	240	5	kimambo	kimambo	PROPN
dti-1371	240	6	s	s	PROPN
dti-1371	240	7	,	,	PUNCT
dti-1371	240	8	mtei	mtei	NOUN
dti-1371	240	9	l	l	NOUN
dti-1371	240	10	,	,	PUNCT
dti-1371	240	11	et	et	PROPN
dti-1371	240	12	al	al	PROPN
dti-1371	240	13	.	.	PROPN
dti-1371	240	14	disseminated	disseminate	VERB
dti-1371	240	15	tuberculosis	tuberculosis	NOUN
dti-1371	240	16	in	in	ADP
dti-1371	240	17	human	human	ADJ
dti-1371	240	18	immunodeficiency	immunodeficiency	NOUN
dti-1371	240	19	virus	virus	NOUN
dti-1371	240	20	infection	infection	NOUN
dti-1371	240	21	:	:	PUNCT
dti-1371	240	22	ineffective	ineffective	ADJ
dti-1371	240	23	immunity	immunity	NOUN
dti-1371	240	24	,	,	PUNCT
dti-1371	240	25	polyclonal	polyclonal	ADJ
dti-1371	240	26	disease	disease	NOUN
dti-1371	240	27	and	and	CCONJ
dti-1371	240	28	high	high	ADJ
dti-1371	240	29	mortality	mortality	NOUN
dti-1371	240	30	.	.	PUNCT
dti-1371	241	1	int	int	PROPN
dti-1371	242	1	j	j	PROPN
dti-1371	242	2	tuberc	tuberc	PROPN
dti-1371	242	3	lung	lung	PROPN
dti-1371	242	4	dis	dis	PROPN
dti-1371	242	5	.	.	PUNCT
dti-1371	243	1	aug	aug	PROPN
dti-1371	243	2	2011;15(8):1087–92	2011;15(8):1087–92	PROPN
dti-1371	243	3	.	.	PUNCT
dti-1371	244	1	http://www.la-press.com	http://www.la-press.com	X
dti-1371	244	2	http://www.la-press.com	http://www.la-press.com	X
dti-1371	245	1	http://bvsms.saude.gov.br/bvs/publicacoes/recomendacao_terapia.pdf	http://bvsms.saude.gov.br/bvs/publicacoes/recomendacao_terapia.pdf	X
dti-1371	246	1	http://bvsms.saude.gov.br/bvs/publicacoes/recomendacao_terapia.pdf	http://bvsms.saude.gov.br/bvs/publicacoes/recomendacao_terapia.pdf	PROPN
dti-1371	246	2	http://siclom.aids.gov.br	http://siclom.aids.gov.br	VERB
dti-1371	246	3	http://bvsms.saude.gov.br/bvs/politicas/hepatites_aconselhamento.pdf	http://bvsms.saude.gov.br/bvs/politicas/hepatites_aconselhamento.pdf	NOUN
dti-1371	246	4	http://bvsms.saude.gov.br/bvs/publicacoes/guia_controle_tuberculose.pdf	http://bvsms.saude.gov.br/bvs/publicacoes/guia_controle_tuberculose.pdf	NOUN
dti-1371	246	5	http://bvsms.saude.gov.br/bvs/publicacoes/guia_controle_tuberculose.pdf	http://bvsms.saude.gov.br/bvs/publicacoes/guia_controle_tuberculose.pdf	NOUN